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ABSTRACT 
Part of the success of Mycobacterium tuberculosis lies in its ability to thrive inside macrophages, 
where it is exposed to strong antimicrobials molecules, such as reactive oxygen species (ROS). 
However, the role of defense mechanisms against ROS in M. tuberculosis pathogenesis remains 
unclear. We used, for the first time, a functional genomic approach to investigate M. tuberculosis 
responses against ROS. By screening a transposon mutant library we identified a high number of 
mutants, with increased susceptibility to H2O2, in genes related to cell envelope functions, including 
mmpL9. This revealed the importance of M. tuberculosis cell envelope against oxidative stress. 
However, we have also identified genes implicated in other kind of defense mechanism against 
ROS, such as moaD1. Infection of human macrophages has shown that both mmpL9 and moaD1 
have a role in M. tuberculosis intracellular lifestyle, and previous studies suggested the same for 
several other genes identified during our screening. Therefore, these represent potential virulence 
factors useful for the development of future anti-tuberculosis strategies.  
DNA repair, recombination and replication (3R) are important mechanisms in maintaining genome 
stability by repairing DNA damages, such as those induced by ROS, however, variations on 3R genes 
potentially increase genomic variability, due to an increase in mutation rates. Thus, analysis of 
polymorphisms in 3R genes could indicate which strains are more prone to adapt and evolve. We 
have analyzed polymorphisms in 3R genes in a collection of strains of a successful family of M. 
tuberculosis strains, the Beijing/W family. Specific 3R polymorphisms were found to characterize 
particular groups of Beijing/W strains for which a phylogeny was constructed. Certain groups were 
found to be predominant, suggesting that strains of these genotypes might have some selective 
advantage. Therefore, particular 3R SNPs may define pathogenic features that have contributed to 
the evolution of the Beijing/W family.  
 
 
Keywords: Mycobacterium tuberculosis, Reactive oxygen species, macrophage, DNA repair 
recombination and replication, The Beijing/W family, Polymorphisms 
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RESUMO 
Mycobacterium tuberculosis, a bactéria responsável pela tuberculose, infecta cerca de 1/3 da 
população mundial e é responsável pela morte de aproximadamente 1,5 milhões de pessoas por 
ano. Estes números podem ser explicados, em parte, pela capacidade desta bactéria persistir no 
interior de macrófagos, num ambiente extremamente agressivo, no qual é exposta a diferentes 
moléculas antimicrobianas tais como as espécies reactivas de oxigénio. Estas, sendo altamente 
reativas, causam danos em todo o tipo de moléculas incluindo lípidos, proteínas e DNA. Desta 
forma, os mecanismos de defesa utilizados pelo M. tuberculosis contra as espécies reativas de 
oxigénio são sem dúvida importantes para este, porém, o seu papel na virulência e patogénese 
desta bactéria ainda é pouco claro.  
O trabalho desenvolvido nesta tese consistiu na investigação dos mecanismos de defesa 
utilizados pelo M. tuberculosis contra as espécies reactivas de oxigénio. Com este objectivo, 
realizou-se pela primeira vez, um screening de uma biblioteca de mutantes construída por  
transposição, na estirpe clinica da família Beijing/W - GC1237, de forma a selecionar mutantes 
sensíveis a espécies reativas de oxigénio. A análise de cerca de 6000 mutantes permitiu a selecção 
de 18, sensíveis a peróxido de hidrogénio, para os quais a amplificação e posterior sequenciação do 
sítio de inserção do transposão levaram à identificação de 11 genes. Verificou-se que grande parte 
dos genes apresenta funções associadas ao invólucro celular bacteriano, o que revela que o 
invólucro do M. tuberculosis representa a primeira barreira de defesa contra as espécies reactivas 
de oxigénio nesta bactéria. O gene mmpL9 foi um dos identificados, cuja proteína se encontra 
possivelmente envolvida no transporte de lípidos para o invólucro celular. Curiosamente, três 
mutantes com diferentes mutações neste gene foram seleccionados. Identificaram-se também 
alguns genes envolvidos noutro tipo de mecanismos tais como, moaD1, envolvido na síntese do 
cofactor molibdénio. 
Uma vez que o M. tuberculosis tem de fazer face às espécies reativas de oxigénio no interior de 
macrófagos, o passo seguinte consistiu em analisar o fenótipo de alguns destes mutantes nestas 
células. Para o efeito, macrófagos humanos foram infectados com um dos mutantes no gene 
mmpL9 ou com o mutante no gene moaD1, uma vez que estudos anteriores demonstraram o papel 
de diferentes MmpLs na virulência desta bactéria e que outros genes envolvidos na síntese do 
cofactor molibdénio são importantes para a sobrevivência do M. tuberculosis no interior de 
macrófagos. Em ambos os casos observou-se uma diminuição na capacidade de crescimento destas 
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estirpes no interior destas células, em comparação com a estirpe selvagem. A complementação 
destas estirpes mutantes restaurou o fenótipo da estirpe selvagem, o que demonstra o papel 
destes genes no crescimento de M. tuberculosis em macrófagos humanos. Porém, a 
complementação restaurou apenas parcialmente a sensibilidade destes mutantes às espécies 
reactivas de oxigénio in vitro, em comparação com a estirpe selvagem. No entanto, mmpL9 e 
moaD1 deverão ter um papel na resposta às espécies reativas de oxigénio em M. tuberculosis, caso 
contrário, a complementação não teria restaurado de todo o fenótipo selvagem, nas condições 
referidas.   
A comparação da sequência do gene mmpL9 da nossa estirpe selvagem, GC1237, com a estirpe 
de referência laboratorial, H37Rv, revelou a presença de uma deleção de um nucleótido na posição 
218. Contudo, os nossos resultados obtidos a partir da infecção de macrófagos com o mutante 
mmpL9 e com a mesma estirpe após complementação da mutação sugerem que o gene mmpL9 
deverá ser expresso apesar desta deleção. É possível que ocorra uma reniniação da tradução a 
partir de um codão de iniciação situado a montante da deleção, na posição 258, no gene mmpL9. 
Para além disso, a complementação do nosso mutante mmpL9 com o respectivo gene da estirpe 
H37Rv, restaurou apenas parcialmente o fenótipo da estirpe selvagem, GC1237, durante a infecção 
de macrófagos. Estas observações sugerem que a proteína MmpL9 na estirpe GC1237 poderá ser 
diferente da existente na estirpe H37Rv. A análise da sequência de todos os genes mmpL existentes 
no genoma de M. tuberculosis, numa coleção de estirpes que representam diferentes famílias, 
sugeriu que a deleção identificada poderá realmente ter um efeito na proteína. Verificou-se ainda 
que esta deleção é aparentemente específica para todas as estirpes modernas da família Beijing. 
Isto indica que a deleção do nucleótido 218 poderá ter conferido alguma vantagem selectiva a 
estas estirpes que contribuiu para a sua evolução.    
Para além de moaD1 e mmpL9, alguns dos outros genes identificados durante o screening como 
importantes para a resposta de M. tuberculosis às espécies reativas de oxigénio, foram igualmente 
descritos, em estudos anteriores, como importantes para a capacidade desta bactéria sobreviver 
intracelularmente. Isto indica uma correlação entre sensibilidade ao stress oxidativo e capacidade 
de sobreviver ou replicar-se no interior de macrófagos. No entanto, a infecção de macrófagos 
tratados com inibidores da NADPH oxidase, a enzima que produz as espécies reativas de oxigénio 
nestas células, com os mutantes nos genes mmpL9 e moaD1, não permitiu confirmar esta hipótese. 
É possível que estes mutantes sejam sensíveis a outras moléculas antimicrobianas encontradas no 
interior do macrófago, tais como as espécies reativas de azoto, que, em conjunto com as espécies 
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reativas de oxigénio, são responsáveis pelo crescimento atenuado observado em macrófagos. Em 
conclusão, este trabalho permitiu a identificação de genes envolvidos na defesa do M. tuberculosis 
contra as espécies reactivas de oxigénio, os quais aparentam ter igualmente um papel na 
sobrevivência desta bactéria nas suas células hospedeiras, os macrófagos. Estes genes representam 
potenciais factores de virulência que poderão ser úteis para o desenvolvimento de futuros 
antibióticos ou vacinas. 
Numa segunda parte desta tese, realizou-se uma análise dos polimorfismos existentes em genes 
de reparação, recombinação e replicação (3R) de DNA numa família específica de estirpes de M. 
tuberculosis, a família Beijing. Os mecanismos de reparação, recombinação e replicação são 
extremamente importantes na manutenção da estabilidade genómica, através da reparação de 
danos causados no DNA, tais como os induzidos pelas espécies reativas de oxigénio. Por outro lado, 
estes mecanismos podem ser igualmente responsáveis pela introdução de variabilidade genética. 
Polimorfismos nos genes que codificam para as proteínas envolvidas nestes mecanismos poderão 
induzir um aumento na taxa de mutação, e consequentemente, a acumulação de mutações 
vantajosas para as estirpes, como por exemplo, mutações responsáveis pela resistência a 
antibióticos. Deste modo, a análise de polimorfismos nos genes 3R poderá indicar que estirpes 
estão mais predispostas a adaptar-se ou evoluir. A família Beijing é uma família de M. tuberculosis 
que apresenta uma maior virulência e que tem sido identificada um pouco por todo o mundo como 
estando frequentemente associada a resistência a antibióticos. Deste modo, analisaram-se 
polimorfismos em genes 3R numa coleção de estirpes Beijing, isoladas em várias partes do mundo. 
Diferentes polimorfismos foram identificados que permitiram a discriminação de vários grupos, 
para os quais foi construída uma árvore filogenética. Estes resultados foram congruentes com os 
resultados obtidos utilizando outros marcadores genéticos, o que significa que as mesmas 
associações filogenéticas foram obtidas, para a colecção de estirpes utilizada neste estudo, usando 
polimorfismos nos genes 3R ou outro tipo de marcadores genéticos.  
Uma grande percentagem das estirpes foi agrupada num dos grupos, Bmyc10, que incluiu 
estirpes isoladas em diferentes partes do mundo. Um estudo anterior demonstrou que estirpes 
com características genéticas que definem as deste grupo são igualmente predominantes numa 
outra região geográfica, não representada no nosso estudo. Em conjunto, estes resultados 
sugerem que o genótipo das estirpes do grupo Bmyc10 poderá ter-lhes conferido alguma 
vantagem selectiva que permitiu a sua evolução. Isto é igualmente sugerido num estudo anterior, 
no qual a caracterização do efeito da mutação no gene mutT2, que caracteriza todas as estirpes do 
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grupo Bmyc10, indica que esta induz uma alteração na função da proteína que pode ser vantajosa 
para as estirpes que a possuem. Portanto, alguns dos polimorfismos identificados no nosso estudo 
poderão ter um efeito na função das respectivas proteínas, o que significa que este tipo de análise 
é importante para compreender o significado dos mesmos.   
Em conclusão, a análise de polimorfismos em genes 3R demonstrou que diferentes grupos 
podem ser identificados na família Beijing caracterizados por polimorfismos específicos. Estes 
podem ter conferido alguma vantagem que permitiu a expansão de certos grupos e contribuiu para 
a evolução desta família. A análise da variabilidade genética entre estirpes é importante uma vez 
que estas podem reflectir diferenças patogénicas. Este estudo poderá contribuir para aprofundar 
os nossos conhecimentos acerca dos mecanismos que determinam o êxito das estirpes da família 
Beijing. 
 
 
Palavras-Chave: Mycobacterium tuberculosis; Espécies reactivas de oxigénio; Macrófago; 
Reparação, recombinação e replicação de ADN; Família Beijing; Polimorfismos 
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NTF   Noise Transfer Function  
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PDIM   Phthiocerol Dimycocerosate 
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PPRs   Pattern Recognition Receptors  
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RD   Region of Difference  
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TMM   Trehalose Monomycolate  
Trx   Thioredoxin  
UV   Ultraviolet 
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3 Introduction 
 Tuberculosis an ancient disease 1.1
Tuberculosis (TB) is an ancient disease. Skeletal abnormalities, typical of TB, were found in 
Egyptian mummies, dated of several thousand years ago, and DNA analyses have later confirmed 
the presence of the disease-causing pathogen Mycobacterium tuberculosis. At this time TB was 
probably sporadic, but, as population densities increased, the disease reached epidemic 
proportions in Europe and North America in the 18th and 19th centuries (Daniel, 2006). 
The development of a live attenuated vaccine, Bacillus Calmette-Guérin (BCG), by Albert 
Calmette and Camille – Guérin in 1921, and the discovery of the first antibiotic against TB, 
streptomycin, by Selman Waksman in 1943, led to the opinion that appropriate control measures 
had become available for fighting TB. Between 1950 and 1965 TB-control programs were 
established. However, these initiatives have had limited success in developing countries. In 
industrialized countries there was a pronounced reduction of infection and death rates. 
Consequently, TB programs became a lower priority because the disease was considered close to 
elimination. In the early 1980s, cases of TB began to raise due to factors such as increases in prison 
and homeless populations, intravenous drug use and especially Human Immunodeficiency 
Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS) epidemics. By 1993 increasing TB could no 
longer be ignored so the World Health Organization (WHO) declared the disease a global 
emergency (Daniel, 2006) (Harries and Dye, 2006). In 2000, the World Health assembly endorsed 
the establishment of a Global Partnership to Stop TB with several priorities for the next 50 years 
(WHO at www.who.int/topic/tuberculosis/en/).  
 
 TB today’s major issues  1.2
Despite the efforts to combat the disease, TB remains today a major public-health problem. 
Every 15 seconds someone dies from TB, which means that about 1.5 million people die each year 
from this treatable disease. The current TB epidemic is being sustained and fuelled by two 
important factors: the HIV infection, and its association with active TB disease, and increasing 
resistance of M. tuberculosis strains to anti-TB drugs (WHO at 
www.who.int/topic/tuberculosis/en/).  
Despite the availability of an effective antibiotherapy for decades, tuberculosis control has been 
seriously challenged due to the appearance of drug-resistant strains. Drug resistance in M. 
tuberculosis arises mainly from spontaneous mutations in the chromosome (Heym et al., 1994), 
and not from mobile genetic elements such as plasmids or transposons, acquired by horizontal 
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gene transfer, as observed in other bacteria. Then, irregular drug supply, inappropriate prescription 
and poor patient adherence to treatment allow selection of strains carrying drug-resistance 
mutations. These strains can be transmitted and other mutations involved in resistance to 
individual drugs can be accumulated resulting in the appearance of multidrug-resistant (MDR) 
strains, defined as resistant to at least rifampin and isoniazid, the most effective first-line anti-TB 
drugs (WHO at www.who.int/topic/tuberculosis/en/). The WHO estimates that there were 290 000 
MDR-TB cases among notified TB cases in 2010 (Figure 1). The estimated number of prevalent 
MDR-TB cases seems to reach 650 000 among the 12 million total prevalent cases of TB (WHO, 
2011). The number of extensively-drug resistant strains (XDR), defined as MDR plus resistance to 
any fluoroquinolone and to one of the three injectable second line drugs (capreomycin, kanamycin, 
or amikacin), has been increasing every year, and, by the end of 2010, 77 countries had reported at 
least one case of XDR TB to WHO (WHO at http://www.who.int/tb/challenges/mdr/en/index.html). 
More recently, the appearance of totally drug-resistant tuberculosis (TDR), resistant to all 
antituberculosis drugs, seriously threatens TB control (Velayati et al., 2009).  
 
 
 
 
 
 
 
 
 
 
 
Figure 1 - Estimated MDR-TB cases among notified TB patients in 2010. From WHO at 
http://www.who.int/tb/challenges/mdr/en/index.html. 
 
More than one in ten TB cases occur among HIV-infected people, and almost one in four deaths 
among people with HIV is due to TB. In 2010 350 000 people died of HIV-associated TB (WHO, 
2011)(WHO at http://www.who.int/tb/publications/TBHIV_Facts_for_2011.pdf). In fact, 
immunodeficiency caused by HIV infection greatly increases susceptibility to infection and the risk 
of developing TB, which is 21-34 times higher in HIV co-infected individuals than in non-infected 
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0-300 
301-3,000 
3,001-30,000 
30,001-60,000 
>60,000 
  
5 Introduction 
(WHO, 2011). On the other hand, TB may accelerate the course of HIV infection, increasing the viral 
load in some patients (Day et al., 2004; Whalen et al., 1995). In addition to contribute to an 
increase in TB burden in general, HIV might also be contributing to the increase of MDR-TB 
prevalence (Wells et al., 2007). Co-infection of TB in HIV patients further complicates treatment 
because it has to be combined with antiretroviral therapy. This leads to an increased pill burden, 
drug-drug interactions that may lead to suboptimal concentrations of anti-TB drugs, and finally 
overlapping side effects (Swaminathan et al., 2010; Wells et al., 2007). Moreover, TB patients co-
infected with HIV are more likely to progress to disease, and thus potentially accelerate the 
propagation and spread of these MDR strains (Gandhi et al., 2010). The intersection of drug-
resistance and HIV epidemics might represent a lethal combination and further threaten TB 
control. 
The development of an effective vaccine against TB could also have a significant impact in the 
control of the disease. The only available vaccine today is BCG, a live vaccine derived from an 
attenuated Mycobacterium bovis strain, obtained after serial passages (Calmette, 1931). It has 
been used since 1921, yet, it has given little contribution to contain the current TB pandemic. It is 
effective in protection against disseminated TB in children, like meningitis and miliary TB (Trunz et 
al., 2006), but, it seems to have variable efficacy against adult pulmonary TB – the most prevalent 
form of disease – being particularly limited in endemic areas (Colditz et al., 1994; Fine, 1995). TB 
vaccine research has made huge progress and as a result twelve vaccine candidates have been 
developed and entered clinical trials (Kaufmann, 2011). Nevertheless, we do not know with 
certainty whether they will confer robust protection against TB in humans.  
Finally, enormous progress has been made in the last decade resulting in the appearance of 
much promising tools for diagnosing TB (Palomino, 2012). Still, no tests are available that are 
universally applicable to all patients including HIV-coinfected people and children with TB, for 
which diagnosis is usually more difficult. Additionally, an important gap in this field is the 
development of tools to determine progression to disease in people infected with M. tuberculosis 
without active disease (latent TB). This would be extremely important given that one-third of the 
world’s population seem to be latently infected with M. tuberculosis (WHO at 
www.who.int/topic/tuberculosis/en/). 
Although the number of incident cases has decreased substantially during the last twenty-years, 
Portugal has still an elevated rate of TB incidence, being the highest among western European 
countries ((WHO, 2011) - Annex 3).  There is also a high prevalence of MDR-TB and alarming rates 
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of XDR-TB, particularly in the Lisbon Health Region (Direcção Geral de Saúde (DGS) at 
http://www.dgs.pt/upload/membro.id/ficheiros/i012626.pdf) (Perdigao et al., 2008).  
 The genus Mycobacterium  1.3
The first notion that TB could be an infectious disease was described by Benjamin Martens in 
1790, followed by Jean-Antoine Villemin who demonstrated, in 1865, the transmissible and 
infectious nature of TB in animals (Daniel, 2006). However, it was Robert Koch, in 1882, who first 
described the tubercle bacillus, M. tuberculosis (Koch, 1882; Koch, 1982). Nevertheless, the 
identification of mycobacteria, however, occurred earlier with the discovery of the leprosy bacillus 
in 1873 (Hansen, 1874(Mange, 1992).  
Mycobacteria are aerobic non-motile rod-shaped actinobacteria with a high G+C content in their 
DNA (61-71%). These bacteria are characterized by an unusual cell envelope composed by mycolic 
acids with long branched chains (60 to 90 carbons), which confer alcohol and acid-fast staining 
properties (Levy-Frebault and Portaels, 1992; Shinnick and Good, 1994). Along with 
Corynebacterium and Nocardia, they form a well-defined sub-group (CMN) of actinobacteria, which 
share properties such as the production of mycolic acids (Embley and Stackebrandt, 1994; Ventura 
et al., 2007). Other mycolic acid-containing genera include Gordonia, Rhodococcus, Tsukamurella 
and Dietzia among others (Gurtler et al., 2004) being thus considered to be closely related to 
mycobacteria.  
The genus Mycobacterium is highly diverse and comprises more than 100 species (Dworkin et 
al., 2006). It can be divided into two major groups’ – fast and slow growers, a traditional division 
was found to be congruent by 16S rRNA analyses (Stahl and Urbance, 1990). This definition is based 
on the time required for visible colonies to appear on a solid medium, after plating suspensions 
diluted enough to give well separated colonies (Shinnick and Good, 1994):  
I. Fast growers (colonies in less than seven days) – usually non-pathogenic mycobacteria 
and free-living saprophytes that include M. smegmatis, commonly used as a non-
pathogenic model in the laboratory, to study essentially genetics or physiology of 
mycobacteria (O'Toole, 2010). An exception would be M. abssecus, a fast grower that is 
pathogenic.  
II. Slow growers (colonies in more than seven days) – usually associated with human or 
animal disease and include important pathogens such as M. leprae, M. ulcerans, and M. 
tuberculosis complex members. There are, however, slow growers that are not 
pathogenic, such as M. gordonae. 
  
7 Introduction 
1.3.1 The Mycobacterium tuberculosis complex 
The M. tuberculosis complex includes several closely related species, responsible for 
tuberculosis, with different phenotypic properties and host preferences. M. tuberculosis and M. 
africanum are almost exclusively human pathogens. M. microti causes disease in voles and M. 
pinnipedii causes TB in seals and sea lions. M. caprae infects both goats and deer and, finally, M. 
bovis has the largest host range although it can be mainly isolated from cattle (Brosch et al., 2002; 
Mostowy et al., 2005; Smith et al., 2006). Some very rare isolates of tubercle bacilli, with the ability 
to cause disease in humans, were found to belong to the same phylogenetic lineage as M. 
tuberculosis complex members as shown by 16sRNA analyses (van Soolingen et al., 1997). These 
bacteria, referred to as M. canetti, have shown unusual smooth colony morphology, in contrast to 
the rough colonies produced by the other M. tuberculosis complex members.  
 
1.3.2 Mycobacterial cell envelope 
Mycobacteria possess a remarkably complex cell envelope consisting of three principal layers: 
the cytoplasmic membrane, the cell wall core and an outer membrane (Figure 2). Cell walls are 
constituted by a peptidoglycan – arabinogalactan polymer core with covalently bound mycolic 
acids (the mycolyl-AG-peptidoglycan complex) that, along with non-covalently bound, extractable 
lipids, form an outermost bilayer structure (Hoffmann et al., 2008; Zuber et al., 2008). Thus, 
despite the classification of mycobacteria as Gram-positive bacteria it seems that the 
mycobacterial cell envelope contains an outer membrane containing pore-forming proteins 
(Niederweis et al., 2010), and, by inference, a periplasmic space (Hoffmann et al., 2008; Zuber et 
al., 2008) (Figure 2).  This complex structure represents a permeability barrier that contributes to 
the intrinsic resistance of mycobacteria to antibiotics, dehydration and chemical damage (Brennan 
and Nikaido, 1995; Nguyen and Thompson, 2006). An outer layer (also called capsule) surrounding 
the outer membrane (Figure 2), mainly composed of polysaccharides, proteins and only minor 
amounts of lipids (Ortalo-Magne et al., 1995), also seems to exist in various mycobacterial species 
(Sani et al., 2010). Most of these compounds were found released in the culture fluids of in vitro-
grown bacteria but seem to coat intracellularly grown bacteria (Daffe and Draper, 1998). 
Numerous extractable lipids are present in mycobacterial cell walls, being many of these 
suspected to be present in the outermembrane. However, their exact arrangement and 
distribution remains poorly understood. These include: phthiocerol dimycocerosate (PDIM), a 
major lipid of the cell wall, important for virulence, architecture and permeability (Camacho et al., 
1999; Cox et al., 1999); phenolic glycolipids (PGLs), that share a common lipid core with PDIMs and 
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are also associated with virulence, but are produced by only a few groups of M. tuberculosis (Reed 
et al., 2004; Tsenova et al., 2005); as well as glycolipids such as diacyltrehaloses (DAT), 
triacyltrehaloses (TAT), sulfatides (SLs), and the mycolic acid derivatives trehalose monomycolate 
(TMM) and trehalose dimycolate (TDM) (also known as cord factor) (Kaur et al., 2009).  
Other important molecules in the mycobacterial cell envelope are mannosylated molecules such 
as lipoarabinomannan (LAM), the related lipomannan (LM), and phosphatidyl-myo-inositol 
mannosides (PIMs) (Kaur et al., 2009), that seem to be anchored not only to the outer membrane 
but also to the cytoplasmic membrane (Pitarque et al., 2008) (Figure 2). In M. tuberculosis and 
other pathogenic mycobacteria LAM is mannose-capped (ManLAM) (Brennan and Nikaido, 1995).   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 – Mycobacterial cell envelope constitution. LAM: lipoarabinomannan, PIMs: phosphatidyl-myo-
inositol mannosides, TDM: trehalose dimycolate, TMM: trehalose monomycolate. Adapted from Catalão et al. 
(2012), with authors’ permission. (Catalao et al., 2012) 
 
As most of these molecules are the first to contact with host cellular constituents, the 
importance of these in facilitating host cell entry and modulating the host cell response has been 
well documented (discussed in more detail in section 1.5.1).  
A large proportion of the M. tuberculosis genome is devoted to fatty acid and lipid metabolism 
(Cole et al., 1998). The colocalization of some mmpL (mycobacterial membrane protein Large) 
genes with genes involved in polyketide biosynthesis (pks) and lipid metabolism suggested that 
MmpLs are generally involved in lipid synthesis and/or transport (Tekaia et al., 1999). This was 
found to be indeed the case for MmpL7 (Camacho et al., 2001; Cox et al., 1999) as well as MmpL8 
(Converse et al., 2003; Domenech et al., 2004), involved in the transport of PDIM and SL-1, 
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respectively. However, certain MmpLs do not colocalize with genes involved in lipid synthesis (Cole 
et al., 1998) and it seems that MmpL substrate specificity is dictated, in part, by their interaction 
with particular cytosolic enzymes (Jain and Cox, 2005). 
 
 Molecular evolution of mycobacteria 1.4
It is important to investigate diversity of bacterial pathogens for both epidemiological, to 
elucidate prevalence of strains, and biological reasons, because specific strains or groups of strains 
(lineages/families) might have specific relevant phenotypes (e.g. differences in virulence or drug 
susceptibility).  
M. tuberculosis complex members are genetically extremely closely related when compared to 
other bacteria, being thus considered as monomorphic (Achtman, 2008). Therefore, some of the 
genotyping tools applied to other pathogens can be uninformative in M. tuberculosis (Achtman, 
2008). For example, early attempts at using multilocus sequence typing (MLST) to study strain 
diversity in M. tuberculosis complex have shown that these bacteria are characterized by more 
than 99.9% similarity at the DNA level and identical 16S rRNA sequences (Sreevatsan et al., 1997). 
Despite this apparent genetic homogeneity, M. tuberculosis complex members display diverse 
phenotypic characteristics and host ranges and several polymorphic molecular genetic markers 
(Figure 3) have proved to be useful to identify and discriminate M. tuberculosis complex isolates. 
 
1.4.1 Molecular genetic markers that define M. tuberculosis complex genetic diversity 
One of the most widely applied molecular methods to type M. tuberculosis strains has been the 
IS6110 Restriction Fragment Length Polymorphism (RFLP) typing. Individual strains vary in the 
number of copies and in the sites into which IS6110 is inserted. A method using a restriction 
enzyme has been developed and IS6110 Southern blots of the digested DNA separated by 
electrophoresis on agarose gels provide a RFLP pattern (van Embden et al., 1993). Unfortunately, 
this method has some limitations and disadvantages such as poor discrimination between isolates 
with low copy numbers (<5) of IS6110 and it is even absent from certain strains. In addition, it is a 
technically demanding and expensive technique and requires high amounts of DNA (Kato-Maeda et 
al., 2011). This has led to the development of other techniques, frequently based in amplification 
of DNA, being spacer oligonucleotide typing (Spoligotyping) and variable number of tandem repeat 
(VNTR) typing (Frothingham and Meeker-O'Connell, 1998) the most frequently used.  
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Figure 3 - Representation of M. tuberculosis genome of the H37Rv reference strain, indicating the major 
genetic markers used for strain genotyping. As an example one specific mycobacterial interspersed repetitive 
unit (MIRU) locus, insertion sequence (IS6110), large sequence polymorphism (region of difference - RD) and 
single nucleotide polymorphism are shown. Adapted from Nicol et al. (2008). (Nicol and Wilkinson, 2008) 
 
Spoligotyping involves PCR amplification of the DR locus, a single region of M. tuberculosis 
complex strains chromosome that contains multiple copies of a 36-bp direct repeat, separated by a 
DNA spacer with various sequences (Kamerbeek et al., 1997). Strains have the same overall 
arrangement of spacers but differ in terms of presence or absence of specific spacers. Comparison 
with the 43 spacers identified in M. tuberculosis H37Rv, the laboratory reference strain, and M. 
bovis BCG, allows discrimination and classification of strains (Van Soolingen, 2001). Forty-one 
VNTRs of the mycobacterial interspersed repetitive units (MIRUs) have been identified in M. 
tuberculosis genome (Supply et al., 2000). PCR amplification of each locus will reflect the number 
of copies of the repeat unit and is the basis of VNTR typing. Several number and combinations of 
loci have been used to genotype M. tuberculosis strains which might have similar or higher 
discriminatory power than IS6110-RFLP and may also vary according to certain characteristics of 
the sample that is being analyzed, such as geographic origin. Thus, the set of loci might have to be 
adapted to the type of collection of isolates to analyze. Nevertheless, MIRU-VNTR is considered by 
some authors as the gold standard for M. tuberculosis genotyping (Kato-Maeda et al., 2011).  These 
methods are, however, not reliable for evolutionary and phylogenetic studies (Comas et al., 2009) 
because intragenomic recombination events could occur independently at the level of repetitive 
sequences (Achtman, 2008).  
Recently, systematic comparative genomic analyses have identified Single Nucleotide 
Polymorphisms (SNPs) and Large Sequence Polymorphisms (LSPs) as robust markers that generate 
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portable and comparable data for studying population variation. This kind of markers have been 
especially used to infer phylogenetic relations in M. tuberculosis (Baker et al., 2004; Dos Vultos et 
al., 2008; Filliol et al., 2002; Fleischmann et al., 2002; Gagneux et al., 2006a; Gutacker et al., 2006; 
Gutacker et al., 2002; Hershberg et al., 2008). LSPs correspond to genomic deletions that have 
been suggested as an important mechanism for genetic variation in M. tuberculosis. Affected 
sequences might have functional relevance in pathogenesis and immunity since deleted sequences 
can include putative open reading frames as well as intergenic regions and housekeeping genes 
(Alland et al., 2007). LSPs may be informative markers for discrimination of strains and have been, 
therefore, proposed for genotyping and, as these are irreversible mutations, have also been used 
for constructing phylogenies and to investigate M. tuberculosis complex evolution (Alland et al., 
2007; Brosch et al., 2002; Gagneux et al., 2006a; Tsolaki et al., 2005). SNPs also contribute to strain 
variability and may have a functional effect. For example, drug-resistance is mainly caused by SNPs 
in M. tuberculosis (Zhang and Yew, 2009). SNPs have also proved to be useful markers to 
differentiate strains and to study the phylogenetic relatedness of M. tuberculosis strains (Dos 
Vultos et al., 2008; Hershberg et al., 2008). A high number of such polymorphisms can be identified 
by performing whole-genome sequencing which can be extremely informative, particularly for 
genetically monomorphic bacteria like M. tuberculosis (Achtman, 2008).  
Choosing the appropriate genetic marker will depend on the purpose of the study. For 
epidemiologic analyses it is important to have markers with a high discriminatory power that 
change relatively rapidly, but, are stable enough to make connections between related isolates. For 
example, recognition of the regional specificity of circulating M. tuberculosis strains in Portugal 
dates back to 1999 when early RFLP-IS6110 genotyping studies of an MDR cluster in the Lisbon 
Health Region identified a prominent family, designated family Lisboa (Portugal et al., 1999). In 
subsequent years RFLP-IS6110 and 12 loci MIRU–VNTR genotyping identified clusters of circulating 
strains with similar genotypic characteristics (Perdigao et al., 2008; Perdigao et al., 2011), several of 
which, including the Lisboa family, were associated with XDR–TB. The results show that active 
transmission of MDR- and XDR-TB is taking place and that the high prevalence of observed XDR-TB 
is due to the continued transmission of particular genetic clusters such as the Lisboa family, 
identified in 1999 as strongly associated with MDR-TB (Portugal et al., 1999) and now associated 
with XDR-TB (Perdigao et al., 2008; Perdigao et al., 2011).  
To define phylogenetic associations unambiguously, genetic markers, need to be unique and, 
ideally, irreversible. Robust phylogenetic markers will exhibit low rates of convergent evolution 
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(Kato-Maeda et al., 2011) providing solid phylogenetic frameworks in which specific strains can be 
positioned and biologically meaningful groups defined.  
 
1.4.2 Phylogeny of the M. tuberculosis complex 
Although many molecular methods, such as the referred in the previous section, have been 
used to categorize M. tuberculosis complex strains, the phylogenetic relationships among this 
group have only recently started to be detailed. Analyses of genomic deletions (LSPs) have shown 
that the animal-adapted organisms of the M. tuberculosis complex are part of the same 
evolutionary lineage, defined by deletion of region of difference (RD) 9 (Brosch et al., 2002). 
Furthermore, M. bovis, which was initially thought to cause disease in a variety of animals, can be 
divided in different subspecies characterized by additional specific deletions, which include M. 
caprae, M. microti and M. pinnipedii (Brosch et al., 2002; Mostowy et al., 2005). It was suggested 
that the M. tuberculosis complex consists of distinct and genetically defined groups with specific 
host-adapted groups called ecotypes (Smith et al., 2006). M. africanum shares the RD9 deletion 
with these animal-adapted members of the M. tuberculosis complex which has led to the 
speculation that it is not primarily adapted to humans but has an animal reservoir (Smith et al., 
2006). However, this remains to be confirmed and meanwhile, given that M. africanum clearly 
infects and transmits among humans being responsible for up to 40% of human TB in west Africa 
(de Jong et al., 2006; Kallenius et al., 1999), it is considered as human-adapted. The same analysis 
of genomic regions also showed that M. canetti had almost all the RD regions intact (Brosch et al., 
2002). Although these strains share the same 16S rRNA sequence with M. tuberculosis complex 
members as referred previously, they present high levels of nucleotide variation in housekeeping 
genes and clear evidence of horizontal gene transfer (Gutierrez et al., 2005). This suggests that M. 
canetti strains are relatives of a highly diverse progenitor of the M. tuberculosis complex, M. 
prototuberculosis, that might have underwent an extreme bottleneck in a relatively recent past. 
Consequently, much of the original diversity disappeared leaving only M. canetti strains among the 
M. tuberculosis complex members (Gutierrez et al., 2005). 
Other studies have defined the phylogeny of M. tuberculosis and M. africanum, the human-
adapted species of the M. tuberculosis complex. Gagneux et al. (2006) also used LSPs to describe 
six major lineages, two of which included M. africanum. Each lineage seems to be associated with 
particular human populations (Figure 4). Several studies have used SNPs for the same purpose. 
Baker et al. (2004) analysed polymorphisms in seven housekeeping genes identifying 36 
synonymous SNPs (sSNPs) that allowed discrimination of 4 main lineages in M. tuberculosis. These 
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four main lineages correspond to the same identified after by Gagneux et al. (2006) using LSPs 
(Figure 4).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4 – M. tuberculosis phylogeography. Current major lineage assignments (lineage 1 to 6) are indicated 
by coloured lines. (a) Tree originated from the study of Baker et al. (2004) based on 36 synonymous SNPs 
identified by sequencing seven housekeeping genes in a collection of 225 strains. Roman designations correspond 
to lineage assignments in the study. (b) Tree based on large sequence polymorphisms (LSPs) discovered by 
Gagneux et al. (2006). (c) Association of M. tuberculosis lineages with specific geographic regions according to 
data from Gagneux et al. (2006) and Filliol et al. (2006). Adapted from Achtman et al. (2008). (Filliol et al., 2006; 
Gutacker et al., 2006) 
Gutacker et al. (2006) have screened 5069 isolates for 36 sSNPs that have been identified by 
comparison of two M. tuberculosis genomes and defined nine main lineages. Three of these 
lineages corresponded to the ones described by Gagneux et al. (2006) and Baker et al. (2004). Filliol 
et al. (2006) have used a similar approach to identify 159 sSNPs and screened 219 isolates of M. 
tuberculosis and M. bovis. Ten major groups were identified, one of them being specific to M. bovis 
and three corresponding to the same previously described (Baker et al., 2004; Gagneux et al., 
2006a). These studies have identified thus, four main M. tuberculosis lineages and two M. 
africanum lineages, associated with particular geographic locations (Figure 4).  
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The fact that both LSP and SNP-based analyses of large strain collections resulted in single trees 
without homoplasy indicated that horizontal gene transfer is extremely rare in M. tuberculosis 
complex and it has a highly clonal population structure (Supply et al., 2003).  
Although these studies have provided a picture of M. tuberculosis and M. africanum evolution, 
some limitations didn’t allow a better elucidation. The number of SNPs was either too limited 
(Baker et al., 2004) or resulted from comparison of a limited number of genomes which can lead to 
branch collapsing (Filliol et al., 2006; Gutacker et al., 2006) and biased phylogenies. As for the 
phylogeny inferred from LSPs (Gagneux et al., 2006a), genetic distances based on genomic 
deletions are difficult to interpret. In conclusion, genotyping approaches that rely on LSPs or a 
limited numbers of sSNPs can define deep phylogenetic population structures, but they are still 
characterized by low discriminatory power.  
More recently, two studies have contributed to a better knowledge of M. tuberculosis evolution 
by overcoming the limitations of the previous studies (Dos Vultos et al., 2008; Hershberg et al., 
2008), providing a more detailed picture of M. tuberculosis phylogeny. These studies reveal that 
the human-adapted members of M. tuberculosis complex are much more genetically diverse than 
generally recognized and some of this genetic diversity is likely to have functional consequences 
(Hershberg et al., 2008). The genetic diversity found among the human-adapted members of M. 
tuberculosis complex was just as pronounced as that among animal-adapted strains, even though 
the latter are adapted to distinct animal host species (Hershberg et al., 2008).  In the study of 
Vultos et al. (2008) a specific group of genes was analysed: genes involved in DNA repair, 
recombination and replication (3R) genes. In M. tuberculosis the main source of genetic variation 
should arise from random mutations, although it was recently suggested that recent recombination 
might also occur in M. tuberculosis (Namouchi et al., 2012). Defective 3R systems can potentially 
increase genomic variability due to higher mutation rates (Denamur and Matic, 2006; Tonjum and 
Seeberg, 2001). Thus, polymorphisms in 3R genes seems to be an important mechanism in 
evolution and adaptation of microorganisms (Taddei et al., 1997; Tonjum and Seeberg, 2001) as 
strains with higher mutation rates (mutators) may, under certain conditions, have a selective 
advantage. Analysis of polymorphisms in such genes in a collection of strains representative of 
global M. tuberculosis complex diversity has identified high levels of polymorphisms, suggesting 
that these genes may have a role in M. tuberculosis complex evolution (Dos Vultos et al., 2008). In 
2010, Comas et al. (2010) used 21 whole genome sequences to generate the first whole genome – 
based phylogeny of human-adapted M. tuberculosis, and confirmed the existence of six main 
phylogenetic lineages. More recently whole genome analysis of M. tuberculosis complex strains 
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from major lineages has also confirmed previous phylogenetic analysis using finished and partial 
genome data (Namouchi et al., 2012). It was also shown that purifying selection is acting on M. 
tuberculosis genetic diversity (Namouchi et al., 2012), in contrast to what has been previously 
suggested (Hershberg et al., 2008).(Comas et al., 2010) 
There is increasing evidence that the observed M. tuberculosis strain variation is biologically 
significant and that specific genotypes are associated with specific phenotypes. Indeed, different 
M. tuberculosis genotypes show differences in terms of virulence and pathogenesis in animal 
models (Lopez et al., 2003; Palanisamy et al., 2009) as well as survival and transcriptional profiles 
within macrophages (Homolka et al., 2010).  Although this genetic diversity seems to influence 
clinical presentation of the disease in humans (Caws et al., 2008; Thwaites et al., 2008) this is still 
not so clear (Coscolla and Gagneux, 2010) as several factors have a role in the development of TB. 
One of the most studied M. tuberculosis genotypes due to its association with increased virulence, 
as well as other characteristics that suggest that these strains have a selective advantage and are 
more adapted than strains from other genotypes, is the Beijing/W family (East-Asian lineage 
according to Gagneux et al. (2006)).   
 
1.4.3 The Beijing/W family 
The Beijing family was first described in 1995.  A large proportion of M. tuberculosis strains in 
the Beijing area of China had highly similar multi-banded IS6110 RFLP patterns and identical 
spoligotyping patterns (van Soolingen et al., 1995). In the second half of the 1990’s the multidrug 
resistant M. tuberculosis strain identified in New York, “W” strain (Bifani et al., 1996),  was 
recognized as a member of the Beijing genotype family which became the Beijing/W family (Bifani 
et al., 2002; Kurepina et al., 1998). Since then, the Beijing/W genotype was found to be the most 
frequently observed genotype of M. tuberculosis to cause disease globally (Glynn et al., 2002). 
According to the fourth international spoligotyping database, strains from this genotype were 
found to be present in the largest number of countries globally and represented 13% of global 
isolates (Brudey et al., 2006). In some regions including Russia, Bangladesh, South Africa, and 
Western Europe, the incidence of Beijing/W strains seems even to be increasing (Tuberculosis, 
2006). This contrasts to what seems to happen with other genotypes that appear to be 
predominantly restricted to defined geographical regions, and suggests that Beijing/W strains 
might have some selective advantage that have allowed their global spread.  
When compared to other genotypes, Beijing/W strains were found to grow significantly faster in 
human macrophages (Li et al., 2002; Theus et al., 2004) and have shown increased virulence in 
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different animal models of infection (Lopez et al., 2003; Tsenova et al., 2005). However, it is not 
possible to conclusively demonstrate an association between the Beijing/W strain genotype and 
clinical presentation in humans (Coscolla and Gagneux, 2010; Parwati et al., 2010). In addition, 
Beijing/W strains are often associated with drug-resistance (Tuberculosis, 2006).  
Beijing/W strains share several genetic characteristics (Bifani et al., 2002) which differentiate 
them from other all M. tuberculosis genotypes, including: a spoligotyping pattern containing at 
least three of the nine spacers, 35 to 43, with an absence of hybridization to spacers 1 to 34, which 
classically define and identify Beijing/W strains (Kremer et al., 2004); similar IS6110 RFLP patterns 
(15-26 copies); IS6110 insertion between dnaA and dnaN genes encoding DNA replication proteins 
and insertion of variable numbers of IS6110 in the noise transfer function (NTF) chromosomal 
region (Kurepina et al., 1998) that define typical/modern (one or several IS6110 insertions) and 
atypical/ancient (no IS6110 insertions) Beijing/W strains (Mokrousov et al., 2006). VNTR typing has 
been the most frequently used marker to discriminate Beijing/W strains. However, special 
consideration is given to VNTR typing of Beijing/W isolates once the standardized set of 15 or 24 
loci used to type M. tuberculosis strains are not always sufficient to discriminate among Beijing/W 
isolates (Iwamoto et al., 2007). In addition VNTR loci might have different discriminatory powers 
among Beijing/W strains depending on strain collection characteristics such as geographical origin 
(Kremer et al., 2005).  
By comparative whole-genome hybridization of Beijing/W strains Tsolaki et al. (2005) have 
shown that there are LSPs associated with this family. These correspond to genomic regions 
variably deleted in Beijing/W strains in relation to M. tuberculosis H37Rv (RDs). RD105, RD181, 
RD150, RD142, were found to, not only define but also subdivide this family into four different 
subgroups (Tsolaki et al., 2005) that might be associated with different phenotypes. Hanekom et al. 
(2007) have shown that the Beijing/W family can be divided into seven different lineages and that, 
by analysis of epidemiological data, differences between these lineages in their ability to spread 
and cause disease might exist. Thus, even closely related strains from the same lineage can 
accumulate genomic diversity, which can lead to different pathogenic properties. Indeed, an earlier 
study has shown that not all Beijing/W strains are hypervirulent in mice (Dormans et al., 2004). In 
subsequent studies this difference among Beijing/W strains was shown in different animal models 
(Aguilar et al., 2010; Palanisamy et al., 2009) as well as in human macrophages (Theus et al., 2007). 
A very recent study has shown, in guinea pigs, that the LSP-defined Beijing/W sublineages have 
indeed differences in pathogenicity (Kato-Maeda et al., 2012).  
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Several studies have focused on the possible mechanisms underlying the success of Beijing/W 
strains. However, the results reflect, most of the times, this genetic variability observed among 
Beijing/W strains. For example, the increased virulence observed for Beijing/W strains was initially 
associated with the production of a polyketide synthase derived PGL (Tsenova et al., 2005). 
However, it was shown later that PGL could be a virulence factor only for a fraction of Beijing/W 
strains (Reed et al., 2007), not explaining the success of the entire family. It was shown though that 
all Beijing/W strains tested, representing all LSPs-defined Beijing/W sublineages (Tsolaki et al., 
2005), accumulated large quantities of another kind of fatty acids, triacylglycerides associated with 
constitutive overexpression of the dormancy  regulon (DosR)(Reed et al., 2007), a transcriptional 
program that is utilized by the bacterium to adapt for survival during periods of nonreplicating 
persistence in vitro and it has been proposed to be associated with survival of the bacillus during 
latent TB infection (Voskuil et al., 2003). Some authors believed that BCG vaccination is a risk factor 
for developing TB in populations infected with Beijing/W strains and might even be a selective 
force favoring the spread of Beijing/W strains (Abebe and Bjune, 2006). One epidemiological study 
suggested that this association can be found in certain specific group of Beijing/W strains, 
however, most epidemiological studies did not find a higher proportion of Beijing/W strains among 
BCG-vaccinated individuals (Kremer et al., 2009).  
Even though many studies have focused on this subject, the mechanisms responsible for the 
apparent global success of Beijing/W strains remain unclear.  Therefore, it is important to continue 
to investigate genetic diversity of M. tuberculosis strains even among strains from the same 
subgroup/family, because these might be responsible for the phenotypic variability observed, and 
could explain the emergence of specific groups of strains. 
   
 M. tuberculosis infection 1.5
M. tuberculosis infects approximately one third of the world’s population. However, only 5 to 
10% of these infected individuals will develop symptomatic disease at some point in their lives 
(WHO at www.who.int/topic/tuberculosis/en/). In most cases (90-95%) the pathogen is contained, 
but not eliminated, by the immune response mounted by the host (Kaufmann and McMichael, 
2005). This is called latent infection – when a person is infected but is asymptomatic.  
The mechanisms that determine progression to disease are not well understood but seem to be 
determined by environmental and socio-economic factors (e.g. exposure to environmental 
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mycobacteria, overcrowding), host factors (e.g. malnutrition, genetic predisposition) as well as 
mycobacterial factors (e.g. genetic variation of mycobacterium) (Comas and Gagneux, 2009).  
Pulmonary infection due to the interaction of the bacillus with host immune cells results in the 
formation of a granuloma (Flynn et al., 2011), the typical pathologic hallmark of TB. This structure 
provides the conditions for the bacillus to grow, and the immunologic environment, in which cells 
with antimycobacterial functions interact to prevent and control dissemination of infection. 
However, this structure does not always avoid progression into disease. Therefore, understanding 
the molecular mechanisms occurring inside granulomas, that are likely to contribute to host 
protection as well as disease progression, is essential to better understand TB infection. 
1.5.1 Recognition of M. tuberculosis and initiation of immune response 
Infection starts after inhalation of aerosols containing small numbers of bacilli that have been 
expulsed to the air by an infected individual. Once, bacteria reach the lung alveoli  these are taken 
up by phagocytes, primarily resident alveolar macrophages, although dendritic cells (DCs) can also 
be infected (Kaufmann and McMichael, 2005) (Figure 5). Interaction with these innate immune 
cells is the first line of host defense against pathogens. M. tuberculosis initial interactions with host 
cells are greatly mediated by pattern recognition receptors (PPRs), such as Toll-like receptors (TLRs) 
and C-type lectins. These receptors recognize microbial determinants and bridge innate and 
adaptive immune responses by regulating pro- and anti-inflammatory cytokine production as well 
as endosomal and phagosomal traffic.  
TLRs play a critical role in the recognition of several pathogens (Akira et al., 2006). In M. 
tuberculosis one of the most important TLRs identified so far is TLR2 (Ferwerda et al., 2005) that 
recognizes mycobacterial structures expressed at the surface of the bacteria such as LAM and PIM, 
as well as the 19 kDa lipoprotein (Ryffel et al., 2005). The role of TLRs in controlling M. tuberculosis 
in mice remains, however, controversial (Drennan et al., 2004; Reiling et al., 2002; Sugawara et al., 
2003). Nonetheless, polymorphisms in TLR2 have been associated with increased susceptibility to 
TB in humans, suggesting that these receptors do have an important role in human host defense 
against mycobacteria (Velez et al., 2010).  
TLRs signals result in the activation of nuclear transcription factor (NF)-kB and, consequently, 
the transcription of genes producing pro-inflammatory cytokines, chemokines, as well as nitric 
oxide (Ryffel et al., 2005). TLR2 was also found to be essential for M. tuberculosis-induced reactive 
oxygen species (ROS) production (Yang et al., 2009). In addition, TLR-dependent ROS were found to 
be important signaling molecules and priming factors in the upregulation of early inflammatory 
responses during TB Infection (Lee et al., 2009a; Shin et al., 2008; Yang et al., 2008). However, it 
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has been shown that either expression of early secreted antigenic target protein 6 (ESAT-6), a 
secreted antigen of M. tuberculosis associated with lower innate immune responses to infection, or 
a peptide derived from it, is able to attenuate TLR signalling (Pathak et al., 2007). TLRs might have 
thus a dual role during M. tuberculosis infection.  
TLRs are strongly implicated in the induction of cytokines and chemokines, but they are not 
strongly linked to phagocytosis (Underhill, 2007). Phagocytosis of M. tuberculosis by human 
macrophages occurs primarily via the mannose receptor (MR) (Schlesinger, 1993), a C-type lectin, 
expressed in high levels by alveolar macrophages (Stephenson and Shepherd, 1987). M. 
tuberculosis ManLAM recognition through these receptors seems to inhibit production of the pro-
inflammatory cytokine IL-12 (Nigou et al., 2001). Furthermore, it was shown that M. tuberculosis 
association with these receptors are also implicated in inhibition of phagosome fusion with 
lysosomes in primary human macrophages (Kang et al., 2005; Torrelles et al., 2006), a key 
mechanism for M. tuberculosis evasion of host immune responses (discussed in more detail in 
section 1.6.1). Therefore, M. tuberculosis interaction with MRs inhibits the phagocytic response 
and induces and anti-inflammatory response, favouring bacteria’s infection. Phagocytosis of 
pathogens can also be mediated by opsonins, host factors such as immunoglobulin that attach to 
the surface of the pathogen, acquiring a conformation that is recognized by phagocytic receptors. 
Fcγ receptors that bind to the Fc portion of immunoglobulins, are responsible for opsonized 
phagocytosis of mycobacteria leading to phagolysosomal fusion (Armstrong and Hart, 1975). Until 
recently there were not studies about the relevance of such receptors during infection with M. 
tuberculosis in vivo probably due to the prevailing view that humoral immunity has little or no role 
in defence against this pathogen. Maglione et al. (2008) have shown that this kind of receptors are 
important for M. tuberculosis recognition and host defence, as a mice lacking this receptor had 
enhanced susceptibility and immunopathology to infection, associated with increased production 
of immunosuppressive cytokines.  (Maglione et al., 2008) 
Another C-type lectin described as important to bind M. tuberculosis in dendritic cells is DC-
SIGN (dendritic cell-specific intercellular adhesion molecule-3 grabbing nonintegrin) that also 
recognizes ManLAM and other ligands in mycobacterial cell envelope (Tailleux et al., 2003). 
Interestingly, DC-SIGN is also expressed by alveolar macrophages in tuberculosis patients (Tailleux 
et al., 2005) suggesting an important role for this molecule during TB in humans. Even though 
different studies about SNPs in the promoter region of DC-SIGN gene CD209 have shown 
contradictory results (Barreiro et al., 2006; Vannberg et al., 2008), a role for DC-SIGN in protection 
against infection by M. tuberculosis seems to be the case. Mycobacteria recognized by SIGNR3, a 
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DC-SIGN homologue in mice, expressing phagocytes induced key inflammatory cytokines, including 
TNF-α (Tanne et al., 2009) as well as phagolysosome fusion in contrast to MR receptors also 
recognizing ManLAM (Kang et al., 2005). However, a previous study has suggested that binding of 
mycobacterial components to human DCs DC-SIGN leads to enhanced release of the anti-
inflammatory cytokine IL-10 and impair DC maturation through ManLAM in vitro (Geijtenbeek et 
al., 2003). Thus, the role of DC-SIGN in TB pathogenesis remains to be further investigated. 
The precise receptor involved in M. tuberculosis recognition may have a major impact on the 
survival chances of this pathogen once inside macrophages. Recognition of particles through TLRs 
results in an inflammatory response and increased respiratory burst while internalization via MRs 
prevents this kind of responses which occur in activated macrophages. Salmonella typhi appears to 
survive inside phagosomes by entering a receptor-mediated pathway not coupled with 
macrophage activation (Ishibashi and Arai, 1990), however, for mycobacteria, it is not clear if there 
is selective receptor-mediated intracellular survival as pathogenic strategy. It seems more likely 
that different entry routes result in different cytokine production and traffic fates leading to 
differential survival of M. tuberculosis.   
 
1.5.2 Granuloma formation  
The interaction of M. tuberculosis with phagocytes results in the production of pro-
inflammatory cytokines, such as TNFα and IL-12, as well as chemokines. These molecules will drive 
the recruitment of monocytes, neutrophils and B cells. Effector T cells that have been, in the 
meantime, primed against mycobacterial antigens by DCs, in the draining lymph nodes, will also be 
recruited to the infection sites (Figure 5). These cells produce their own cytokines and chemokines, 
such as IFNγ, that will activate and enhance the antibacterial activity of macrophages, and amplify 
cellular recruitment (Flynn et al., 2011; Kaufmann and McMichael, 2005; Russell, 2007).  However, 
an intense inflammatory response like this has propensity to tissue damage. Therefore, anti-
inflammatory cytokines like IL-10, IL-27 and TGF-β are also produced and downregulate pro-
inflammatory cytokines, as well as T cell proliferation and activation, balancing the response 
between bacterial eradication and host survival and culminating in the formation of a granuloma 
(Flynn et al., 2011; Russell, 2007). The granuloma contains, but does not eliminate the infection, as 
some resistant bacilli, capable of surviving under stressful conditions generated by the host, escape 
killing. 
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Figure 5 – M. tuberculosis infection and granuloma formation. (a) Mycobacterium tuberculosis infection starts 
with inhalation of bacilli that reach the lung alveoli. (b) In the alveolus, the main host cells are alveolar 
macrophages. However, bacteria can also be taken up by dendritic cells (DCs), which carry M. tuberculosis either 
to the lung parenchyma, leading to initiation of the local inflammatory response, or to the draining thoracic lymph 
nodes. (c) In draining lymph nodes, mycobacterial antigenic peptides are presented to the specific naïve T cells 
through cross-presentation. Activated T cells proliferate, become effector T cells and leave the lymph node. (d) 
Effector T cells reach the site of inflammation under the influence of chemokines and other mediators. 
Extravasations of the mononuclear cells initiate the formation of a granuloma at the infection site. The classic TB 
granuloma is composed of a central core of infected macrophages surrounded by epithelioid and foamy 
macrophages and a peripheral rim of lymphocytes (B cells, CD4
+
 T cells and CD8
+
 T cells) in association with a 
fibrous cuff of extracellular matrix laid by fibroblasts. Adapted from Griffiths et al. (2010). (Griffiths et al., 2010) 
 
In an early stage the granuloma is an organized, stratified, and vascularized structure composed 
of mainly macrophages in the center that are surrounded by a mantle of lymphocytes enclosed 
within a fibrous cuff that marks the periphery of the granuloma (Figure 5). As this structure 
matures, it develops an extensive fibrous capsule, gets less vascularized and, in later stages, starts 
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to become necrotic in the center of the structure (Russell, 2007). Ultimately, the granuloma 
caseates, ruptures and spills infectious bacilli into the airways, resulting in active pulmonary 
disease (Russell, 2007). In chronic or latent TB, granulomas can become calcified and contain the 
pathogen (Russell, 2007; Ulrichs and Kaufmann, 2006) for many decades. Although the precise 
state of M. tuberculosis in these latent granulomas is not clear it seems that it exists mainly in a 
dormant non-replicative state (Ulrichs and Kaufmann, 2006), in a hypoxic environment and with 
nutrient deprivation.  The dosR regulon was found to play a critical role in preparing M. 
tuberculosis for this hypoxic environment and an essential step towards dormancy, involving 
induction of several genes expression (Schnappinger et al., 2003; Voskuil et al., 2003). These 
dormant non-replicating bacteria may resuscitate into an active and replicative state. However, 
how this determines transformation into active disease remains to be determined.  
Macrophages are the primary cellular components of the granuloma and the initiating cells for 
the formation of the granuloma (Flynn et al., 2011). These are the cells that most frequently 
interact with M. tuberculosis as well as with the other cells within the granuloma. Thus, 
understanding the interactions between M. tuberculosis and the macrophage is essential.  
 
 M. tuberculosis interactions with macrophages 1.6
M. tuberculosis is extremely adapted to host macrophages and it has developed several evasion 
mechanisms to allow its survival inside these cells. Optimal mycobacterial growth during infection 
seems to be even dependent on the entry into macrophages. M. tuberculosis-infected mice 
depleted of macrophages had decreased bacterial loads and increased survival (Leemans et al., 
2001). On the other hand, macrophages are important to contain infection. Activated macrophages 
seem to be important for early infection control, when only innate immunity is operant (Clay et al., 
2007) and to contribute to mycobacterial growth restriction in infected mice (Leemans et al., 
2005). Infections using M. marinum and embryonic zebrafish model in the absence of macrophages 
led rapidly to high bacterial burdens (Clay et al., 2007) contradicting the previous results on mice 
(Leemans et al., 2001). Thus, macrophages seem to play a dual role during infection: they provide 
the preferred hiding and replication site of M. tuberculosis and protection from extracellular host 
defense mechanisms, but display, at the same time, antimicrobial functions.  
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1.6.1 M. tuberculosis evasion of macrophage’s antimicrobial mechanisms  
Macrophages are professional phagocytes extremely qualified to internalize and eliminate most 
invading organisms (Flannagan et al., 2009). After phagocytosis, the phagosome fuses with early 
endosomes, late endosomes and lysosomes (Desjardins et al., 1994), culminating in the formation 
of phagolysosomes. During the course of maturation, phagosome becomes a highly acidic, 
oxidative and degradative environment with microbicidal substances. However, M. tuberculosis has 
the ability to subsist inside these cells. Several studies have been done in which bacterial, as well as 
host transcriptome, have been analyzed to have a better idea of the intracellular/phagosomal 
environment as well as host-pathogen interactions. One of the first studies (Schnappinger et al., 
2003) has confirmed that M. tuberculosis inhabits, in mouse macrophages, a nitrosative, oxidative, 
hypoxic and nutritional limited environment. It has also shown that M. tuberculosis seems to shift 
to lipid metabolism, as carbon and energy source, given the limitation of nutrients, as it was 
previously suggested (McKinney et al., 2000). Many of these responses seem to be different from 
those described for other intracellular pathogens like E. coli and Salmonella enterica (Schnappinger 
et al., 2003). Another transcriptomic analysis made using human macrophages has shown similar 
results to the ones obtained by Schnappinger et al. (2003) and reveals the differences between 
macrophages and DCs in response to infection with M. tuberculosis (Tailleux et al., 2008). One of 
such differences was in production of superoxide, found to be much more pronounced in 
macrophages than in DCs. More recently, a core intracellular transcriptome was established 
through the examination of different strains representing the global phylogeographic diversity 
of M. tuberculosis (Homolka et al., 2010). It was shown that genetic diversity resulted in functional 
diversity, reflecting the power that genetic variation exerts on gene expression, and, consequently, 
on host interactions. Among the important genes, for M. tuberculosis intracellular lifestyle, shared 
by all strains there were genes involved in hypoxia, radical stress, cell wall remodeling and lipid 
metabolism. All these studies represent, however, M. tuberculosis infection of macrophages in 
culture which might not reflect all the environments that the bacteria face in the human host. 
Interestingly, a study has analyzed the transcriptome of M. tuberculosis from clinical lung samples 
(Rachman et al., 2006). Overall, this study identified the same class of genes previously identified in 
the in vitro transcriptomic studies referred above. The major difference was that a higher 
proportion of genes was identified reflecting a more accurate representation of M. tuberculosis 
transcriptomic profile during natural infection.  
M. tuberculosis has developed several strategies to evade mechanisms of antimicrobial 
destruction by macrophages allowing its survival inside these cells. One of the most studied 
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mechanisms used by M. tuberculosis to survive inside macrophages is the inhibition of normal 
phagosome maturation.  
 
1.6.1.1 Inhibition of phagosome maturation 
ManLAM recognition through MRs seem to be implicated in inhibition of phagosome fusion 
with lysosomes (Astarie-Dequeker et al., 1999; Kang et al., 2005), as previously referred. This 
component of M. tuberculosis cell envelope interferes with the recruitment of early endosome 
antigen 1 (EEA1), required for fusion of early phagosomes with late endosomal and lysosome 
compartments (Flannagan et al., 2009). This seems to be mediated by interference with calcium 
flux in the macrophage cytoplasm (Malik et al., 2003) that will also prevent accumulation in the 
phagosomal membrane of phosphatidylinositol-3-phosphate (PI3P) (Vergne et al., 2003), a docking 
site for several effector proteins involved in fusion of phagosomes and lysosomes, including EEA1 
(Flannagan et al., 2009).  
Besides cell wall components, secreted proteins have also been implicated in the modulation of 
M. tuberculosis phagosome, even though how these are released from bacterial cells to the 
macrophage cytosol remains an intriguing question. SapM is a mycobacterial phosphatase that 
specifically hydrolyses PI3P, consequently reducing its concentration (Vergne et al., 2005). Thus, M. 
tuberculosis seems to possess different mechanisms that target the same protein (PI3P) in order to 
arrest early endosome maturation. PtpA is a low-molecular-weight tyrosine mycobacterial 
phosphatase that seems to interfere with human Vps33B (vacuolar protein sorting 33B) (Bach et 
al., 2008), a host cytosolic protein that is part of a complex that regulates vesicle docking and 
fusion (Flannagan et al., 2009). PtpA acts probably by dephosphorylation of Vps33B, therein, 
interfering with VPS33B association with small Rab GTPases, like Rab7, required for proper 
membrane fusion (Chao et al., 2010; Flannagan et al., 2009). Another mechanism of phagosome 
maturation arrest (PMA) relies on prolonged retention on the phagosome by M. tuberculosis of 
coronin-1 (or TACO) (Deghmane et al., 2007), a host factor involved in regulation of actin-based 
dynamics (de Hostos, 1999) that specifically prevents lysosomal delivery. It seems that coronin-1 
retention is mediated by LpdC (lipoamide dehydrogenase C) (Deghmane et al., 2007), a component 
of the antioxidant enzyme complex peroxynitrite reductase/peroxidase (Rhee et al., 2005). 
However, the exact mechanism to this retention is unclear. A nucleotide diphosphate kinase (Ndk) 
inhibits phagosome maturation by deactivation of Rab5 and Rab7 GTPases (Sun et al., 2010). Rab 
proteins are thought to be involved in targeting and tethering the endomembrane organelles to 
form phagosomes (Flannagan et al., 2009).  
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Several other mycobacterial proteins have been proposed to play a role in PMA, although, many 
times, the exact mechanism or cellular target that interferes with phagosome maturation is 
unknown. It is the case of PknG, a serine/threonine protein kinase, present in the genome of all 
pathogenic mycobacteria, which inactivation by gene disruption or chemical inhibition results in 
maturation of phagosome containing mycobacteria (Walburger et al., 2004). It is proposed that this 
protein might phosphorylate and interfere with a host protein that is involved in phagosome 
maturation, therefore, preventing its activity. Many other potential factors involved in PMA have 
been identified in independent screenings using M. tuberculosis mutants (Brodin et al., 2010; 
MacGurn and Cox, 2007; Pethe et al., 2004). However, if these are specific for PMA remains to be 
elucidated given that these studies don’t identify most of the mutants in common.  
The prevention of phagosome maturation allows pathogenic mycobacteria to reside in an early 
phagosome that can access to nutrients such as iron via recycling endosomes (Clemens and 
Horwitz, 1996) and avoid antigen-presenting compartments, consequently altering host immune 
responses (Ramachandra et al., 2001).  In addition, this phagosome has a pH close to neutral (6.4), 
correlated with an absence of the vesicular proton-ATPase responsible for acidification of the 
phagosome (Sturgill-Koszycki et al., 1994).  However, there is still a drop in pH from 7 to 6.4 that 
seems to be a signal resulting in the expression of several genes in M. tuberculosis (Rohde et al., 
2007), possibly regulated by PhoP (Walters et al., 2006), the transcriptional regulator of the two-
component system, PhoPR. Indeed, PhoPR seems to be an important for M. tuberculosis to 
successfully adapt to the environment found in the host. PhoP regulates a diverse regulon of more 
than 150 genes (Gonzalo-Asensio et al., 2008; Walters et al., 2006) including genes involved in lipid 
metabolism, general metabolism, and respiration. It also seems to control M. tuberculosis hypoxic 
response, by regulating part of the genes regulated by the DosR regulon, including the dosRS genes 
(Gonzalo-Asensio et al., 2008). M. tuberculosis phoP mutants are attenuated for growth in mice 
(Perez et al., 2001; Walters et al., 2006) and human (Ferrer et al., 2010; Walters et al., 2006) 
macrophages which could be, in part, due to their impaired ability to induce PMA (Ferrer et al., 
2010).  
PMA was initially proposed as a requirement for the survival of the pathogen (Armstrong and 
Hart, 1971). But years later it was shown that live M. tuberculosis can traffic to phagolysosomes, by 
opsonization with specific anti-mycobacterial antibodies without affecting bacterial survival 
(Armstrong and Hart, 1975). Indeed, mutants that traffic to late compartments that do not have 
decreased intracellular survival have been identified (Brodin et al., 2010; MacGurn and Cox, 2007; 
Pethe et al., 2004). This means that M. tuberculosis capacity to persist inside macrophages depends 
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also in its ability to resist against nitrosative and oxidative stress, caused by reactive nitrogen and 
oxygen species, as well as acidic conditions, lysosomal hydrolases and antibacterial peptides 
produced by macrophages (Flannagan et al., 2009).  
 
1.6.2 Nitrosative and oxidative stress relevance in tuberculosis 
Upon phagocytosis, the first microbicidal activity any microbe will encounter in macrophages 
are ROS. The phagocyte NADPH oxidase (phox) complex assembles in the phagocytic cup early in 
the process of phagocytosis and generates ROS (Minakami and Sumimotoa, 2006). Reactive 
nitrogen species (RNS) are produced by inducible nitric oxide synthase (iNOS). In contrast to 
NADPH oxidase, iNOS activity requires de novo protein synthesis and its transcription is triggered 
after macrophage activation through PPR signaling together with pro-inflammatory cytokines, such 
as IFNγ (Fang, 2004). Macrophage activation also leads to an increased production of ROS (Bedard 
and Krause, 2007). Both RNS and ROS can be quite harmful to intracellular pathogens (Flannagan et 
al., 2009). 
The importance of nitric oxide production in control of tuberculosis is well established in the 
mouse model (MacMicking et al., 1997). An early study has also shown that generation of nitrogen 
species by iNOS, upon mouse macrophage activation, was responsible for M. tuberculosis growth 
inhibition and killing inside these cells (Chan et al., 1992). However, the role of RNS in humans has 
been discussed because it is still not clear if these molecules are mycobactericidal in human 
macrophages. Human alveolar macrophages were able to kill M. bovis BCG through a NO-
dependent manner (Nozaki et al., 1997). However, another study has shown that the early 
inhibition of mycobacterial growth by human alveolar macrophages is NO-independent (Aston et 
al., 1998). Other authors have also suggested that killing of the tubercle bacilli is NO-independent 
in human macrophages after activation trough TLRs (Thoma-Uszynski et al., 2001) and that these 
cells activated with IFNγ didn’t produce detectable amounts of NO. On the other hand, it was 
demonstrated that iNOS expression is up-regulated in alveolar macrophages from human 
pulmonary TB lesions (Nicholson et al., 1996), associated with increased pulmonary NO exhalation 
(Wang et al., 1998). The same has been observed in human granulomas caused by M. tuberculosis 
(Choi et al., 2002; Facchetti et al., 1999). These observations in human lesions from people with TB 
support the idea that NO must have a role in human host defense against infection with M. 
tuberculosis.  
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The biological significance of ROS is clearly demonstrated in patients with chronic 
granulomatous disease (CGD), a disease characterized by total absence or low level of ROS caused 
by a deficiency of Phox. These persons are highly susceptible to bacterial, fungal and yeast 
infections (Heyworth et al., 2003). Increasing numbers in cases of mycobacterial diseases are being 
recognized in patients with CGD. A number of patients with BCG disease, clinical disease caused by 
BCG vaccine, and tuberculosis have been reported (Bustamante et al., 2007). Nevertheless, the 
significance of ROS in host defence against M. tuberculosis remains controversial. Despite the early 
demonstration that ROS can be mycobactericidal (Walker and Lowrie, 1981), studies have shown 
later that M. tuberculosis could be in fact resistant to killing by oxidative stress caused by 
macrophages (Manca et al., 1999). However, no effect on M. tuberculosis intracellular growth in 
Phox-deficient mice macrophages was observed (Chan et al., 1992), even though phagocytes 
collected from patients with CGD failed to destruct intracellular BCG (Lamhamedi-Cherradi et al., 
1999). In addition, studies using M. tuberculosis-infected mice defective in the production of ROS 
are not always congruent (Adams et al., 1997; Cooper et al., 2000; Jung et al., 2002), but in general, 
these mice seem to be relatively resistant to TB. These results might be explained by the fact that 
M. tuberculosis possesses efficient resistance mechanisms against ROS, thus rendering 
antimicrobial effects of these agents ineffective and masking the effects of M. tuberculosis growth 
during infection in the absence of ROS.  
 
1.6.3 M. tuberculosis responses against oxidative stress caused by ROS 
1.6.3.1 The formation of ROS 
ROS are constantly produced as by-products of aerobic respiration. Therefore, oxidative stress is 
an unavoidable consequence of the aerobic lifestyle. Aerobic organisms have evolved in order to 
maintain levels beneath toxicity avoiding oxidative stress caused by these endogenous ROS (Storz 
and Imlay, 1999). Other sources might increase ROS concentrations and perturb this balance in the 
redox state of the cell and oxidative stress occurs. This happens when bacteria is captured by 
phagocytes, which generate ROS as part of their antimicrobial response (Flannagan et al., 2009).  
Phox, expressed mainly in macrophages (including alveolar macrophages) and neutrophils, 
generates ROS through the reduction of molecular oxygen (Bedard and Krause, 2007). Phox is a 
multi-subunit complex, consisting of a transmembrane heterodimer composed of NOX2 (gp91phox) 
and p22phox, known as cytochrome b, the catalytic part of Phox. In resting macrophages, these 
transmembrane components are localized mainly in plasma membranes (Bedard and Krause, 2007; 
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Bylund et al., 2010). Upon phagocytosis it assembles with three cytosolic subunits, p47 phox, p67 phox 
and p40 phox, as well as with Rac, and becomes activated (Minakami and Sumimotoa, 2006) (Figure 
6).   
 
 
 
 
 
 
 
 
 
 
 
Figure 6 - Assembly of the phagocyte NADPH oxidase NOX2. Upon activation, the cytosolic components 
p47
phox
, p67
phox
, p40
phox
, and Rac2 translocate to cytochrome b and form a functional NADPH oxidase. The active 
enzyme complex transports electrons from cytoplasmic NADPH to extracellular or phagosomal oxygen to generate 
superoxide (O2
−
). Adapted from Bylund et al. (2010). 
 
The active oxidase transfers electrons from cytosolic NADPH to molecular oxygen, releasing 
superoxide (O2
-) into the phagosomal lumen (Bedard and Krause, 2007) (Figure 6 B). Superoxide 
has a low reactivity, and, consequently, low bactericidal potential. It cannot cross bacterial lipidic 
membranes at neutral pH but it may do it at acidic pH, found in the phagolysosomes (Storz and 
Imlay, 1999).  However, superoxide rapidly dismutates into hydrogen peroxide (H2O2) 
(spontaneously especially at low pH, or catalysed by superoxide dismutase) which readily 
permeates biological membranes and oxidize several molecules. Finally, H2O2 in turn can produce 
hydroxyl radicals (•OH) (Figure 7), which are strong oxidants, when reacting with iron in what is 
known as Fenton reaction (discussed below).  
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Figure 7 – Reactive oxygen species decomposed from 
superoxide produced by phagocyte oxidase. Adapted from 
Fang et al. (2004). 
 
 
 
The contribution of NOX2 to microbial killing lies in both direct effects, due to ROS damaging 
character on proteins, lipids and nucleic acids (Imlay, 2008; Storz and Imlay, 1999; Zahrt and 
Deretic, 2002), as well as indirect effects through changes in the phagosomal pH and ion 
concentrations (Bedard and Krause, 2007). ROS also seem to be involved in cellular signaling, 
especially because of their potential for protein oxidation. For example, phosphatases inhibition by 
oxidation of cysteines in their catalytic region (Denu and Tanner, 1998), might affect the 
phosphorylation state of numerous other proteins involved in signal transduction. In macrophages, 
ROS seems to have an important function in activation of kinases and transcription factors, gene 
expression, regulation of proliferation, and apoptosis (Bedard and Krause, 2007).  
Bacterial pathogens have developed strategies to counteract production of ROS by the host, 
which interfere with the synthesis of these products, catabolize or repair the damage caused by 
them. Most of what we know about these mechanisms is due to its study in E. coli and S. 
typhimurium, the two model systems for oxidative stress responses (Zahrt and Deretic, 2002).  
 
1.6.3.2 ROS scavenging systems 
In early studies mycobacterial cell wall was found to be implicated in ROS resistance particularly 
due to LAM (Chan et al., 1991) and PGL-1 (Chan et al., 1989) ability to scavenge oxygen-radicals.  
Antioxidant enzymes are present in most bacteria dealing with endogenous or exogenous ROS 
(Zahrt and Deretic, 2002) including: catalases that catalyze the decomposition of hydrogen 
peroxide to water and oxygen, superoxidases that convert two superoxide anions into a molecule 
of hydrogen peroxide and peroxidases that catalyze the reduction of hydrogen peroxide by organic 
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reductants, such as glutathione. M. tuberculosis has a protein with both catalase and peroxidase 
activities, KatG (Heym et al., 1993; Manca et al., 1999). A katG mutant was hypersensitive to H2O2 
and attenuated in wild-type mice as well as in wild-type mouse macrophages. However, it was 
virulent in gp91-deficient mice and in macrophages from these phox-deficient mice, unable to 
produce an oxidative burst (Ng et al., 2004). Thus, KatG contributes to M. tuberculosis virulence by 
catabolizing peroxides produced by Phox. M. tuberculosis also has two superoxide dismutases: 
SodA a Mn,Fe enzyme (Zhang et al., 1991) and SodC a Cu,Zn enzyme (Wu et al., 1998). SodC was 
found to be important for bacteria’s resistance against exogenous superoxide as well as H2O2, as 
sodC mutants had increased susceptibility to these ROS when compared to wild-type (Dussurget et 
al., 2001; Piddington et al., 2001). A sodC mutant had also enhanced susceptibility to killing by 
IFNγ-activated murine peritoneal macrophages, but not by Phox-deficient or non-activated murine 
macrophages (Piddington et al., 2001), suggesting that SodC is important for M. tuberculosis 
resistance against ROS produced by activated macrophages. However, sodC mutants were not 
attenuated in mice or guinea pigs (Dussurget et al., 2001; Piddington et al., 2001). It was suggested 
that SodA might compensate for SodC deletion in vivo. SodA seems to be essential for M. 
tuberculosis growth as an attempted of inactivating its gene failed (Dussurget et al., 2001). 
However, a M. tuberculosis mutant having diminished production of SodA, was more susceptible to 
H2O2 and significantly attenuated in mice (Edwards et al., 2001), which exhibited increased 
apoptosis of mononuclear cells. On the other hand, a BCG strains overexpressing SodA induced a 
reduction in apoptosis in macrophages, as well as an impaired IFNγ and increased IL-10 release in 
mice (Jain et al., 2011). As previously referred, ROS induce several cellular functions. These include 
induction of apoptosis through the inhibition of phosphatases, and consequently, activation of 
signaling molecules such as MAP kinases (Bedard and Krause, 2007). M. tuberculosis has the ability 
to inhibit apoptosis which was recently found to be correlated with the inhibition of ROS 
accumulation (Miller et al., 2010). Therefore, antioxidant enzymes, such as SodA and KatG, seem to 
be involved in M. tuberculosis apoptosis inhibition through elimination of ROS (Edwards et al., 
2001; Miller et al., 2010). By affecting ROS levels, in the host cell, M. tuberculosis not only avoids 
killing, but also interferes with other host defense mechanisms against pathogens.   
Other antioxidant enzymes found in M. tuberculosis include an alkyl hydroperoxide reductase, 
AhpC, involved in detoxification of organic peroxides, as shown by the increased sensitivity of an 
ahpC mutant to cumene hydroperoxide, but not hydrogen peroxide (Springer et al., 2001). Even 
though M. tuberculosis ahpC mutant had a decreased survival in macrophages (Master et al., 
2002), growth was not affected in mice, suggesting that AhpC doesn’t have a significant role during 
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infection in vivo (Springer et al., 2001). The ahpC gene belongs to an operon along with ahpD. AhpD 
was found to be implicated in AhpC peroxidase activity, along with DlaT (SucB) and LpdC (Rv0462) 
enzymes, involved, as well, in important metabolic pathways. AhpC, AhpD, DlaT and LpdC were 
found to form a peroxynitrite reductase-peroxidase complex responsible for peroxynitrite 
detoxification (Bryk et al., 2002).  
 
1.6.3.3 Protein and lipid repair 
Specialized enzyme systems comprising members of the oxidoreductase family are involved in 
generalized protein reduction. In E. coli the thioredoxin (Trx) system comprises two thioredoxins 
and a thioredoxin reductase. The glutaredoxin (Grx) system is composed of glutathione, three 
glutaredoxins, and a glutathione oxidoreductase (Holmgren, 2000).  
M. tuberculosis has mycothiol, instead of glutathione, and several thioredoxins, including AhpD 
(referred above), involved in AhpC reduction, as well as a thioredoxin reductase (Akif et al., 2008). 
Mutants in genes involved in mycothiol biosynthesis have shown increased susceptibility to 
oxidative stress (Buchmeier et al., 2006; Buchmeier et al., 2003), although no significant growth 
defects were observed during mice infection (Vilcheze et al., 2008). M. tuberculosis thioredoxins 
are involved in protection against peroxides (Zhang et al., 1999) and trx genes are transcribed 
under a variety of oxidative stress conditions, suggesting a role in M. tuberculosis oxidative stress 
response. WhiB proteins were initially thought to have a role as transcriptional regulators, 
however, most of these proteins were found to be disulfide reductases with properties similar to 
thioredoxins (Alam et al., 2009), involved in M. tuberculosis oxidative stress response. It was shown 
that each of the M. tuberculosis whiB family member has a unique transcriptional response pattern 
to different stresses and two of these, whiB3 and whiB6, were found to be commonly induced by 
diamide and cumene hydroxiperoxide (Geiman et al., 2006).  
Sulfur assimilation is important for the biosynthesis of cysteine, methionine, and a variety of 
cofactors that will then be integrated in reduced-sulfur-containing molecules, such as mycothiols 
and thioredoxins. Genes involved in this pathway are induced in M. tuberculosis inside 
macrophages (Schnappinger et al., 2003), showing the importance of these molecules in M. 
tuberculosis intracellular lifestyle. CysH is an enzyme involved in this pathway and a deletion 
mutant in the cysH gene shows an increased sensitivity to H2O2 and peroxynitrite. This mutant had 
an attenuated phenotype in wild-type mice, in the persistence phase of infection, but was fully 
virulent in NOX2-/- mice treated with iNOS inhibitor (Senaratne et al., 2006). The attenuated 
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phenotype of ΔcysH mutant in mice was, probably, due to an impaired antioxidant response 
caused by a decrease in reduced-sulfur-containing molecules such as mycothiols.  
Methionine sulfoxide reductase (Msr) is responsible for the conversion of methionine sulfoxide, 
the product of oxidized methionine, whether in proteins or as free amino acid. Two Msr exist in 
almost all living organisms, MsrA and MsrB that are responsible for the reduction of the two 
stereomeric forms of methionine sulfoxide: methionine S-sulfoxide and methionine R-sulfoxide. In 
E. coli or Helicobacter pylori one of these genes has been shown to be important for bacteria’s 
oxidative stress response. In M. tuberculosis, only a double mutant in both msrA and msrB showed 
increased susceptibility to hypochlorite but not to other oxidants such as hydrogen peroxide (Lee 
et al., 2009b). Therefore, their role in protection of M. tuberculosis against oxidative stress in 
macrophages remains unclear.  
The membrane-associated protease Rv3671c also seems to protect M. tuberculosis against 
oxidative stress probably by degrading damaged proteins, however, this has still to be confirmed 
(Biswas et al., 2010).  
A M. tuberculosis overexpressing Wag31, a protein that regulates polar cell wall synthesis, was 
found to be attenuated in human macrophages and had increased susceptibility to hydrogen 
peroxide (Mukherjee et al., 2009). Wag31 protects PBP3 protein (FtsI) (involved in synthesis of 
septal peptidoglycan) from proteolysis induced in oxidative stress conditions in mycobacteria. 
These results suggest that M. tuberculosis had also developed mechanisms to preserve cell shape 
under oxidative stress conditions, in order to survive. 
Curiously, a locus - mel2 - with homologous genes involved in bioluminescence in other bacteria 
seems to protect M. tuberculosis against oxidative stress. A M. tuberculosis mutant in this locus has 
increased susceptibility to ROS and a defective growth in activated mouse macrophages that was 
less obvious in Phox-/- macrophages. Disease was found to be less severe in mice infected with this 
mutant strain but similar to wild-type in Phox-/-. Although the mechanism by which this occurs 
remains unknown, mel2 mutants have increased levels of oxidized lipids (Cirillo et al., 2009). Thus, 
it might be involved in protection or repair of oxidized lipids. 
The mechanisms described above show that M. tuberculosis oxidative stress response include 
not only antioxidant enzymes and other molecules that scavenge ROS, but also, mechanisms 
involved in the repair of the damages caused in proteins and lipids. ROS also cause damage in the 
DNA (Demple and Harrison, 1994), which means that M. tuberculosis should have efficient DNA 
repair mechanisms as well. Indeed, several transcriptomic analyses show that DNA repair genes are 
induced after exposure to H2O2 (Boshoff et al., 2003; Cabusora et al., 2005; Schnappinger et al., 
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2003; Voskuil et al., 2011). DNA repair mechanisms have also been identified as important for M. 
tuberculosis survival during infection in mouse (Schnappinger et al., 2003) and human (Cappelli et 
al., 2006) macrophages; as well as in mouse (Sassetti and Rubin, 2003) and human (Rachman et al., 
2006) lung tissues.  
 It was suggested, from early studies in E. coli, that most of the cell death that occurs upon H2O2 
exposure is probably due to DNA damage (Imlay and Linn, 1986), emphasizing the potential killing 
effect of ROS trough DNA damage. Pathogens have adapted and DNA repair mechanisms have 
been shown to be essential for the survival of the intracellular pathogens Salmonella typhimurium 
(Buchmeier et al., 1995) and H. pylori (O'Rourke et al., 2003) by repairing DNA damage resulting 
from oxidative stress.     
 
1.6.3.4 Oxidative DNA damage caused by ROS 
Oxidative DNA damages constitute, probably, the most varied class of DNA damages (Demple 
and Harrison, 1994). ROS induce a vast number of different types of DNA damages, including: 
strand breaks (particularly single- although double-strand breaks might also occur), base loss 
leading to abasic (apurinic, apyrimidinic or AP) sites, and base damages. Over 80 products of DNA 
base damage caused by ROS are known, among which, the oxidation product of guanine, 7,8-
dihydro-8-oxo-2'-deoxyguanosine (8-oxoG) either in the DNA or nucleotide pool, is one of the most 
frequent (Friedberg et al., 2006). M. tuberculosis is at greater risk of acquiring this kind of lesion 
due to the high GC content of its genome (Cole et al., 1998). 
The hydroxyl radical (•OH) is the most reactive of the primary ROS, oxidizing organic molecules 
almost indiscriminately. In the DNA it can add or abstract hydrogen atoms and originate many 
products. However, oxidation of DNA is surely not a result of free •OH. Its reactivity is so high that 
it reacts with another cellular component before it reaches DNA. Consequently, to oxidize DNA, 
•OH must be generated immediately next to a nucleic acid molecule (Friedberg et al., 2006). 
Hydrogen peroxide, as opposite to •OH, is not as highly reactive with DNA. However, it acts as a 
much stronger oxidant when decomposed by ferrous ions. In fact, the main source of DNA damage 
by ROS is thought to be the formation of Fenton oxidants, such as •OH, by reaction of H2O2 with 
iron-complexed DNA (Figure 8) (Friedberg et al., 2006). Another frequent base damage, induced by 
H2O2, is 2,6-diamino-4-hydrixy-5-formamidopyrimidine (FaPy) (Friedberg et al., 2006) resulting also 
from the oxidization of guanine. Free superoxide (O2
-) is also not very reactive with DNA. However, 
as referred previously, O2
- dismutate into H2O2 and it has the ability to release protein-bound iron 
to produce Fe2+ that will be used in the Fenton reaction (Figure 8) (Friedberg et al., 2006). 
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Figure 8 – Cellular reactions leading to oxidative DNA damage via the Fenton Reaction. Superoxide 
dismutates into H2O2 and releases protein-bound iron, which in turn can react to form oxidants such as ⋅OH that 
will cause DNA damage. Adapted from Friedberg et al. (2006). 
 
 
1.6.3.5 M. tuberculosis DNA repair   
To prevent DNA damage it was recently shown that M. tuberculosis seems to be physically 
protected by Lsr2, a histone-like protein (Colangeli et al., 2009). An M. smegmatis mutant was 
found to be hypersusceptible to H2O2 and attenuated in wild-type, but virulent in Phox
-/- deficient, 
macrophages. No mutants in lsr2 gene could be constructed in M. tuberculosis, highlighting the 
importance of such protein for this pathogen and as a future drug target (Colangeli et al., 2009). 
Due to the technical difficulty of working with such a slow growing pathogen, the study of M. 
tuberculosis DNA repair systems has advanced slower than for other bacteria. As a result, most of 
the assumptions are still made based on homology rather than on functional studies. Genes 
necessary to perform base excision repair, nucleotide excision repair and recombinational repair 
were identified. In addition, genes involved in the SOS response – a mechanism that responds to 
DNA damage by inducing various genes required for DNA repair - were also identified. In contrast, 
no homologs of mismatch repair genes were identified (Cole et al., 1998; Mizrahi and Andersen, 
1998), a finding that should have potentially significant implications with respect to genome 
stability. 
Major DNA repair mechanisms that control DNA damages in bacteria and the corresponding 
homologues found in M. tuberculosis are represented in Figure 9 (Dos Vultos et al., 2009). 
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Figure 9 – Major mechanisms repairing DNA damages in bacteria. Listed beside each pathway are the 
homologues of DNA repair proteins found in M. tuberculosis. Mismatch repair homologs were found in M. 
tuberculosis, and so this pathway is not shown in the figure. Adapted from Dos Vultos et al. (2009). 
 
1.6.3.5..1 Base excision repair pathway 
Base excision repair (BER) is probably one of the most frequently used DNA repair systems in 
nature since it is responsible for the repair of the majority of DNA damages (Friedberg et al., 2006). 
BER is initiated by DNA glycosylases, which excise the chemically altered or inappropriate bases 
from DNA – like 8-oxoG – by cleavage of the N-glycosyl bond between the base and the 
deoxyribose sugar. This forms a site in DNA without a base, called AP site. AP endonucleases 
specifically recognize these sites in the DNA and produce nicks immediately 5’ to the AP site. Some 
DNA glycosylases have an associated AP lyase activity that cleaves the phosphodiester backbone 3’ 
to the AP site. Then, the action of an exonuclease or DNA-deoxyribophosphodiesterase (dRpase) 
completes the removal of the damaged nucleotide and DNA polymerase and DNA ligase conclude 
the repair (Dianov and Lindahl, 1994; Friedberg et al., 2006; Seeberg et al., 1995) (Figure 9).  
 
- Oxidative DNA damage repair by BER 
Oxidative DNA damage is primarily processed by the BER pathway, given that DNA bases are 
particularly susceptible to oxidation mediated by ROS (Dizdaroglu, 2005). As referred, one of the 
most frequently occurring stable and abundant oxidized base lesions in DNA is 8-oxoG. This lesion 
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has strong promutagenic properties. During replication, 8-oxoG frequently mispairs with the 
nucleotide A (Shibutani et al., 1991). This error is not detected by replicative DNA polymerases 
leading to G→T/C→A transversions (Cheng et al., 1992). Enzymatic systems dealing with the 8-
oxoG are represented on Figure 10. Prior to DNA replication, at 8-oxoGC sites, repair can be 
effected by conventional BER with MutM (Fpg) DNA glycosylase operating on the 8-oxoG damage 
(Figure 10B, right pathway). If this base is not removed before replication, DNA polymerase can 
introduce a C opposite to the lesion leading to another opportunity for MutM to catalyse the repair 
(Figure 10B, left pathway). But DNA polymerase can also introduce an A opposite to 8-oxoG (Figure 
10B, central pathway). In this situation, MutY DNA glycosylase excises the A that is usually replaced 
by a C resulting in a 8-oxoGC base pair that is, again, repaired by the BER system involving the DNA 
glycosylase MutM.  
Moreover, ROS can contaminate the nucleotide pool with 8-oxod-GTP. MutT hydrolyses 8-oxo-
dGTP back to the monophosphate form, removing it from the dNTP pool (Figure 10C, right 
pathway). If replication occurs with some 8-oxo-GTP in the dNTP pool, usually T is preferentially 
inserted opposite to A. However, if 8-oxo-GTP is incorporated instead of T, 8-oxoG may be 
removed either by MutM (Figure 10C, left pathway) or MutY (Figure 10C, central pathway), as 
described above.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10 - Enzymatic systems that protect from the mutagenic effects of 8-oxoguanine. Details are discussed 
in the text. Adapted from Friedberg et al. (2006). 
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This triplet of DNA repair enzymes – MutM, MutY and MutT – comprises the G° system that is 
involved in handling with the potential mutagenic effects of guanine oxidation (David et al., 2007; 
Michaels and Miller, 1992). Four mutT homologues have been annotated in mycobacterial 
genomes, which contain a single mutY homolog (Cole et al., 1998; Mizrahi and Andersen, 1998). 
The study of knockout mutants for MutT1, MutT2, MutT3 and Rv3908 (MutT4) in M. tuberculosis 
has revealed that only the absence of mutT1 leads to an increase in the mutation frequency 
(mutator phenotype) (Dos Vultos et al., 2006) although at a much lower level than the observed for 
other bacteria. This may be due to the existence of other enzymes capable of counteracting this 
kind of oxidative stress. Biochemical analysis show that M. tuberculosis MutY is involved in the 
excision of A opposite to 8-oxoG in the DNA, as it happens in E. coli. However, excisions of G or T 
opposite to 8-oxoG can also occur (Kurthkoti et al., 2010). M. tuberculosis genome possesses two 
homologues of mutM (Cole et al., 1998), however, one of these (rv0944) may code for a protein 
that is not functional (Guo et al., 2010).  A study of MutM deficient M. smegmatis has shown that 
this protein plays an important role in protecting bacteria from oxidative DNA damage. The 
complementation of this mutant with the M. tuberculosis mutM gene, coding for the main MutM 
(Rv2924c), could restore the sensitive phenotype to oxidative stress (Jain et al., 2007). 
Interestingly, M. tuberculosis MutM was also found to be important for infection of non-human 
primates (Dutta et al., 2010).  
Another enzymes that excise oxidized bases are endonuclease VIII (Nei) and Nth. These act 
primarily on oxidized pyrimidines, in contrast to Fpg that acts primarily on oxidized purines 
(Dizdaroglu, 2005). Homologues of these proteins are present in M. tuberculosis (Cole et al., 1998; 
Mizrahi and Andersen, 1998). 
DNA glycosylases give rise to AP sites. Additionally, these sites can also arise spontaneously or 
be directly induced by ROS (Demple and Harrison, 1994). Such lesions are repaired by the 
ubiquitous AP endonucleases, including XthA and Nfo, which belong to the oxidative defence 
regulon in E. coli (Storz and Imlay, 1999). These proteins are both encoded in the genome of M. 
tuberculosis (nfo corresponds to end) (Cole et al., 1998) (Figure 9) and their biological importance is 
shown by the fact that no variations are observed for xthA in clinical strains (Dos Vultos et al., 
2008). The existence of two enzymes for the same function highlight that dealing with abasic sites 
is a crucial aspect of DNA repair and may be a reflection of either the high number of DNA 
glycosylases that M. tuberculosis possesses, or the constant aggression by ROS in the host. 
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The filling of gaps that result from AP endonuclease activity is mediated mainly by polymerase I, 
PolA (Dianov and Lindahl, 1994; Seeberg et al., 1995). M. tuberculosis possesses a DNA-dependent 
PolA (Cole et al., 1998). In E. coli, it was demonstrated that overproduction of DnaE protein (an  
subunit of DNA polymerase III) could restore viabilityy, in a conditionally unviable strain deficient in 
PolA (Witkin and Roegner-Maniscalco, 1992). M. tuberculosis contains two apparently functionally 
redundant replicative DNA polymerases designated DnaE1 and DnaE2 (Cole et al., 1998), but lacks 
PolII. DnaE2 was found to be upregulated in vitro by several DNA damaging agents (including H2O2), 
as well as during infection in mice. It seems to be an error prone polymerase that is the primary 
mediator of survival through inducible mutagenesis and plays a role in the emergence of drug 
resistance (Boshoff et al., 2003). Indeed, mutations in the rpoB gene that confer resistance to 
rifampicin, were associated with an increased dnaE2 expression, suggesting a role for DnaE2 in 
adaptation of fitness impaired, rifampicin resistant, M. tuberculosis strains. It was postulated that 
by increasing expression of this error-prone polymerase the probability of a subsequent adaptation 
would also be augmented (Bergval et al., 2007). Other genes, dnaZX, dnaQ and dnaN, encoding , 
 and ß subunits of polymerase III, respectively, are also found in the M. tuberculosis genome as 
well as the DNA ligases: LigA, LigB, LigC and LigD (Cole et al., 1998; Mizrahi and Andersen, 1998) 
(Figure 9). 
Although the study of M. tuberculosis repair of oxidative damage by BER needs to be deepened, 
it is already clear that these bacteria are well adapted to environments where oxidative stress is 
prevalent. This is illustrated by the sheer number of putative genes whose products might be 
involved in dealing with this kind of aggressions and by the restricted nucleotide diversity that 
these genes present (Dos Vultos et al., 2008). In addition, the analysis of rpoB mutation patterns in 
both clinical (O'Sullivan et al., 2005) and laboratory (Morlock et al., 2000) strains has led to the 
conclusion that oxidative damage is generally not the driving force behind mutations in the M. 
tuberculosis genome. Finally, genes of the BER system were found to be essential for M. 
tuberculosis survival in mice (Sassetti and Rubin, 2003) revealing the importance of this system to 
resist oxidative damage during infection in vivo.  
 
- BER Repair of  DNA damages caused by other forms of stress  
Several DNA glycosylases involved in the repair of other kinds of damaged bases were also 
found in the genome of M. tuberculosis (Mizrahi and Andersen, 1998). It is the case of tagA and 
alkA, important genes in repairing alkylative DNA damages that can be induced by RNS (Durbach et 
al., 2003; Taverna and Sedgwick, 1996). The tagA gene encodes a highly specific 3-methyladenine 
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DNA glycosylase I that is constitutively expressed (Bjelland et al., 1993). AlkA encodes a 3-
methyladenine DNA glycosylase II (O'Brien and Ellenberger, 2004), which is a component of the 
adaptive response controlled by ada. The ada gene encodes O6-alkylguanine-DNA alkyltransferase 
I. A second type of O6-alkylguanine-DNA alkyltransferase is encoded by the ogt gene in E. coli 
(Friedberg et al., 2006). In M. tuberculosis, ada and alkA are predicted to encode fused proteins 
and to be part of an operon including ogt (Cole et al., 1998). M. tuberculosis mutants lacking this 
operon were shown to be hypersensitive to the genotoxic effects of N-methyl-N’-nitro-N-
nitrosoguanidine (MNNG), an alkylating mutagen (Durbach et al., 2003). The exposure to the DNA 
damaging agents - UV radiation, mitomycin C and H2O2, results in the upregulation of this operon 
as well (Boshoff et al., 2003). However, these mutants were not attenuated in mice, suggesting 
that nitrosative stress does not induce cytotoxic DNA damage in M. tuberculosis in vivo (Durbach et 
al., 2003).  
 
1.6.3.5..2 Nucleotide excision repair pathway 
Nucleotide excision repair (NER) is an alternative pathway to BER, in which genomic damage is 
repaired by means of incisions in regions flanking the damaged DNA, leading to the excision of an 
oligonucleotide rather than a single base (Friedberg et al., 2006). In E. coli NER involves UvrA, B and 
C proteins, which interact in complex. UvrA binds to DNA and leads to the formation of an UvrA-
UvrB-DNA complex that recognizes the damage. Then, UvrA dissociates and UvrB recruits UvrC that 
catalyse incisions 5’ and 3’ to DNA damage. DNA helicase (UvrD), polymerase, and ligase reactions 
then eliminate the damaged oligonucleotide and complete repair (de Laat et al., 1999) (Figure 9).  
 
- Oxidative DNA repair by NER 
Although this system is not pivotal for handling oxidative damage (it is the core mechanism for 
repair of UV-induced damage) evidence indicates a demonstrable function as a secondary defence 
against oxidative damages in E. coli and in Saccharomyces cerevisae (Demple and Harrison, 1994). 
It is an extremely important DNA repair system that recognizes a wider range of damaged bases 
than the BER system, due to the use of more generic endonucleases. 
Homologues of uvrABC were found in M. tuberculosis (Cole et al., 1998). The expression of uvr 
genes was increased in M. tuberculosis within human macrophages, which highlights the 
importance of the uvr system for M. tuberculosis survival upon infection (Graham and Clark-Curtiss, 
1999). Additionally, uvr genes seem to be involved in H2O2 response network (Cabusora et al., 
2005) being expression of uvrA and uvrB increased upon exposure to H2O2 (Boshoff et al., 2003). 
  
40 Chapter 1 
However, inactivation of uvrB resulted in severe sensitivity to acidified nitrite and UV light but not 
to ROS in M. tuberculosis. Yet, an uvrB mutant attenuated phenotype was reverted only in mice 
lacking both iNOS and Phox, suggesting that UvrB is important for resistance against combined RNS 
and ROS during infection in vivo (Darwin and Nathan, 2005). Importantly, uvrB was also shown to 
be required for M. tuberculosis growth in primate lungs (Dutta et al., 2010). An M. smegmatis uvrB 
mutant, however, has shown increased susceptibility to oxidative DNA damages (Kurthkoti et al., 
2008) and a recent study has shown that M. tuberculosis deficient in UvrA is also sensitive to 
several DNA damaging agents including ROS (Rossi et al., 2011). It seems, thus, that NER proteins 
are important players in the repair of oxidative DNA damages in mycobacteria.  
Although most bacteria carry just one gene encoding DNA helicase II, M. tuberculosis possesses 
two putative genes encoding this protein: uvrD1 and uvrD2 (Cole et al., 1998). Interestingly, uvrD1 
seems to be critical for mycobacterial repair of UV damage and is upregulated upon H2O2 stress 
(Boshoff et al., 2003), suggesting a role in NER. This has been recently confirmed. M. tuberculosis 
uvrD1 mutant has shown an increased susceptibility to UV irradiation as well as to mitomycin C and 
ROS-inducing agents (Houghton et al., 2012). The role of UvrD1 in mycobacterial DNA repair is of 
significant interest given that deletion of uvrD1 attenuates M. tuberculosis growth in macrophages 
and persistence in mice (Houghton et al., 2012).  
 
1.6.3.5..3 Recombinational repair 
Oxidative DNA damage includes DNA strand breaks, particularly single strand breaks (SSBs) 
because two nearby attacks in each strand are very rare under physiological conditions. But, if this 
happens, double strand breaks (DSBs) can occur. DSBs can also arise if a replication fork encounters 
a SSB in the DNA, and SSBs may occur if the replication fork encounters another kind of lesion in 
the DNA (Friedberg et al., 2006). Thus, SSBs and DSBs might occur by a direct or indirect effect of 
oxidative DNA damaging agents. These lesions are potentially lethal and require repair through 
homologous and non-homologous recombination mechanisms (Demple and Harrison, 1994; 
Slupphaug et al., 2003). In homologous recombination (HR) a second intact copy of the broken 
chromosome segment serves as template, which in prokaryotes corresponds to the newly 
replicated sister chromatid (Friedberg et al., 2006). Proteins involved in HR play key roles in DNA 
repair mechanisms and two major pathways can be found: the RecBCD and RecF pathways. It is 
now evident that DSBs initiate recombinational events carried out by the RecBCD pathway, 
whereas single strand gaps initiate recombinational events carried out by the RecF pathway 
(Morimatsu and Kowalczykowski, 2003). In E. coli, RecBCD is a helicase that splits the duplex and 
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digests them until it reaches a recombinational hotspot (Singleton et al., 2004) (Figure 11A). In the 
RecF pathway, RecQ and RecJ process gapped DNA before RecFOR proteins recognize the single 
strand gap (Figure 11B) (Morimatsu and Kowalczykowski, 2003). Both pathways provide an ssDNA 
molecule coated with RecA, facilitating the invasion of a homologous molecule (Figure 11). Strand 
exchange is promoted by RecA, resulting in formation of a holliday junction that will be resolved by 
the RuvABC complex or the RecG ligase (Friedberg et al., 2006). In M. tuberculosis the RecBCD 
pathway seems to be intact (Mizrahi and Andersen, 1998). The RecF pathway was initially thought 
to be defective given that recJ is absent. However, recR is one of the genes upregulated in M. 
tuberculosis upon capreomycin exposure (Fu and Shinnick, 2007), a drug used for treatment of 
MDR-TB. Furthermore, both recR and recF are upregulated upon translational inhibition induced by 
drugs (Boshoff et al., 2004) suggesting that, despite of the absence of recJ, this pathway is active in 
M. tuberculosis.  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11 – Early steps during the repair of double strand breaks (DSBs) (A) and single strand breaks (SSBs) (B) 
in the DNA by homologous recombination mechanisms. (A) In the RecBCD pathway, RecBCD binds to the end of a 
DSB, unwinds and degrades the double strand DNA until it finds a DNA sequence (χ). RecA is then loaded onto the 
χ-containing single-stranded DNA. (B) In the RecF pathway, RecQ and RecJ process the gapped DNA. Then RecFOR 
recognize the SSB-coated GAP and lead to RecA filament assembly. Adapted from Friedberg et al. (2006). 
 
A B 
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As referred, DSBs can also be repaired by another mechanism: the non-homologous end-joining 
(NHEJ). NHEJ does not rely on a homologous DNA template, which means it can operate in 
situations when only one chromosomal copy is available (Friedberg et al., 2006). NHEJ requires the 
approximation of the broken ends, a process that is assisted by the DNA-end-binding protein Ku, 
followed by the sealing of, at least, one of the broken strands by a specialized DNA ligase (Figure 9). 
Unlike HR, which is generally error free, NHEJ can be either faithful, if the ends are sealed directly, 
or mutagenic, if the ends are remodelled by nucleases or polymerases before sealing by DNA 
ligases (Shuman and Glickman, 2007). This pathway was thought to be restricted to eukaryotes but 
it was recently identified in prokaryotes, including M. tuberculosis (Gong et al., 2005), being LigD 
the specialized DNA ligase involved in (Della et al., 2004). Mycobacteria possess a backup 
mechanism for LigD-independent error-prone repair of blunt-end DSBs, probably involving LigC. 
This is suggested by the fact that blunt-end NHEJ efficiency in LigD-deficient cells is reduced by 20-
fold when ligC is deleted (Gong et al., 2005). Another Ku-dependent protein is, UvrD1. However, 
exactly how it contributes to DSB repair remains to be determined. This suggests a cross-talk 
between NHEJ and NER pathways (Sinha et al., 2007).  
The reason why do only certain bacterial species possess this pathway is unclear. In 
mycobacteria, even though expression profiles suggest that M. tuberculosis ligD and ku 
transcription is not regulated during infection in human macrophages (Cappelli et al., 2006),  NHEJ 
may be important for survival within these cells, where bacteria are continuously exposed to 
genotoxic compounds that induce DSBs, such as ROS. This may explain why M. tuberculosis has 
retained a functional NHEJ apparatus that has been lost by other species. On the other hand, this 
mechanism would contribute to mutagenesis that can sometimes be a selective advantage 
(Shuman and Glickman, 2007), for example for the acquisition of antibiotic resistance mutations. 
 
- RecA – a central molecule in DNA damage response 
RecA is a central component of bacterial response to DNA damage. Not only it has a direct role 
in recombinational DNA repair as described above, but it also controls the expression of other 
genes whose function promotes increased survival following DNA damage, in conjunction with the 
repressor protein LexA (Friedberg et al., 2006; Little, 1982). This is the so-called SOS response. M. 
tuberculosis has, with the exception of polB and umuD, the genes required for a functional SOS 
system in E. coli (Cole et al., 1998; Mizrahi and Andersen, 1998). As in most species of bacteria, the 
expression of M. tuberculosis recA has been shown to be inducible by DNA damaging agents 
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(Boshoff et al., 2004). RecX seems to be a negative regulator of RecA in M. tuberculosis (Venkatesh 
et al., 2002). 
Recently, the mechanisms underlying M. tuberculosis response to DNA damage were studied, 
through a global analysis of gene expression following DNA damage induced by mitomycin C, in 
both wt and recA- M. tuberculosis. Curiously, the majority of genes induced by DNA damage didn't 
have known roles in DNA repair. However, it was noticed that most of the inducible genes with 
known or predicted function in DNA repair did not depend on recA for induction (Rand et al., 
2003), a rare occurrence in bacteria, only documented for Acinetobacter calcoacetius (Rauch et al., 
1996). Among those, were genes involved in NER, BER, and recombination. As it has been 
previously suggested (Brooks et al., 2001), it appears that an alternative mechanism of gene 
regulation, RecA/LexA – independent, important for DNA repair, exists in M. tuberculosis (Rand et 
al., 2003). A motif has been identified that seems to define the RecA/LexA-independent promoter 
(RecA-NDp) (Gamulin et al., 2004). 
It remains unclear why does M. tuberculosis have multiple mechanisms for DNA damage 
induction. A possible explanation is that each mechanism responds to different stimuli. For 
example, the RecA-NDp-mechanism may be important for survival in macrophages, given that the 
majority of genes under the control of this promoter are induced in the macrophage environment 
to a significant level (Gamulin et al., 2004; Schnappinger et al., 2003). Implication of the RecA-NDp-
mediated response in the regulation of a variety of genes that are involved in M. tuberculosis 
oxidative stress response, such as ahpC, argues for this possibility (Gamulin et al., 2004).  
 
1.6.3.5..4 The lack of Mismatch repair 
Mismatch repair (MMR) systems are important for mutation avoidance by repairing 
mismatched base pairs in the DNA (Friedberg et al., 2006). For example, MMR also contributes to 
the repair of 8-oxoG as a backup for the repair of newly replicated strains (Friedberg et al., 2006). 
One of the most striking characteristics of M. tuberculosis DNA repair system is the absence of 
homologs for MMR, which highly suggests that these bacteria do not perform this kind of repair 
(Dos Vultos et al., 2009). This should have potentially significant implications with respect to 
genome stability and could lead us to regard M. tuberculosis as possible natural mutator. Even 
though it has been show recently that M. tuberculosis complex strains show high levels of 
polymorphisms in DNA repair, replication and recombination genes (Dos Vultos et al., 2008), M. 
tuberculosis genomes are very stable when compared to other organisms such as H. pylori, where 
the absence of a functional MMR system was correlated to a remarkably high level of genetic 
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diversity (Kang and Blaser, 2006). Nevertheless, its capacity to adapt to host conditions has been 
demonstrated by the appearance of MDR as well as XDR, and, more recently, TDR strains resistant 
to all available drugs against TB (Zumla et al., 2012). 
The possibility of a higher fidelity in the processivity of DNA as a compensation for the lack of 
MMR can be posed, as M. tuberculosis has a slower rate of DNA synthesis when compared to E. coli 
(Hiriyanna and Ramakrishnan, 1986). The use of codons in a context-specific way may also 
contribute to the stability of the genome in deficient MMR M. tuberculosis by reducing the number 
of targets for frameshift mutations (Wanner et al., 2008). In addition, besides the important role in 
counteracting directly the damages in DNA provoked by host conditions, it is possible that NER (as 
well as BER) is involved in compensating for MMR deficiency, a model that has recently been 
proposed (Guthlein et al., 2008).  
 
1.6.3.6 Oxidative stress response regulation 
S. typhimurium and E. coli oxidative stress response is primarily controlled by SoxR and OxyR 
regulators. SoxR, in response to superoxide, induces expression of several genes including sodA. 
OxyR is activated by hydrogen peroxide and stimulates transcription of genes such as katG 
(catalase) and ahpCF (alkylhydroxyperoxidase reductase). Although OxyR is the most common 
regulator of responses to hydrogen peroxide, other regulators might exist. PerR was identified in 
Bacillus subtilis and in Staphylococcus aureus as transcriptional repressor that regulates 
transcription of most of the genes regulated by OxyR (Imlay, 2008).    
In M. tuberculosis and other closely related species of the M. tuberculosis complex, oxyR is a 
pseudogene containing multiple frameshift mutations and deletions (Deretic et al., 1995). In some 
fast-growing mycobacteria, such as M. smegmatis, oxyR seems to be absent from their genomes. In 
contrast, an intact oxyR has been observed in several other mycobacterial species including M. 
leprae, M. marinum and M. avium (Pagan-Ramos et al., 1998). As for soxRS, no apparent homolog 
seems to exist in M. tuberculosis genome (Cole et al., 1998). This apparent absence of important 
oxidative stress response regulators in M. tuberculosis would explain the very little transcriptional 
response to H2O2 or menadione (a superoxide producer) (Garbe et al., 1996) when compared to 
other species, like E. coli or Salmonella (Zahrt and Deretic, 2002). The same was observed inside 
macrophages. Few potential antioxidant genes were induced in M. tuberculosis (Schnappinger et 
al., 2003). These observations suggested a constitutive expression of the antioxidant genes usually 
under the regulation of OxyR and SoxRS. Indeed this seems to be the case as shown recently by a 
transcriptomic analysis of M. tuberculosis response to oxidative stress. Expression of katG and 
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ahpC was maintained at high basal levels (Voskuil et al., 2011). This might be an advantage for M. 
tuberculosis and explain part of its success during host infection. However, even in the absence of 
these classical regulators M. tuberculosis was capable of a large transcriptional response to H2O2 
(Voskuil et al., 2011). Thus, other transcriptional regulators might be involved in the control of M. 
tuberculosis oxidative stress responses.  
IdeR, an iron-dependent transcriptional repressor, seems to play a role in M. tuberculosis 
oxidative stress response (Rodriguez et al., 2002). Inactivation of IdeR in M. tuberculosis results in 
increased sensitivity to oxidative stress. However, no difference in expression of genes involved in 
oxidative stress protection was found between ideR mutant and the wild-type. Therefore, the 
sensitive phenotype of the ideR mutant to oxidative stress might be due to an indirect effect, 
caused by changes on iron levels, instead of a direct interference with gene expression. Iron 
deficiency can lead to oxidative stress by decreasing the activity of iron-containing enzymes such as 
superoxide dismutases and catalases. On the other hand, increased intracellular free iron, 
participate in Fenton reactions, resulting in the enhanced generation of oxygen radicals and 
oxidative stress.  
Several sigma factors might also be involved in regulation of oxidative stress responses in 
mycobacteria. M. tuberculosis sigH mutant is more susceptible than wild-type to oxidative stress 
caused by H2O2 and other oxidative agents. In addition, SigH seems to regulate expression of 
thioredoxin/thioredoxin reductase genes (Manganelli et al., 2002; Raman et al., 2001) as well as  
sodA (Mehra and Kaushal, 2009). Other sigma factors (SigF, SigJ) might be also implicated in 
mycobacterial oxidative stress responses, as mutants in these genes are more susceptible to 
oxidative agents (Gebhard et al., 2008; Hu et al., 2004). However, no known antioxidant genes have 
been identified as regulated by these sigma factors, suggesting that the contribution of these 
transcriptional regulators might be indirect. The same happens for CarD, a recently identified 
transcriptional regulator in M. tuberculosis, which expression is induced by H2O2 and depletion 
leads to sensitivity to oxidative stress and other conditions (Stallings et al., 2009).   
Even though the referred regulators seem to, somehow, contribute to oxidative stress response 
regulation in mycobacteria, these are not specific for oxidative stress being also involved in the 
regulation of other kind of stresses/responses. A very recent study has shown that OxyS might be 
an oxidative stress response regulator in mycobacteria lacking OxyR (Li and He, 2012). OxyS is a 
LysR-type transcriptional regulator – the most abundant type of transcriptional regulators in 
prokaryotes involved in regulation of diverse functions including oxidative stress responses 
(Maddocks and Oyston, 2008). In fact, it was previously shown that OxyS might play a role in M. 
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tuberculosis oxidative stress response, as increasing concentrations of OxyS lowered levels of AhpC 
and made bacteria more sensitive to organic hydroperoxides. However, deletion of oxyS did not 
affect expression of katG (Domenech et al., 2001), suggesting that this was not the main katG 
regulator. Li et al. (2012) have shown though that M. tuberculosis OxyS binds to katG promoter, 
and this binding is inhibited by H2O2. Furthermore, M. smegmatis overexpressing OxyS had a 
reduced expression of katG and increased susceptibility to H2O2, suggesting that this was, indeed, a 
transcriptional repressor of katG (Li and He, 2012). These characteristics of OxyS are similar to that 
of FurA that also regulates expression of katG in M. tuberculosis (Sala et al., 2003). OxyS seems to 
regulate not only katG but also ahpC (Domenech et al., 2001). Further studies need to be 
performed to characterize the OxyS regulon and confirm if this could be a substitute regulator to 
OxyR. In addition, RoxY was identified in M. smegmatis as a repressor of OxyS, suggesting that 
oxidative stress regulation in mycobacteria that lack OxyR might be more complex than imagined. 
 
  
Objectives 
The main goal of this thesis is to investigate M. tuberculosis defense mechanisms against 
oxidative stress and their role in mycobacterial host adaptation and evolution. This particular kind 
of studies are relevant given that M. tuberculosis resistance mechanisms against reactive oxygen 
species (ROS) should contribute to the success this pathogen, however, their role in pathogenesis 
remains poorly understood. On the other hand, DNA repair, replication and recombination (3R) 
proteins are involved in the repair of the damages such as the ones induced by ROS, being 
important players in maintaining genome integrity, however, 3R proteins can also be responsible 
for genome variability and contribute to microbial adaptation and evolution, through allelic 
variation of its genes. Given that certain M. tuberculosis families seem to have some selective 
advantage over others, it is important to investigate the basis for their genetic variability. 
 
To achieve this goal two research studies were performed: 
A. Screening of a transposon mutant library for mutants with an impaired ability to resist to ROS 
in order to address the following questions: 
 Which genes are identified as important for M. tuberculosis resistance against ROS? 
 How do these genes contribute to M. tuberculosis virulence by allowing its survival in host 
cells?  
 
B. Analysis of polymorphisms in 3R genes in strains belonging to a successful family of M. 
tuberculosis to address the following questions: 
 Do we find 3R polymorphisms associated with this family? 
 Could some of these polymorphisms confer some selective advantage and contribute 
to the evolutionary success of these strains? 
 
The ultimate goal of this kind of studies is to identify potential virulence factors useful for the 
development of new anti-tuberculosis drugs or vaccine candidates. It could serve the purpose of 
identifying the strains that are more capable of evolving, and/or resisting treatment, which would 
be particularly relevant, given the increase of M. tuberculosis drug-resistant strains.
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 ABSTRACT 2.1
Mycobacterium tuberculosis has the remarkable capacity to survive within the hostile 
environment of the macrophage and to resist potent antibacterial molecules such as reactive 
oxygen species (ROS). Thus, understanding mycobacterial defence mechanisms against ROS may 
contribute to the development of new anti-tuberculosis therapies. Here we identified genes 
involved in such mechanisms by screening a high-density transposon mutant library and showed 
that most of these genes are involved in the intracellular lifestyle of the pathogen. Many of these 
genes were found to play a part in cell envelope functions further strengthening the important role 
of the mycobacterial cell envelope in protecting against aggressions such as the ones caused by 
ROS inside host cells.   
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 INTRODUCTION 2.2
Part of the success of Mycobacterium tuberculosis lies in its ability to thrive inside macrophages, 
in a very harsh environment, where bacteria are exposed to strong antimicrobial molecules such as 
reactive oxygen species (ROS) (Flannagan et al., 2009). Therefore, defence mechanisms against ROS 
are important for M. tuberculosis pathogenicity. Understanding the molecular basis of such 
mechanisms will provide clues for the development of target-specific drugs or effective attenuated 
strain-based vaccine candidates.  
The generation of ROS is initiated by the phagocyte NADPH oxidase (Phox) that produces 
superoxide anions. These anions have a low bactericidal potential, however, they rapidly dismutate 
into H2O2, particularly at acid pH in the phagosome. H2O2 can produce hydroxyl radicals, the most 
powerful oxidant, when reacting with iron in what is known as Fenton reaction(Friedberg et al., 
2006). These molecules are highly reactive agents, damaging proteins, lipids, carbohydrates and 
nucleic acids (Bedard and Krause, 2007). The biological importance of ROS is clearly demonstrated 
in patients with chronic granulomatous disease (CGD) characterized by a total absence or low level 
of ROS, resulting from Phox genetic deficiency. These individuals are highly susceptible to bacterial, 
fungal and yeast infections (Bedard and Krause, 2007) and increasing numbers of cases of 
mycobacterial diseases, including tuberculosis, are being diagnosed in such patients (Bustamante 
et al., 2007). Nonetheless, the significance of ROS in host defence against M. tuberculosis remains 
controversial.  
Despite the early demonstration that ROS were mycobactericidal (Walker and Lowrie, 1981), 
years later it was shown that M. tuberculosis could be resistant to killing by oxidative stress in 
macrophages (Manca et al., 1999). M. tuberculosis genes showing similarities with genes known to 
be involved in ROS resistance in different bacterial species were identified (Cole et al., 1998; Zahrt 
and Deretic, 2002). However, transcriptomic analysis showed that many of these genes are not 
induced in oxidative conditions (Garbe et al., 1996; Schnappinger et al., 2003). This is explained by 
a relatively high constitutive expression level of such genes (Voskuil et al., 2011) that, associated 
with an absence of the classic oxidative stress response regulators (SoxR and OxyR) (Zahrt and 
Deretic, 2002), leads to reduced induction ratios. This suggests that bacilli are continuously primed 
for oxidative stress defense revealing once again the importance of this kind of responses in M. 
tuberculosis. Still, evidence for a role in defence against ROS mainly comes from M. tuberculosis 
katG mutant, with an alteration of both catalase and peroxidase activities, which was attenuated in 
wild-type mice but grew normally in phox-deficient mice (Ng et al., 2004).  
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The construction of transposon mutant libraries in mycobacteria has enabled the newly 
identification and study of several potential virulence factors (Camacho et al., 1999; Cox et al., 
1999; McAdam et al., 2002). So far, different screening-based approaches using mutant libraries 
have been conducted to identify M. tuberculosis mutants sensitive to different conditions found 
inside host macrophages, including acidic (Vandal et al., 2008) as well as nitric (Darwin et al., 2003) 
stresses. With the aim to identify and investigate genes required for resistance against ROS in M. 
tuberculosis, we screened, for the first time, a transposon mutant library to identify mutants with 
impaired ability to resist oxidative stress.  
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 MATERIAL AND METHODS  2.3
2.3.1 Bacterial Strains and growth conditions 
M. tuberculosis strains GC1237 (Caminero et al., 2001) and H37Rv were grown in Middlebrook 
7H9 media (Difco) supplemented with ADC and 0,05% Tween 80, except when referred, or in 
Middlebrook 7H11 media (Difco) supplemented with OADC and 0,5% glycerol for CFU analysis. 
Mutant strains were grown in the presence of kanamycin 20 µg/ml and complemented strains 
grew in the presence of both kanamycin and hygromycin 20 µg/ml and 50µg/ml, respectively.  
Luminescent bacteria were obtained by transforming M. tuberculosis strains, by electroporation as 
described (Parish and Stoker, 1998), with a luciferase-expressing plasmid derived from pSMT3 
(Humphreys et al., 2006). Positive clones were selected with 50 µg/ml hygromycin and 
luminescence emission from luciferase was confirmed in a luminometer.  
 
2.3.2 Mutant library screening 
Mutants of the M. tuberculosis GC1237 strain transposon library (Brodin et al., 2010) were 
grown individually at 37ºC in 96-well plates in 7H9 medium for 3 weeks. Optical density (OD) was 
measured, at 620nm, and mutants which presented growth defects at this phase were excluded 
from subsequent analysis. For those mutants, which no growth defects were observed, aliquots 
(10-20 µl) were sub-cultured in 200 µl 7H9 medium containing 9mM of H2O2 (Sigma-Aldrich). OD 
was measured two to three weeks later in a plate spectrophotometer and the ratio of the OD value 
of the mutant to that of the wild-type strains (growth index) was calculated. Mutants with a growth 
index below 0.4 were considered as sensitive to H2O2 (Table 2). 
 
2.3.3 Identification of transposon insertion sites 
Genomic DNA from selected transposon mutants was extracted and the exact location of the 
transposon insertion was determined by sequencing amplicons generated by ligation-mediated 
inverse PCR (Cox et al., 1999). Briefly, 1-2 µg of DNA was digested with BssHII, a low-moderate 
frequency cutting restriction enzyme that doesn’t cut the transposon, followed by heat inactivation 
of the restriction enzyme and analysis in an agarose gel to check for complete digestion. An aliquot 
of the digested DNA (<0,5ng) was diluted (1:10) and ligated overnight at 16ºC, followed by ethanol 
precipitation.  Using these products a PCR was done to amplify the DNA regions adjacent to the 
transposon using TaKaRa La Taq DNA polymerase  (TaKaRa, Shiga, Japan) with the primers 
corresponding to the left (Tn_L) and the right (Tn_R) (Table 1) ends of the transposon. The 
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amplified products were sequenced using an ABI prism 3100 Genetic Analyser (Applied Biosystems) 
with Big Dye Terminator v3.1 cycle sequencing Kit (Perkin Elmer Applied Biosystems, Courtaboeuf, 
France). Sequences were mapped in M. tuberculosis H37Rv genome available at Tuberculist (Cole 
et al., 1998).  Transposon insertions within the mmpL9, moaD1, ppe54 and ppe56 genes were also 
confirmed by Multiplex-PCR using a primer flaking the site of transposon insertion (genename_F) 
with primers hybridizing inside the transposon (Tn_L and Tn_R2) (Table 1). 
 
 
Table 1. List of oligonucleotides (5’-3’) used in this study.  
Primer name  Sequence 
Tn_L  GTCGGCCATTAGCTTCT 
Tn_R CACCACCGATCCTCAT 
Tn_R2 GCACCACCGATCCTCAT 
mmpL9_F GCATCAGAACCTATGTCACCG 
mmpL9_R GATCGCATGGTCAACATCA 
moaD1_F CGCTGTCAGCGTCACTATC 
ppe54_F GGTATCGGCAATGTAGGTACTCA 
ppe56_F CATCCTCATCGGCGATA 
pMV_F  ATTCTAGAGCATCATCCTCCCACGAC 
pMV_R ATAAGCTTTATCAACCCCGGTGCAGAT 
 
 
2.3.4 Complementation of mmpL9 and moaD1 mutants 
To genetically complement the mmpL9 mutant, the mmpL9 gene with its putative promoter 
region from the wild-type strain M. tuberculosis GC1237 or H37Rv, was introduced in the 
integrative vector pMV306, conferring hygromycin resistance (Lee et al., 1991). The 
complementation construct was generated by amplifying the mmpL9 gene along with 629bp 
upstream intergenic region from GC1237 or H37Rv chromosomal DNA, using Phusion High-fidelity 
DNA polymerase (Finnzymes), with the primers pMV_F and pMV_R (Table 1), containing the 
restriction sites of XbaI and HindIII, respectively. The amplified product was gel purified, digested 
with XbaI and HindIII, and cloned between XbaI and HindIII sites in pMV306. The resulting plasmid 
was sequenced to confirm that no mutations were present, and transformed into the mutant by 
electroporation as described (Parish and Stoker, 1998). Transformed bacteria were recovered using 
hygromycin and kanamycin selection (50 µg/ml both) and the presence of the wild-type gene was 
confirmed by PCR using primers mmpL9_F and mmpL9_R (Table 1). 
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The moaD1 mutant was complemented using the pYUB412-derived cosmid (Bange et al., 1999) 
I528, which carries a DNA fragment covering the 3454 to 3485 Kb region of the M. tuberculosis 
H37Rv chromosome and a hygromycin resistance cassette. Bacteria were transformed and selected 
as described for mmpL9 mutant complementation. 
 
2.3.5 Susceptibility to oxidative stress, starvation and acidic pH  
Bacteria were collected from cultures, washed twice with PBS and clumps were dissociated by 
needle passages, as performed for macrophage infection. To assess the killing effect of H2O2, 
single-cell suspensions were adjusted to approximately 1x106 CFU/ml in 7H9 medium without ADC. 
Then, bacteria were exposed to 9mM H2O2 for 4 hours at 37ºC. Control untreated bacteria were 
also included. Dilutions were made, plated and CFUs were counted after 3 weeks growth at 37ºC. 
Percentage of survival was calculated by dividing the number of H2O2 treated CFUs by the number 
of untreated CFUs and multiplying by 100. For growth rate analysis, bacteria were grown in 7H9 
medium at 37ºC in the presence of increasing concentrations of H2O2 (4mM, 6mM, 9mM, 12mM 
and 15mM), or at pH 4.5, and OD values were measured, at 600nm, every three days, during 2 to 3 
weeks.  
Susceptibility to complete starvation was determined essentially as previously described (Parish, 
2003). Briefly, single-cell suspensions were adjusted to approximately 1x106CFUs/ml in sterile 
distilled water and incubated at 37ºC. Aliquots were taken 5 and 10 days after, dilutions were 
made and plated, and CFUs were analysed 3 weeks later. Percentage of survival was calculated by 
dividing the number of CFUs at day 5 or 10 by the number of CFUs at time zero and multiplying by 
100. 
 
2.3.6 Human monocyte isolation for subsequent macrophage generation 
Freshly collected buffy coats were obtained in accordance with institutional requirements and 
written consent from healthy donors. PBMC fraction was collected using a Ficoll gradient (Ficoll-
PaqueTM Plus, GE Health Care) and monocytes were purified by positive selection using anti-CD14 
conjugated magnetic microbeads (Milteny Biotec) and Quadro MACS Separation System (Milteny 
Biotec) according to manufacturer’s protocol. Monocytes were distributed into 6-well plates and 
allowed to adhere in a 5% CO2 incubator at 37°C in 3ml of RPMI-1640 (Sigma-Aldrich) containing 2 
mM of L-glutamine (Gibco), 10% of heat inactivated foetal bovine serum (PAN Biotech) and 50 
ng/ml of cytokine rhM-CSF (recombinant human macrophage colony stimulating factor) (R&D 
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Systems) to differentiate into macrophages. Cultures were fed every 2 days with this medium 
containing full doses of cytokine during 6 days. 
Before infection, macrophages were recovered using a non-enzymatic cell dissociation solution 
(Sigma-Aldrich), counted and adjusted to 2x105 per well in 24-well plates, where they were allowed 
to adhere.  
 
2.3.7 Macrophage Infections 
Bacteria were grown in 7H9 medium without Tween at 37°C. In the infection day, bacteria were 
recovered, washed two times and resuspended in 1 ml PBS. Clumps were disassociated by 30 
passages through a 0,8x40 mm needle and 50 passages though a 0,45x10 mm needle (3 times). OD 
was measured, at 600 nm, and correlated with bacterial number in order to adjust the multiplicity 
of infection (MOI) used for infection. The medium was removed from blood-monocyte derived 
macrophages and replaced with 500µl of bacterial suspensions in RPMI-1640, containing 2 mM of 
L-glutamine and 10% of heat inactivated foetal bovine serum. After 4 hours of infection, medium 
was removed along with non-ingested bacteria and cells were incubated with fresh medium. At 
each time point post-infection, macrophages were lysed, dilutions were made and samples were 
plated in 7H11 Middlebrook agar. After 3 weeks growth at 37ºC, bacteria were quantified by CFUs 
analysis. When using luminescent M. tuberculosis, bacteria were quantified immediately after 
macrophage lysis, in a luminometer. Each infection experiment was carried out using triplicates for 
each condition/strain. 
When using NADPH oxidase inhibitors, macrophages were incubated for 1 hour with 100µM 
Apocynin (Calbiochem) and 10µM Diphenyleneiodonium (DPI) (Sigma-Aldrich) prior to infection. 
Dimethyl sulfoxide (DMSO) was added to cultures at 0.1% (vol/vol) as a solvent control. The ROS 
scavenger 4-Hydroxy-TEMPO (0.1 and 0.2 mM; Sigma-Aldrich) as well as superoxide dismutase 
(55U/ml; Sigma-Aldrich) were added during the 4 hour infection period and washed away from 
cells along with non-ingested bacteria. To activate macrophages, 1α,25-Dihydroxyvitamin D3 (10
-8, 
10-7 or 10-6 M; Sigma-Aldrich), the active form of vitamin D3, was added to cells after the 4 hour 
infection period and left in the medium during the entire post-infection period. Ethanol 95% was 
added to cultures at 0.1% (vol/vol) as a solvent control for Vitamin D3. In these experiments 
macrophages were infected with M. tuberculosis strains expressing luciferase. 
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2.3.8 Superoxide Anion detection in human macrophages 
Superoxide production by macrophages was measured using the LumiMax Superoxide Anion 
Detection kit (Agilent Technologies). Monocyte derived-macrophages (2x105) were incubated with 
apocynin (50 and 100µM) and DPI (1 and 10 µM) for 1 hour at 37ºC, 5% CO2. Then, macrophages 
were collected and resuspended in the SOA assay medium, provided with the kit. A solution 
containing luminol, an enhancer, and PMA (Phorbol 12-myristate 13-acetate;Sigma), a NADPH-
oxidase stimulator, or M. tuberculosis, was added to macrophages following manufacturer’s 
instructions. The chemiluminescence resulting from oxidation of luminol by the superoxide anion 
was then detected using a luminometer.  
 
2.3.9 Analysis of polymorphisms in mmpL genes in M. tuberculosis genomes 
Twenty-four genomes, three recently sequenced by our lab (Namouchi et al., 2012) and 21 
publicly available, from major M. tuberculosis lineages were analysed to identify SNPs in the 13 
mmpL genes present in M. tuberculosis genomes (Cole et al., 1998). This was performed as 
described by Namouchi et al. (2012).  
 
2.3.10 Statistics 
Statistical significance was determined using the Student’s two-tailed, unpaired, t-test. Analyses 
were performed using the GraphPad Prism software (GraphPad Software, CA, USA).  
 
2.3.11 Ethics Statement 
Human monocytes were purified from buffy coats obtained from healthy blood donors 
(Etablissement Français du Sang, EFS, Rungis). All donors participating to this study had given 
their written consent under a EFS contract C- CPSL UNT N°09/EFS/062, following articles L1243-
4 and R1243-61 of the French Public Health Code and approved by the French Ministry of 
Science and Technology. Supply and handling of human red cells followed the guidelines of the 
agreement between Institut Pasteur, EFS and the regulation of blood donation in France. As a 
“collection” is defined by Decree 2007-1220 as “a collection, for scientific use, of biological 
samples from a group of persons who have been identified and selected on the basis of clinical 
or biological characteristics of one or several members of the group”, and as the blood samples 
used in our study were not obtained from individuals that have been “identified or selected on 
the basis of clinical or biological characteristics”, these samples do not constitute a so-called 
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“collection”, which waives the need for ethical approval by the ethical committee “Comité de 
Protection des Personnes”, in agreement with Decree 2007-1220, article R1243-63. 
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 RESULTS 2.4
2.4.1 Screening for mutants with increased susceptibility to oxidative stress 
In order to optimize the conditions to screen a mutant library for mutants with increased 
susceptibility to H2O2, we tested a small set of DNA repair mutant strains. These were knockout 
mutants in mutT1, mutM, and mutY genes, involved in handling oxidized guanine, an important 
DNA lesion caused by ROS (Demple and Harrison, 1994). Analysis of growth rates in the presence of 
increasing concentrations of H2O2 show that 9 mM H2O2 totally inhibited the mutY mutant growth, 
while the wild-type (H37Rv), as well as the mutT1 and mutM mutant strains, were still able to grow 
(Figure 1). At 12mM H2O2 growth was totally inhibited for all strains (Figure 1). The mutY mutant 
presented a slight growth defect in the absence of H2O2 that could also be due to sensitivity to 
oxidative stress caused by endogenous ROS resulting from aerobic respiration (Imlay, 2008; Storz 
and Imlay, 1999). These results show that the mutY mutant has an increased susceptibility to H2O2 
and allowed us to define the conditions to use in our screening.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Growth curves of M. tuberculosis H37Rv, ΔmutT1, ΔmutM and ΔmutY in increasing 
concentrations of hydrogen peroxide. Data represent means of triplicates in a representative 
experiment. 
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The difference observed between the mutY, mutT1 and mutM mutants might be explained by 
the fact that M. tuberculosis possesses multiple homologs of mutT and mutM in the genome, while 
a single mutY homolog has been annotated in mycobacterial genomes (Cole et al., 1998). For 
example, mycobacterial MutT1 and MutT2 seem both to have 8-oxo-GTP hydrolase activity (Dos 
Vultos et al., 2006). 
Next, we screened a transposon mutant library constructed in a virulent M. tuberculosis clinical 
isolate (GC1237) of the Beijing/W family (Brodin et al., 2010). M. tuberculosis GC1237 growth in the 
presence of H2O2 was similar to H37Rv (Figure 2). Sensitive mutants were identified by comparing 
their OD values to the ones of the wild-type after 3 weeks growth in the presence of 9 mM H2O2. 
The analysis of approximately 6000 mutants allowed the selection of 18 H2O2 sensitive mutants 
corresponding to 11 different genes and two intergenic regions identified by sequencing the 
transposon insertion sites after inverse PCR (Table 2). No significant growth defect was observed 
for these mutants in the absence of H2O2, indicating that their sensitivity to H2O2 is specific (Table 
2). 
 
 
 
 
 
 
 
 
 
Figure 2 - Growth curves of M. tuberculosis GC1237 in increasing concentrations of hydrogen 
peroxide. Data represent means of triplicates in a representative experiment. 
 
2.4.2 Sensitive mutants to oxidative stress are affected in cell envelope functions  
Interestingly, many of the sensitive mutants to oxidative stress we have identified harbour defects in 
genes involved in M. tuberculosis cell envelope functions (Table 2). These include four different ppe 
genes, that code for cell surface proteins, present almost exclusively in pathogenic mycobacteria, 
thought to be involved in virulence (Akhter et al., 2012), as well as an ABC transporter (Rv0986) 
implicated either in the transport of an adherence factor or in mycobacterial cell wall architecture and 
integrity (Rosas-Magallanes et al., 2007).  
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Table 2. List of identified sensitive mutants to oxidative stress using hydrogen peroxide.  
 
Cell envelope associated function     Insertion sequences and phages 
Intermediary metabolism and respiration    Unknown 
Conserved hypotheticals 
 
a
Annotations are from tuberculist http://genolist.pasteur.fr/TubercuList/.  
b, c
 Growth index is the ratio of the optical density value of the mutant to that of the wild-type strain after 3 weeks 
growth in the absence (b) or presence (c) of H2O2 9mM. Mutants with a growth index below 0.4 were selected as 
sensitive to H2O2.
*
Tn inserted 41 bp upstream the gene start codon. 
Mutant  
id 
Gene 
(transposon insertion site) 
Product 
Putative function
a 
Growth 
Index
b
 
Growth 
Index 
H2O2
c
 
Reference 
118B7 Rv0305c (2701:2702) 
 
PPE6 
Unknown 
0,99 0.35 This study 
118F3 Rv0986 (430:431) 
 
ABC transporter 
Thought to be involved in active transport 
of adhesion component across the 
membrane 
1,04 0.24 (Fontan et al., 2008; 
Pethe et al., 2004; 
Rosas-Magallanes et al., 
2007) 
100C5 Rv1548c (1125:1126) 
 
PPE21 
Unknown 
0.85 0.38 (Voskuil et al., 2004) 
98F4 Rv2339(1290:1291) 
 
Transmembrane transport protein MmpL9 
Thought to be involved in fatty acid 
transport 
0.80 0.13 (Domenech et al., 2005; 
Lamichhane et al., 2005; 
MacGurn and Cox, 
2007) 
100D7 Rv2339 (957:958) 
 
Transmembrane transport protein MmpL9 
Thought to be involved in fatty acid 
transport 
1,02 0.31 (Domenech et al., 2005; 
Lamichhane et al., 2005; 
MacGurn and Cox, 
2007) 
117C10 Rv2339 (812:813) 
 
Transmembrane transport protein MmpL9 
Thought to be involved in fatty acid 
transport 
0,95 0.23 (Domenech et al., 2005; 
Lamichhane et al., 2005; 
MacGurn and Cox, 
2007) 
104D8 Rv3343c (2758:2759) 
 
PPE54  
Unknown 
1.13 0.31 (Brodin et al., 2010; 
Voskuil et al., 2004) 
115C10 Rv3343c (5907:5908) 
 
PPE54  
Unknown 
1,01 0.32 (Brodin et al., 2010; 
Voskuil et al., 2004) 
99G11 Rv3350c (1441:1442) 
 
PPE56  
Unknown 
0.93 0.23 (Voskuil et al., 2004) 
115B9 Rv3350c (5059:5060) 
 
PPE56  
Unknown 
1,03 0.27 (Voskuil et al., 2004) 
115C9 RV3350c (5059:5060) 
 
PPE56  
Unknown 
0,98 0.30 (Voskuil et al., 2004) 
115C4 Rv3112 (49:50) 
 
Molybdenum cofactor biosynthesis protein 
MoaD1 
Involved in molybdenum cofactor 
biosynthesis 
0,92 0.38 (Brodin et al., 2010) 
100E6 Rv1507c (591:592) 
 
Conserved hypothetical protein  
Unknown 
0.95 0.36 (Brodin et al., 2010) 
111E12 Rv3594 (774:775) 
 
Conserved hypothetical protein  
Unknown 
0,74 0.09 This study 
96F9 Rv1509 (637:638) 
 
Hypothetical protein  
Unknown 
0,89 0.34 This study 
100D1 Rv2337c  (-41)* Hypothetical protein  
Unknown 
1,05 0.15 This study 
106H11 Rv3430c (1049:1050) 
 
Possible transposase 
Involved in the transposition of the 
insertion sequence IS1540 
0,75 0.20 (Dutta et al., 2010) 
98G4 Rv2480c-Rv2481c 
(2786248:2786249) 
Possible transposase for insertion sequence 
element IS6110 (fragment)-Hypothetical 
protein 
0.76 0.14 - 
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Strikingly, we could independently isolate three different mutants in the mmpL9 gene, which 
suggests an important role for MmpL9 in M. tuberculosis response to oxidative stress (Table 2). 
MmpLs (mycobacterial membrane protein large) are thought to be involved in lipid synthesis 
and/or transport (Tekaia et al., 1999).  
Some genes with no apparent known function were also identified in our screen (Table 2). 
However, rv1507c belongs apparently to a cluster of genes organized in an operon (rv1503c-
rv1507c), involved in di-O-acyl-trehalose (DAT) lipid synthesis (Brodin et al., 2010). The rv1509 gene 
seems to form an operon along with rv1508a. BLAST analysis identified methyltransferase domains 
in the Rv1509 protein. Rv1508a shows homology with GDP-D-Mannose-Dehydratase (GMD). GMD 
is involved in the production of L-fucose from GDP-D-mannose. Fucose is part of PGLs found in 
Beijing/W strains. However, other GMP has been identified that seems to be already involved in 
this pathway (Malaga et al., 2008). Thus, whether Rv1508a along with Rv1509 are involved in lipid 
synthesis is unclear. Rv3594, another protein with unknown function found in our screen, shows 
similarities with an N-acetylmuramoyl-L-alanine-amidase, a peptidoglycan hydrolase. 
Peptidoglycan hydrolases participate in bacterial cell wall growth and regulation as well as in 
different lysis phenomena (Vollmer et al., 2008). 
We have also identified a few genes not associated with M. tuberculosis cell envelope functions. 
It was the case of moaD1, recently confirmed as involved in the biosynthesis of the molybdenum 
cofactor (MoCo) in M. tuberculosis (Williams et al., 2011).  
Curiously, a mutant in a putative transposase (Rv3430c) was selected as sensitive to oxidative 
stress. A significant proportion of insertion element genes including transposases were also found 
to be highly induced in M. tuberculosis after exposure to several DNA-damaging agents, including 
H2O2 (Boshoff et al., 2003). However, the correlation between these mobile genetic elements and 
oxidative stress or DNA damage/repair is not clear. This gene was also found to be important for 
M. tuberculosis survival in the lungs of non-human primates (Dutta et al., 2010), suggesting a role 
for Rv3430c in vivo. 
 
2.4.3 Quantification of sensitivity of mutants to oxidative stress  
The sensitive phenotype of our newly identified mutants to oxidative stress was further 
analyzed and quantified on the individual level.  This was done by analyzing the killing effect of 
H2O2 in several of those mutants possibly affected in cell envelope components including, two PPE 
mutants, ppe54 and ppe56, and an mmpL9 mutant, as well as for the moaD1 mutant possibly 
implicated in other kind of defense mechanism against oxidative stress. As several mutants, 
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carrying independent transposon insertions, were identified we have randomly chosen a ppe54 
(104D8), a ppe56 (115B9) and an mmpL9 (100D7) mutant (Table 2).  
The results represented in Figure 3 show that all mutant strains, except ppe54, have an 
increased sensitivity to killing by H2O2 when compared to their wild-type counterpart. We observed 
a decrease in survival ranging from around 40% (104D8, ppe56 mutant) to nearly 80% (100D7, 
mmpL9 mutant), while the killing rate for the wild-type strain was less than 20% (Figure 3). There 
was no difference in colony size or morphology of the mutants when compared to the wild-type 
strain in the absence of H2O2 (data not shown). These results confirm the sensitive phenotype of 
these strains to oxidative stress in the presence of H2O2 and reveal its bactericidal effects.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Susceptibility of transposon mutants to oxidative stress. Percentage of survival of the M. 
tuberculosis 100D7 (mmpL9), 115C4 (moaD1), 104D8 (ppe54), 115B9 (ppe56) transposon mutants and 
wild-type (GC1237) strains was determined by comparing bacteria treated with 9mM of hydrogen 
peroxide to untreated controls. Data and error bars represent means and standard deviations of the 
results from triplicates in a representative experiment carried out three times with similar results. 
Statistically significant differences were calculated using the Student’s two-tailed, unpaired, t-test, and 
are indicated by asterisks *P<0,05; ***P<0,001; ****P<0,0001. 
 
The difference in sensitivity to H2O2 between the ppe54 mutant and the wild-type strain was not 
statistically significant. This suggests that the effect of H2O2 on this strain is not bactericidal but 
probably only bacteriostatic as we observed growth inhibition in the presence of H2O2 during the 
screen (Table 2). Additionally, two different mutants, carrying independent transposon insertions 
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in the ppe54 gene, were selected (Table 2), confirming the sensitivity to oxidative stress of any 
strain carrying a mutation in this gene.  
 
2.4.4 MmpL9 and MoaD1 are important for M. tuberculosis survival in human 
macrophages 
Because bacteria have to face oxidative stress conditions inside host cells we decided to analyze 
growth in human macrophages of the moaD1 and mmpL9 mutants which were the most sensitive 
strains to killing by H2O2 (Figure 3). Additionally, MmpLs have been identified as important 
determinants of M. tuberculosis virulence (Camacho et al., 1999; Converse et al., 2003; Cox et al., 
1999; Domenech et al., 2005), even though reports regarding mmpL9 mutant phenotype in mice 
are contradictory (Cox et al., 1999; Domenech et al., 2005; Lamichhane et al., 2005; MacGurn and 
Cox, 2007). Genes involved in the same biosynthetic pathway as moaD1 have been previously 
shown to be important for bacterial intracellular lifestyle (Rosas-Magallanes et al., 2007), 
suggesting an important role for MoCo in M. tuberculosis survival inside host cells. 
Monocyte-derived macrophages were infected with mutant, wild-type and complemented 
strains and after six days post-infection cells were lysed and bacteria were plated to analyze CFUs. 
As shown in Figure 4, both moaD1 and mmpL9 (100D7) mutants displayed an impaired intracellular 
growth when compared to their wild-type counterpart (Figure 4A and B). At day 6 post-infection, 
the moaD1 mutant showed a 4-fold increase in intracellular growth while the wild-type showed a 
12-fold increase, with respect to time-point zero. Complementation of the moaD1 mutant using an 
integrative vector restored the wild-type phenotype inside macrophages (Figure 4A). These results 
suggest that MoCo might be indeed important for mycobacterial growth inside host cells.  
Infection of human macrophages with the mmpL9 mutant resulted in an increase of 2.5-fold 
while the wild-type had a 15-fold increase in CFUs, after 6 days (Figure 4B). Sequence analysis of 
the mmpL9 gene of the wild-type strain GC1237 revealed, when compared to H37Rv, the presence 
of one nucleotide deletion at position 218. To better understand the possible effects of this 
frameshift mutation, we decided to complement the mmpL9 mutant with mmpL9 of either GC1237 
or H37Rv. As shown in Figure 4B, complementation restored the wild-type phenotype inside 
macrophages using mmpL9 of GC1237. However, it seems to be only partially restored when 
complemented with H37Rv mmpL9.  
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Figure 4. Intracellular growth of mmpL9 and moaD1 mutants in human macrophages. Monocyte-
derived macrophages where infected with wild-type, moaD1 (A) or mmpL9 (B) mutant and 
complemented (COMP) strains, at an MOI of 1:100 (bacteria per macrophage).  At time point zero (0) 
and six days of infection, cells were lysed and bacteria were enumerated. Data and error bars represent 
means and standard deviations of the results from triplicates in a representative experiment carried out 
three times with similar results. Statistically significant differences were calculated using the Student’s 
two-tailed, unpaired, t-test, and are indicated by asterisks *P<0,05; **P<0,01;***P<0,001. 
 
 
Unfortunately, we could not detect, using Western blotting, expression of either H37Rv or 
GC1237 mmpL9 carrying a hemagglutinin tag, under the control of its own or of a strong promoter 
(hsp60), in either M. tuberculosis or M. smegmatis, using different growth conditions and whole 
cell lysate preparation methods (data not shown).  
 
 
 
2.4.5 The mmpL9 deletion at position 218 is conserved in Beijing/W strains 
To investigate the possible effects of the deletion identified in mmpL9 for the GC1237 strain, we 
searched for SNPs in the 13 M. tuberculosis mmpL genes (Cole et al., 1998) in a collection of strains 
representing main M. tuberculosis lineages. Statistical analysis of the identified SNPs suggests that 
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the mmpL9 gene does not accumulate more polymorphisms than the other mmpLs (Table 3), 
excluding the hypothesis of pseudogene formation but not that of an effect, of the observed 
polymorphisms, on protein’s functions.  
 
 
Table 3. Statistical analysis of SNP density in mmpL genes in a collection of M. tuberculosis genomes.  
Name Length (bp)
 
SNPs Binomial test
a 
Bonferroni correction
b 
mmpL1 2877 3 0,926187042 12,96661859 
mmpL2 2907 9 0,167599855 2,346397974 
mmpL3 2835 13 0,008366836 0,117135699 
mmpL4 2904 6 0,565387826 7,915429562 
mmpL5 2895 7 0,406734347 5,694280858 
mmpL6 1194 6 0,026461116 0,370455623 
mmpL7 2763 5 0,670824515 9,391543207 
mmpL8 3270 9 0,270440559 3,786167821 
mmpL9 2889 7 0,404469247 5,662569455 
mmpL10 3009 2 0,980458231 13,72641523 
mmpL11 2901 5 0,716449242 10,03028939 
mmpL12 3441 11 0,128927703 1,804987847 
mmpL13a 912 4 0,071781264 1,004937698 
mmpL13b 1413 1 0,862276271 12,07186779 
Total 36210 88     
 
a
The binomial test was used to identify mmpL genes that accumulate more SNPs than expected. The p-value was 
calculated according to the number of SNPs and length of each gene and the total number of SNPs and genes 
length.  
b
The final p-value was estimated after Bonferroni correction. 
 
 
Additionally, analysis of polymorphisms in mmpL9 in these collection of strains have shown that 
the deletion in nucleotide 218 is specific to all modern and ancestral Beijing/W strains, being 
absent from early ancestral Beijing/W strains, such as 94_M4241A, and strains of any other M. 
tuberculosis family/lineage (Figure 5).  
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Figure  5. Graphical representation of the distribution of polymorphisms in mmpL9 in several  M. 
tuberculosis genomes. Polymorphisms in mmpL9 were analyzed in 24 different M. tuberculosis 
genomes (Namouchi et al., 2012) that correspond to the following groups/lineages according to 
Gagneux’s classification (Gagneux et al., 2006a): 1-8: Beijing/W strains; 9-16: Euro-American strains; 17-
20: Indo-oceanic strains; 21-22: West-African strains. Black vertical lines correspond to SNPs. Gap 
correspond to deletion in position 218 identified in all modern and ancestral (2-8) but not in early 
ancestral (1) Beijing/W strains.   
 
 
2.4.6 MmpL9 and MoaD1 are required to counteract other forms of stress existent in 
macrophages    
The wild-type phenotype was partially achieved for both moaD1 and mmpL9 complemented 
strains in susceptibility tests using H2O2 (Figure 6). The reasons behind these observations are not 
understood. It could be due to differences in the fine tuning of expression of these genes once they 
are placed outside their normal chromosomal context.  Nonetheless, the mmpL9 and moaD1 genes 
should have a function in M. tuberculosis oxidative stress, otherwise complementation would not 
have restored the wild-type phenotype at all. These results were unexpected once 
complementation totally restored the wild-type phenotype in macrophages (Figure 4). To 
investigate if the attenuated growth of the mmpL9 and moaD1 mutants in macrophages was due, 
at least in part, to their sensitivity to ROS, we’ve analysed their phenotype in macrophages treated 
with Phox-inhibitors.  
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Figure 6. Survival of mmpL9 and moaD1 mutant and complemented strains exposed to hydrogen 
peroxide. Percentage of survival of M. tuberculosis wild-type (GC1237), moaD1 (A) and mmpL9 (B) 
mutant and complemented (COMP) strains was determined by comparing bacteria treated with 9mM 
of hydrogen peroxide to untreated controls. Data and error bars represent means and standard 
deviations of the results from triplicates in a representative experiment. Statistically significant 
differences were calculated using the Student’s two-tailed, unpaired, t-test, and are indicated by 
asterisks ***P<0,001; ****P<0,0001. 
 
 
Macrophages were treated with apocynin and diphenyleneiodonium (DPI), the most common 
used NADPH inhibitors (Flannagan et al., 2009).  To analyse if Phox could be effectively inhibited 
using these compounds we measured superoxide production in these cells. Almost 90% reduction 
in superoxide production using apocynin (100µM) and more than 70% using DPI (10µM) was 
observed (Figure 7A). These compounds did not seem to significantly affect the viability of 
macrophages as assessed by trypan blue exclusion (Figure 7B).  
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Figure 7. Macrophages treated with the NADPH oxidase inhibitors, apocynin and DPI.  
Macrophages (~2x105) were treated for 1h with DPI (1, 10µM) and apocynin (50, 100 µM). Untreated 
macrophages were used as control. Superoxide production was measured by quantifying 
chemiluminescence resulting from oxidation of luminol in a luminometer (RLUs - Relative light units), 
after stimulation of macrophages with PMA (A).  Effect on cell viability was determined by counting 
cells unstained (viable) with trypan blue. DMSO was included as a solvent control. No statistical 
significant differences between cells treated with inhibitors and untreated cells were observed (B).  
Data and error bars represent means and standard deviations of the results from triplicates. 
 
Macrophages were treated with the inhibitors and infected with luminescent M. tuberculosis 
mmpL9 and moaD1 mutants, as well as the wild-type strain. As shown in figure 8, no statistically 
significant differences were observed between untreated and inhibitor-treated macrophages 
infected with either mutants or the wild-type strain (Figure 8). We realized, however, that infected 
macrophages treated with DPI had a different morphology compared to untreated macrophages, 
when observed under the light microscope (data not shown) even though this compound didn’t 
seem to significantly affect macrophage viability (Figure 7B). This could be probably because DPI is 
a nonspecific inhibitor of many different electron transporters (Bedard and Krause, 2007). Given 
that we did not know which consequences this could have on intracellular bacterial survival, DPI 
was excluded from the subsequent experiments. 
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Figure 8. Intracellular growth of mmpL9 and moaD1 mutants in human macrophages treated with 
Phox inhibitors. Monocyte-derived macrophages (~2x105) where treated with apocynin (100µM) and 
DPI (10µM) prior to infection with luminescent wild-type (GC1237), moaD1 or mmpL9 mutant strains, at 
an MOI of 1:10 (bacteria per macrophage). DMSO was used as a solvent control. After 3 days (D3) of 
infection cells were lysed and bacteria were quantified by detecting luminescence in a luminometer 
(RLUs - Relative light units). Data and error bars represent means and standard deviations of the results 
from triplicates in a representative experiment carried out three times with similar results.  
 
Vitamin D3-activated macrophages have an increased antimycobacterial activity that seems to 
be mediated, at least in part, by superoxide produced by Phox (Sly et al., 2001). By increasing ROS 
production we could possibly increase the difference between treated and untreated macrophages 
with Phox inhibitors, in case there is one. We did indeed observe a reduction in bacterial load 
(Figure 9A) as well as an increased superoxide production (Figure 9B) in macrophages activated 
with 1α,25-Dihydroxyvitamin D3, the active form of vitamin D3, infected with M. tuberculosis 
GC1237. Thus, we decided to use vitamin D3-activated macrophages to analyse the phenotype of 
the mmpL9 and moaD1 mutants in the presence of phox inhibitors. 
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Figure 9. Macrophages activated with Vitamin D3. Monocyte-derived macrophages were treated with 
1α,25-Dihydroxyvitamin D3 (10
-6M), the active form of vitamin D3, and superoxide production was 
measured by quantifying chemiluminescence resulting from oxidation of luminol in a luminometer 
(RLUs - Relative light units), after stimulation with M. tuberculosis GC1237 (A). Macrophages were 
infected with luminescent M. tuberculosis GC1237 at an MOI of 1:10 (bacteria per macrophage), and 
incubated with 1α,25-Dihydroxyvitamin D3 (10
-8, 10-7,10-6M). After 3 days of infection, cells were lysed 
and bacteria were quantified by detecting luminescence in a luminometer (RLUs - Relative light units). 
Data and error bars represent means and standard deviations of the results from triplicates in a 
representative experiment carried out two times with similar results. Statistically significant differences 
were calculated using the Student’s two-tailed, unpaired, t-test, and are indicated by asterisks *P<0,05; 
***P<0,001; ****P<0,0001 (B). Untreated macrophages were used as control. Ethanol was used as a 
solvent control.  
 
Given that the ROS scavengers TEMPO, and the antioxidant enzyme superoxide dismutase (SOD) 
were found to abrogate Vitamin D3 antimycobacterial effect (Sly et al., 2001), we used these 
compounds, along with apocynin, to inhibit ROS production. Infected macrophages treated with 
apocynin, TEMPO, as well as SOD, were incubated with vitamin D3 and bacteria were quantified by 
detecting luminescence. The results presented in Figure 10 show a bacterial growth augmentation, 
for the mutants as well as the wild-type strain, in macrophages treated with TEMPO, when 
compared to untreated cells. However, this increase was similar in all strains, which means no 
difference between mutants and wild-type. No statistically significant difference was observed in 
bacterial growth, for any of the strains, in apocynin or SOD treated macrophages.  
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Figure 10. Intracellular growth of mmpL9 and moaD1 mutants in VitaminD3-activated 
macrophages treated with Phox inhibitors. Monocyte-derived macrophages (~2x105) where treated 
with apocynin (100µM), superoxide dismutase (SOD) (55U/ml) and TEMPO (T ) (0.1 and 0.2 mM), 
infected with luminescent M. tuberculosis wild-type (GC1237), moaD1 or mmpL9 mutant strains, at an 
MOI of 1:10 (bacteria per macrophage), and incubated with 1α,25-Dihydroxyvitamin D3 (5x10
-7M). 
Untreated macrophages were used as control. Ethanol and DMSO were used as a solvent control for 
vitaminD3 and apocynin, respectively. After 3 days of infection, cells were lysed and bacteria were 
quantified by detecting luminescence in a luminometer (RLUs - Relative light units). Data and error bars 
represent means and standard deviations of the results from triplicates in a representative experiment 
carried out two times with similar results. Statistically significant differences were calculated using the 
Student’s two-tailed, unpaired, t-test, and are indicated by asterisks *P<0,05; **P<0,01; ***P<0,001.  
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These results suggest that mmpL9 and moaD1 genes are required to protect M. tuberculosis 
against other kind of stress found inside macrophages. Therefore, we tested susceptibility of these 
mutants to other conditions such as starvation and acidic pH.  Due to technical issues we couldn’t 
obtain results for the moaD1 mutant in acidic conditions. Preliminary results showed no 
statistically significant difference in mutant’s fitness, when compared to the wild-type, in the 
conditions tested (Figure 11). Unfortunately, we didn’t have the opportunity to test for 
susceptibility to reactive nitrogen species (RNS), another group of antimicrobial molecules 
produced by macrophages to destroy intracellular bacteria (Flannagan et al., 2009). 
 
 
 
 
 
 
Figure 11. Susceptibility of mmpL9 and moaD1 mutants to acidic pH and starvation. Growth curves 
of M. tuberculosis GC1237, and mmpL9 mutant in 7H9 medium at pH7 or 4.5 (A). Susceptibility of 
mmpL9 and moaD1 mutants to starvation was determined by quantifying CFUs after 5 and 10 days of 
incubation in sterile water at 37ºC. Percentage of survival was determined by comparing CFUs at the 
referred time points with CFUs at time-point zero, before incubation (B).  
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 DISCUSSION 2.5
The role of ROS during infection with M. tuberculosis remains unclear. Therefore, we decided to 
look for genes involved in M. tuberculosis oxidative stress response using, for the first time, a 
functional genomic approach. By screening a transposon mutant library we found a high number of 
mutants sensitive to H2O2 that were affected in genes involved in cell envelope functions. M. 
tuberculosis cell envelope is an important permeability barrier involved in bacterial protection 
against different kinds of aggression (Brennan and Nikaido, 1995). This has been continuously 
shown. For example, a high percentage of genes identified as responsible for M. tuberculosis 
resistance to acidic stress during a genetic screening, were also found to be involved in bacteria’s 
cell wall functions (Vandal et al., 2008). However, few studies have previously described cell 
envelope components/mechanisms as involved in M. tuberculosis defense against ROS. Our results 
reveal the important role of M. tuberculosis cell envelope in protection against ROS.  
One of the genes identified during our study as associated with cell envelope functions was 
mmpL9. We identified three mutants carrying independent transposon insertions is this gene. Even 
though it is possible that mmpL9 represents a hotspot for transposon insertion, our results suggest 
that it seems to be indeed important for M. tuberculosis survival under oxidative stress conditions 
as well as inside host cells. MmpLs belong to the RND (resistance, nodulation and cell division 
proteins) family of pumps that recognize and mediate the transport of a range of substrates. In M. 
tuberculosis, the colocalization of some mmpL genes with genes involved in polyketide biosynthesis 
(pks genes) and lipid metabolism, suggested that MmpLs are involved in lipid synthesis and/or 
transport (Tekaia et al., 1999). However, their substrate specificity seems to be dictated, in part, by 
their interaction with particular cytosolic enzymes (Jain and Cox, 2005). Thus, mmpL9 might be 
involved in the transport of lipids, even though, it does not colocalize with known genes involved in 
lipid synthesis (Cole et al., 1998). This seems also to be the case for MmpL3 found to be involved in 
the transport of trehalose mycolate in mycobacteria (Grzegorzewicz et al., 2012). Curiously, 
MmpL3 has been previously described as involved in heme iron acquisition as well (Tullius et al., 
2011), suggesting that MmpL transporters might be involved in more than one physiological 
process in M. tuberculosis. Therefore, MmpL9 could be involved in the transport of other kind of 
substances, related to detoxification processes responsible for maintaining an oxidative balance 
within the cell. A previous study has shown that mycobacterial P55 efflux pump, besides being 
involved in drug resistance, is important for different processes in the cell, including oxidative 
stress response (Ramon-Garcia et al., 2009). A Δp55 mutant had increased sensitivity to redox 
compounds including diamide, a thiol-oxidizing agent, suggesting that this pump may be involved 
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in the extrusion of toxic compounds generated by a thiol reductant such as mycothiol (Ramon-
Garcia et al., 2009). Curiously, this mutant was also highly sensitive to drugs targeting the 
peptidoglycan layer of the cell wall, suggesting that P55 is also involved in the transport of some 
important substrate to the cell wall (Ramon-Garcia et al., 2009). A similar scenario might be 
happening for MmpL9. 
Strikingly, we’ve identified a frameshift mutation in the mmpL9 gene of the Beijing/W GC1237 
strain. Nonetheless, the fact that a transposon mutant had an attenuated phenotype inside 
macrophages that was restored after complementation with the wild-type gene suggests that the 
GC1237 mmpL9 gene might be functional. Translation of mmpL9 in GC1237 might occur due to a 
recoding mechanism (Baranov et al., 2001), for example through the reinitiation of translation from 
a second initiation codon, at position 259, in the same reading frame (Figure 12).  
 
 
 
 
 
 
 
Figure 12. Representation of the mmpL9 gene in M. tuberculosis GC1237. The mmpL9 gene in M. 
tuberculosis GC1237 contains a deletion (Δ) in position 218. Reinitiaton of translation might occur from 
a second initiation codon situated upstream the deletion, at position 259, which would explain the 
attenuated phenotype observed in macrophages of the mmpL9 (100D7) mutant carrying a transposon 
inserted at position 957:958.  The initial part of the gene’s sequence is shown where both deletion (-) 
and the putative second initiation codon, which in the same reading frame, are highlighted in bold.   
 
In this case the Beijing/W MmpL9 would be a modified protein, what would explain the partial 
complementation by H37Rv mmpL9 in macrophages. Statistical analysis of polymorphisms in mmpL 
genes showed that this deletion could have indeed an effect on protein’s functions and seems to 
be specific to all modern and ancestral Beijing/W strains. These results suggest that this 
polymorphism might have contributed to the evolution of these strains by conferring some 
selective advantage. This is important because the Beijing/W family is one of the most successful 
groups of M. tuberculosis strains as it has been frequently associated with drug resistance and 
found to be distributed throughout the world (Parwati et al., 2010). 
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Curiously, we did not identify during our screen known antioxidant genes, such as katG or sodC. 
It is possible that these mutants were not represented in our library given that we have screened 
around 6000 mutants, which may not cover the entire 4000 ORFs of the M. tuberculosis genome 
(Cole et al., 1998). On the other hand, some of these mutants might be sensitive to endogenous 
ROS resulting from aerobic respiration (Imlay, 2008; Storz and Imlay, 1999), which can result in 
some in vitro growth defect in the absence of H2O2. In this case, they could have been excluded 
from the study before the screening with H2O2. Indeed, an exhaustive study of M. tuberculosis 
whole genome expression in response to oxidative stress caused by H2O2 has shown that katG, 
sodA, sodC, ahpD, ahpE and ahpC have high basal levels of expression (Voskuil et al., 2011). 
However, most of these are not highly induced by H2O2. In addition these genes are not 
consistently induced in M. tuberculosis in host cells (Fontan et al., 2008; Schnappinger et al., 2003). 
Thus, these genes might be important to counteract low or basal levels of ROS, however, other 
pathways are induced when bacteria are exposed to additional levels of oxidative stress, such as 
those produced during the phagocytic oxidative burst (Imlay, 2008; Storz and Imlay, 1999). On the 
other hand, M. tuberculosis oxidative stress response is concentration-dependent (Voskuil et al., 
2011), as previously shown for E. coli (Imlay and Linn, 1986). Therefore, using different ROS levels 
induce different kinds of responses. Finally, it is also possible that some of these genes have 
redundant functions and some mutants might not be sensitive to H2O2 but to other forms of 
oxidative stress. 
Our results have shown that the molybdenum cofactor (MoCo) seems to be important for M. 
tuberculosis growth inside macrophages and resistance to oxidative stress. The same has also been 
suggested in previous studies. Several genes involved in MoCo biosynthetic pathway have been 
identified as important for M. tuberculosis to counteract oxidative stress conditions (Manganelli et 
al., 2002) and to parasitize macrophages (Rosas-Magallanes et al., 2007). Additionally, MoCo also 
appears to be important for M. tuberculosis to grow in primate lungs (Dutta et al., 2010), which 
reveals the significance of this molecule during infection in vivo. MoCo seems to be required for 
the activity of several M. tuberculosis enzymes that present recognizable MoCo-associated 
domains, including Nitrate reductase (NarGHJI) (Williams et al., 2011).  Nitrate reductase seems to 
have both nitrate respiratory (Sohaskey and Wayne, 2003) and assimilatory functions (Malm et al., 
2009). It also seems that nitrate reductase is involved in protection of hypoxic M. tuberculosis from 
acid killing, as well as against RNS, conditions encountered by this pathogen during host infection 
(Tan et al., 2010). This would explain the importance of MoCo in M. tuberculosis survival in host 
cells. However, the role of this molecule in protection against oxidative stress is less clear. Biotin 
sulfoxide reductase is also a MoCo-enzyme in M. tuberculosis (Williams et al., 2011) that seems 
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important for protection from oxidative stress in E. coli, by reducing biotin sulfoxide, the product of 
oxidized biotin, into biotin (Ezraty et al., 2005). However, whether this enzyme is functional and 
whether it has the same role in M. tuberculosis remains to be determined.  
Several genes identified in our screen seem to also have a role in bacterial survival inside host 
cells. In a previous study, a ppe54 mutant, identified in a screening using the same transposon 
mutant library, exhibited an attenuated growth in mouse macrophages (Brodin et al., 2010). In 
addition, M. tuberculosis ppe54 along with ppe56 and ppe21 expression was found to be induced in 
IFNγ-activated macrophages (Voskuil et al., 2004). The Rv0986 transporter was also previously 
identified as important for M. tuberculosis to bind (Rosas-Magallanes et al., 2007) and replicate 
(Pethe et al., 2004) inside macrophages. We have shown that moaD1 and mmpL9 are important for 
M. tuberculosis growth in human macrophages as well. Strikingly, some of these genes, rv0986, 
ppe54, moaD1 and mmpL9, were also found to be involved in inhibition of phagosome maturation 
by M. tuberculosis in previous studies (Brodin et al., 2010; MacGurn and Cox, 2007; Pethe et al., 
2004). We hypothesize that mutants in these genes are delivered to late phagosome 
compartments as a consequence of being more susceptible to intracellular killing. Any strain 
impaired in intracellular survival will traffic to late endosomes as a secondary effect (Philips, 2008).  
Taken together, these observations, suggest a correlation between resistance to oxidative stress 
and intracellular growth in macrophages. However, we could not provide experimental proof for a 
direct link between increased susceptibility to ROS and reduced intracellular mycobacterial growth. 
There was no significant change in mmpL9 and moaD1 mutants phenotype, when compared to the 
wild-type, in macrophages treated with ROS inhibitors/scavengers, even when cells where 
activated with Vitamin D3, which triggers antimicrobial responses involving ROS production (Sly et 
al., 2001)(Sly et al., 2001; Yang et al., 2009). Vitamin D3 activated macrophages might be able to 
control mmpL9 and moaD1 mutants growth in a ROS-independent manner, for example through 
the induction of autophagy, an apparently central mechanism of vitamin D3 antimicrobial activity 
(Shin et al., 2010; Yuk et al., 2009). On the other hand, there are no potent and specific NOX 
inhibitors, so, apocynin or DPI, may not be effectively inhibiting Phox throughout the infection 
period and could have NOX-unrelated effects (Bedard and Krause, 2007). It is also possible that the 
mmpL9 and moaD1 genes are required to protect M. tuberculosis against other forms of stress 
existent in macrophages. Indeed, several acid-sensitive mutants, with defects in their cell wall, 
were also found to be hypersensitive to oxidative stress (Vandal et al., 2009). However, the mmpL9 
mutant did not appear to have an increased susceptibility to acidic pH. Furthermore, neither 
mmpL9 nor the moaD1 mutants were more susceptible to starvation. Thus, these genes might be 
important to protect M. tuberculosis against RNS or some product resulting from the combination 
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of ROS with RNS inside macrophages, such as peroxynitrite, one of the most potent natural 
oxidants in biological systems (Zahrt and Deretic, 2002). Indeed, few bacterial genes seem to 
exclusively participate in resistance to ROS in vivo (Ehrt and Schnappinger, 2009). Finally, another 
possible explanation for the results obtained using the phox inhibitors is that M. tuberculosis 
oxidative stress resistance mechanisms are extremely efficient thus masking the antimicrobial 
effects of ROS on this pathogen. Consequently, M. tuberculosis infection in the absence of ROS is 
not particularly affected. This also seems to be an explanation for the results observed during M. 
tuberculosis infection in phox-deficient mice (Jung et al., 2002) and macrophages (Chan et al., 
1992).  
Most of the genes identified during our screen have not been described in previous genetic 
screenings as required for M. tuberculosis survival in macrophages (Rengarajan et al., 2005) or in 
animal models such as mice and non-human primates (Dutta et al., 2010; Lamichhane et al., 2005; 
Sassetti and Rubin, 2003). They have also not been previously reported as upregulated in M. 
tuberculosis inside host cells (Fontan et al., 2008; Schnappinger et al., 2003). However, we cannot 
exclude that the genes identified in our and previous reports are involved in the same metabolic 
pathway (as observed for MoaD1), or involved in the synthesis of the same factor. For example, 
MmpL9 and Rv0986 are transporters of a yet unidentified substrate and some of the genes we 
have identified have unknown annotated functions (Table 2). Similarly, numerous genes identified 
during analysis of M. tuberculosis whole genome expression in response to oxidative stress are 
annotated as having unknown functions (Voskuil et al., 2011). We also have to consider that 
differences regarding M. tuberculosis strains and host cells (human or mice cells; primary cell 
cultures or cell lines) employed might also explain the only modest overlap of our results with 
those of previous studies.  
In conclusion, genes involved in M. tuberculosis oxidative stress response are important for this 
pathogen and seem to contribute to its intracellular growth in host cells, which make the products 
of these genes attractive targets for the development of new drugs or vaccine candidates. 
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 ABSTRACT 3.1
Investigating the genetic variability among Mycobacterium tuberculosis is important as it can 
provide a basis for understanding pathogenesis and host adaptation, as well as the evolution of this 
pathogen. Polymorphic genetic markers have been used to determine this genetic diversity. We 
have recently shown that SNPs in DNA repair, recombination and replication (3R) genes are a 
useful high resolution tool for strain discrimination and can be used to study M. tuberculosis 
evolution.  
The Beijing/W family is a successful group of M. tuberculosis strains, often associated with drug 
resistance and widely distributed throughout the world. To investigate the genetic diversity and 
evolution of the Beijing/W family, polymorphisms in 3R genes were analyzed in a collection of 
Beijing/W isolates from different geographic origins. We found SNPs in 3R genes associated with 
the Beijing/W family, which enabled discrimination of different groups and the proposal of a 
phylogeny. One of these groups appeared to be predominant, representing over 60% of all isolates 
in distinct parts of the world. Our results show that the Beijing/W family can be divided into 
different groups, characterized by particular SNPs in 3R genes that may define their pathogenic 
features and contribute to the evolution of this family. These results may contribute to better 
understand the success of the Beijing/W family. 
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 INTRODUCTION  3.2
Mycobacterium tuberculosis is considered as one of the most successful human pathogens, 
infecting nearly one third of the world’s population. However, only 5 to 10% of these infected 
persons will develop the disease (TB) and become sick at a certain point during their lifetimes 
(WHO at www.who.int/topic/tuberculosis/en/). One of the main questions that has occupied 
researchers is what defines who becomes infected and who develops TB. The genetic variability of 
M. tuberculosis seems to have a significant role in the outcome of the disease. Epidemiological data 
suggested that differences in transmissibility and virulence among M. tuberculosis strains are 
related to the genetic background of the organisms (Caminero et al., 2001; Valway et al., 1998). 
Years later, studies using animal models have shown that different M. tuberculosis genotypes 
display indeed differences in pathogenesis and virulence (Dormans et al., 2004; Lopez et al., 2003; 
Palanisamy et al., 2009).  
Polymorphic molecular genetic markers have been used to investigate M. tuberculosis genetic 
diversity. IS6110 restriction fragment length polymorphism typing is one of the most widely used 
methods, however, this technique is time consuming, technically demanding and insufficiently 
discriminatory for isolates containing less than five copies of IS6110 (Kato-Maeda et al., 2011). This 
has led to the development of other methods based on the polymorphism of repetitive sequences, 
either the direct repeat (DR) region (spoligotyping) (Kamerbeek et al., 1997) or mini satellites 
(variable numbers of tandem repeats (VNTR) typing) (Frothingham and Meeker-O'Connell, 1998). 
In the recent years, the availability of whole-genome sequences has enabled comparative genomic 
analysis to identify single nucleotide polymorphisms (SNPs). SNPs have been used to differentiate 
between clinical isolates and are preferred over the use of repeats for the construction of 
phylogenetic trees, because recombination events that could occur, independently, at the level of 
repetitive sequences, are avoided (Achtman, 2008). Large numbers of SNPs have been identified 
and used to genotype worldwide strain collections and investigate M. tuberculosis evolutionary 
history (Baker et al., 2004; Filliol et al., 2006; Gutacker et al., 2006; Hershberg et al., 2008). On the 
other hand, SNPs might have a role in pathogenesis by affecting expression of genes. We have 
recently analyzed SNPs in DNA replication, recombination and repair (3R) genes (Dos Vultos et al., 
2008) in a set of geographically diverse M. tuberculosis strains. Pathogens are constantly exposed 
to stressful environments and aggressions to the DNA, such as reactive oxygen species (ROS), 
produced by host macrophages (Flannagan et al., 2009). DNA replication, recombination and repair 
are responsible for the repair of such damages to the DNA, and, therefore, important mechanisms 
in genome dynamics and stability. On the other hand, variations on 3R genes potentially increase 
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genomic variability, due to an increase in mutation rates, and contribute to the adaptation and 
evolution of bacteria (Denamur and Matic, 2006; Taddei et al., 1997; Tonjum and Seeberg, 2001). 
Our study has revealed an unexpectedly high polymorphic set of genes, useful for strain 
discrimination. Additionally, analysis of polymorphism in these genes may indicate which strains 
are more prone to adapt or evolve (Dos Vultos et al., 2008).  
The Beijing/W family, a group of genetically related strains, has demonstrated particular 
properties when compared to other M. tuberculosis families, including: increased virulence in 
various in vitro (Li et al., 2002; Theus et al., 2004) and in vivo models of infection (Lopez et al., 
2003; Tsenova et al., 2005), association with drug resistance (Tuberculosis, 2006), as well as a wide 
distribution throughout the world (Brudey et al., 2006; Glynn et al., 2002). Taken together this 
suggests that Beijing/W strains have selective advantages over other M. tuberculosis strains and 
represent a serious threat to TB control. Therefore, we decided to investigate genetic diversity and 
evolution of Beijing/W strains by analyzing polymorphisms in 3R genes. This will hopefully 
contribute to better understand the mechanisms underlying the phenotypic and genotypic 
characteristics that explain the success of the Beijing/W family. 
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 MATERIALS AND METHODS 3.3
 
3.3.1 Study isolates and SNP detection 
M. tuberculosis Beijing/W clinical isolates used in this study are listed in Table A1. DNA from the 
58 isolates, with a Beijing/W spoligotype, used for SNP discovery in 3R genes was provided by: 
Madagascar Pasteur Institute, Madagascar (MG); RIVM, The Netherlands (NL) and the Scientific 
Institute of Public Health, Belgium (BE). These DNAs were used to amplify the 22 3R genes (Table 1) 
using TaKaRa LA Taq (TaKaRa, Shiga, Japan) and primers listed in Table 1. A control non-Beijing 
isolate, Myc2 (DNA also provided by the Scientific Institute of Public Health, Belgium (BE)), was also 
included. Myc2 is a clinical strain belonging to the Euro-American lineage according to Gagneux’s 
classification (Gagneux et al., 2006a).  
The amplified products were purified in a single step using exonuclease I (USB, USA) and shrimp 
alkaline phosphatase (USB, USA), as previously described (Werle et al., 1994). The purified products 
were then sequenced by the dideoxy chain-termination method using the Big Dye Terminator v3.1 
cycle sequencing Kit (Perkin Elmer Applied Biosystems, Courtaboeuf, France), according to 
manufacturer’s instructions. Sequencing products were run on an ABI prism 3100 Genetic Analyser 
(Applied Biosystems).  
Sequences were analyzed using the software Genalys obtained at http://software.cng.fr. 
Detection of polymorphic sites was performed by comparison with the non-Beijing strain, H37Rv 
(Myc1) sequences, obtained from Institute Pasteur at http://genolist.pasteur.fr. Beijing/W specific 
SNPs were identified by comparison of sequences with the non-Beijing (Myc2).  
Sequencing was also performed for subsequent SNP analysis of the Beijing/W isolates from 
South Africa (ZA) (Table A1), which DNAs were provided from NRF Centre of Excellence in 
Biomedical Tuberculosis Research/ MRC Centre for Molecular and Cellular Biology in South Africa, 
and the GC1237 strain, available in our laboratory. A mismatched PCR method, using one wild-type 
primer and one containing the SNP which matched/mismatched the template DNA at the 3'-end of 
the primer (Table 1), was used to detect SNPs in the Beijing/W isolates from China (CN) (Table A1).  
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Table 1. List of oligonucleotides used for SNP analysis.  
 
Primer name Sequence (5’-3’) Primer name 
(mismatch) 
Sequence (5’-3’) 
ligD_f GTCACGGCGAAATTCCACGCGATATTTGA  ligD580_f CGGGCATTGGCGGAGGATCT 
ligD_r CCCGACCAGATCCAGCAACGACACGTC  ligD580_wt-f TGCGTTAGCTAGGGTTTCGAGCAG 
ligD_2 TCACCAGCGGCAGCAAGGGATTGCAT  ligD580_mt-r TGCGTTAGCTAGGGTTTCGAGCAA 
ligD_3 GATACACACCGAGGACCACCCGCTGGAATA  ligD162_f CGACGACCTATCCGATCATCG 
ligB_f CCACATAGCCCCCAGGCGGTATTGGTA  ligD162_wt-r GGAAGGTGACCAACCCGATAT 
ligB_r CGCTTGGTCGACGAGCGTGAATCTG  ligD162_mt-r GGAAGGTGACCAACCCGATAG 
ligB_2 GGCACTCTACCGGGCAAAGGGTCTCAG  rccR44_f AAGCGCCCCGCCCAGGACGTG 
ligC_f ACCCCAGCTTCGGGAAATACATCCTGT  rccR44_wt-r CGGACATCGACCGGCTGACCG 
ligC_r TCGCCACACAGACGACAAGTCCCAA  rccR44_mt-r CGGACATCGACCGGCTGACCT 
dnaZX_f CGCCGAAATCACGCCGAACGTTCA  ligD346_f ACCACCATCGCGCCGTACTCA 
dnaZX_r CGAACGAAACAACCTGCAGCTACATCACG  ligD346_wt-r ACCGCCCACGAGACCAGCACG 
dnaZX_2 AACACCTGATCTTCATATTCGCCACCA  ligD346_mt-r ACCGCCCACGAGACCAGCACA 
dnaZX_3 CTGCTGCTGGAAGTGGTTTGCG  uvrC388_r GGATCCCGAAGTGGCGGTAGT 
recD_f GGTGTGTTCACCTGGAACCCGCCCA  uvrC388_wt-f CAACAACACAAGCTGAAGCGG 
recD_r GTCGCCGTGCTGTTCGTGTATGCGATGT  uvrC388_mt-f CAACAACACAAGCTGAAGCGC 
recD_2 TCTCGCAAGGTGTTACGGTGTTGACTGG  mutT4-48_r CGCATCAAATAATGGTGGACG  
recG_f CATGTGCACGACCACCATCCAGGCAC  mutT4-48_wt-f CGGCAACGGCGAAGCGGTCCC 
recG_r CGATGATCCCAGCGTCTGATACGCGA  mutT4-48_mt-f CGGCAACGGCGAAGCGGTCCG  
recG_2 CAGCACAAAAGTGCAGAGCTGGGACATCTT  ogt37_f AGCTGGGCCTGCCTGCACAAC 
recG_3 GATGACGGCAGGGCAGAAGAAGCAAGTTC  ogt37_wt-r GGTCGGGTGTCCAGTGTGTGC 
recX_f CCGACGTGGCTGACGAGATCGAGAAGAA  ogt37_mt-r GGTCGGGTGTCCAGTGTGTGA 
recX_r CCGCCATCAAGTCGAGGTAAATTCGTTCA  uvrC166_f CCGCTACCGCGACGACAAGTC 
ruvB_f GATACGGTGCTGGCCGCCAACCAT  uvrC166_wt-r GCAGGCATGGACGATCGATCTG 
ruvB_r GGGGTCATTGCCAACGGCTCCTTTG  uvrC166_mt-r GCAGGCATGGACGATCGATCTT 
uvrC_f CAATGCACCCGACCAACAGTGGGATAGC  recX8_r GGCCGAGTTCGACATCCTCTA 
uvrC_r CCGGACAGCCCGGTTACCAAGACGA  recX8_wt-f CTTCGCGCTCAGAAGTCGACG 
uvrC_2 TACATCGACAAATGTTCCGCGCCGTGT  recX8_mt-f CTTCGCGCTCAGAAGTCGACA 
uvrC_3 CGGTGCACCGAAACGCAGAAGATGC  recX59_wt-f   GGTGTCATCCACCAGGCCAAC  
recR_f AAGATGGCGCAGGAACGGCTGGGT  recX59_mt-f   GGTGTCATCCACCAGGCCAAG  
recR_r GAGATCAACATTTTGCAGGCAAGGTGCG  recX59-r   CTCGGCCAGGGCAAGGAGAAT  
nei_f TCTGGTCGAGCGGGCCGACGGCAT  recG285_r CGTGCGGCAGGTGCTCGATGT 
nei_r GGTGGCAGGCAATATCTGCCCAAGGCGG  recG285_wt-f TCCCGCCGTCAGCTCAAAAGG 
nth_f ATGACACAAGGAGAGTAAACATGGC  recG285_mt-f TCCCGCCGTCAGCTCAAAAGA 
nth_r AATAGTCATGCAGTTGGGCAACCA  mutT2-58_f CCGGCCATAAACGTCGGAAAC 
rv2979_f GTTCGAAGGTCCACAGGGCCAGAACG mutT2-58_wt-r GAGGTCGGCGACCTCGAGTCC 
rv2979_r TCCAGTTGTATGCCTTGCGACGAGCA  mutT2-58_mt-r GAGGTCGGCGACCTCGAGTCG 
tagA_f TGAGCTCGAGGCGCTACGCTCTCAGC  ogt12_f CCGCAGGAGAAGATCGCAT 
tagA_r CCCCGCCATTGGATTTCCAGCCATA  ogt12_wt-r GCCCGGCCAGGGTTAATAGC 
uvrD1_f CCCGCAAAAACTTGGCGGGAAAAGTG  ogt12_mt-r GCCCGGCCAGGGTTAATAGT 
uvrD1_r GGACTTAGCGTCGGCAATTACACCGGTTGA  recR89_f CGGACGCGATCCGTGTGACGG 
uvrD1_2 CAACCTGAAGAACGAGTTGATCGACCC  recR89_wt-r   GTGCATTGTCGAGGAACCCAAAGAC  
uvrD1_3 CGAGGGTAGCGAGATCACCTACAACGAT  recR89_mt-r   GTGCATTGTCGAGGAACCCAAAGAT  
dnaQ_f CGGGTGGTTACCACCCGGGCAGTTTAC  recF269_f GGCGGAGCACGGGGCTGAACT 
dnaQ_r TCTCGCAAGGTGTTACGGTGTTGACTGG  recF269_wt-r CGGTGCGGACCAACTAGACAAACC 
radA_f TAATGGTGCCGATCTCGGCCGGATT  recF269_mt-r CGGTGCGGACCAACTAGACAAACA 
radA_r GTTGCTGCATAGCGGACATCGAGGGAGAA  uvrD1-462_f  TCCGCGCCGGTATTCCGTACA  
radA_2 GAGATCTACCTCGCCGCACAGTCCGA  uvrD1-462_wt-r   GACGAGCGCGTCACCGAAGCC  
recF_f GGAGCGAGTGTCTTTCGGGTTTACGACTGC  uvrD1-462_mt-r  GACGAGCGCGTCACCGAAGCT  
recF_r CGCCCTCGACCGGCGTCTTGTCC  ligB77_r TGTCGGCGAGACATGCCAAGCT 
mutT2_f CTGCCAGCCGTTGAGGTCGT  ligB77_wt-f    GGGTGGCGTCGACACCGGTGA 
mutT2_f CGGGCATGCAAACCCAAGTTA  ligB77_mt-f GGGTGGCGTCGACACCGGTGG 
mutT4_f TCGAAGGTGGGCAAATCGTG  dnaQ161_f GGACCAGCGGGCGGCCCTGGA 
mutT4_r TGGGGTTCGCTGGAAGTGG  dnaQ161_wt-r CAACGGCCGCACGATGCATTC 
ogt_f CAGCGCTCGCTGGCGCC  dnaQ161_mt-r CAACGGCCGCACGATGCATTT 
ogt_r GACTCAGCCGCTCGCGA  nth122_f CCCGCCGTCCGTGAAAGATCA 
alkA_f AGCCGCGTAGGTAACCT  nth122_wt-r   GCCGGCCACCATGGACAAGTT 
alkA_r TGCTCGAGCATCCGCAG  nth122_mt-r GCCGGCCACCATGGACAAGTG 
alkA_2 CGCATGCAGACCGCCCG  nth34_f TCACCGCCAAACCGCTCAA 
alkA_3 CACTGCACGTTGCCGAC  nth34_wt-r  ATTTCCGCACGTATACTGAGA 
alkA_4 GCTGACGATGCCGTTGCC  nth_34_mt-r ATTTCCGCACGTATACTGAGC 
  dnaZX92_f GCGAGCAACGCCCGCATAGT  
  dnaZX92_wt-r GCAGCATCGACGTGGTAGAGC  
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  Primer name 
(mismatch) 
Sequence (5’-3’) 
  dnaZX92_mt-r GCAGCATCGACGTGGTAGAGT  
  alkA11_f ATCGCCCGCGCCACGACGTCA 
  alkA11_wt-r ACTTCGAACGCTGCTACCGGG 
  alkA11_mt-r ACTTCGAACGCTGCTACCGGA 
  mutT4-99_f GGCGGCGCGCTGCGGCTACAG  
  mutT4-99_wt-r CAACTCGATGTGCCCCTTGGGTAGC  
  mutT4-99_mt-r CAACTCGATGTGCCCCTTGGGTAGT  
  recX153_f GCGGGCGAACGCAGCAAAGAG 
  recX153_wt-r CCTCGCACGCCAAGGTCTGGC 
  recX153_mt-r CCTCGCACGCCAAGGTCTGGT 
  recD277_r  CGGGCCTGGCACCGGGAAGAC  
  recD277_wt-f TCGGCCAGCCGGGCCATCAGC  
  recD277_mt-f TCGGCCAGCCGGGCCATCAGT  
  radA186_f TCCGGACGGCGCGCGCTCTAT 
  radA186_wt-r CCTGCGTGACCCCGCCGGTGA 
  radA186_mt-r CCTGCGTGACCCCGCCGGTGG 
  tagA179_f GTGCGCAACCGCGCCAAGATT  
  tagA179_wt-r  CCAGCATGCTTGGATATGGTCGTCG 
  tagA179_mt-r CCAGCATGCTTGGATATGGTCGTCA 
 
(f) for forward and (r) for reverse oligonucleotides used for amplification and sequencing reactions. 
Oligonucleotides whose name finishes in number were used for sequencing reactions. (wt) for wild-type and (mt) 
for mutant oligonucleotides used for detection of SNPs by mismatched PCR. 
 
 
3.3.2 LSPs detection 
Tsolaki et al. (2005) have described Large Sequence Polymorphisms (LSPs) for the Beijing/W 
family. These, designated regions of Difference (RDs) (RD105, RD181, RD150, RD142), correspond 
to genomic regions present in M. tuberculosis H37Rv but variably deleted in Beijing/W strains. The 
initial set of 58 Beijing/W isolates were tested for the presence or absence of these RDs through a 
Deletion-Targeted Multiplex PCR (DTM-PCR), as previously described for RD105 detection in 
Beijing/W strains (Chen et al., 2007). Briefly, two primers were designed flanking each one of the 
RD regions (P1 and P2) and one primer hybridizing inside each the RD region (P3) (Table 2). 
Multiplex-PCR reactions were performed using TaKaRa LA Taq (TaKaRa, Shiga, Japan) and different 
sets of primers for each RD (Table 2). The presence or absence of deletions was determined, 
following electrophoresis on an agarose gel, by comparison with M. tuberculosis H37Rv PCR 
products, used as control. 
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Table 2. List of primers used in Multiplex-PCR for Large Sequence Polymorphisms (LSPs) analysis.  
 
 
 
 
 
 
 
 
 
 
 
3.3.3 SNP Data analysis for Phylogenetic tree construction  
SNPs were concatenated resulting in one character string (nucleotide sequence) for each clinical 
isolate analyzed. A FASTA file was created to run in the Network software (Bandelt et al., 1999) to 
build a phylogenetic tree based on the median-joining method. This software assumes that there is 
no recombination between genomes.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Region of difference (RD) Primer sequence (5’ – 3’) 
RD105 
P1(105) - GGAGTCGTTGAGGGTGTTCATCAGCTCAGT 
P2(105) - GCGCCAAGGCCGCATAGTCACGG 
P3(105) - GGTTGCCCACTGGTCGATATGGTGGACTT 
RD181 
P1(181) - CGCAACGGCCGCGGTGAACTCT 
P2(181) - CGGGCGGCTGCGGGAACCTT 
P3(181) - CTGGCCTGGTTCGGCTTGGTCCC 
RD150 
P1(150) - TGTGGCGTGGCTCGGCAAATAG 
P2(150) - CGGGACGGCAAACGGGTGAT 
P3(150) - CGGCGTCATCGCGTATCTGA 
RD142 
P1(142) - CGTCCGCGACGACGAACAA 
P2(142 - TCACTTTCCATTTCCAGCGGCAACT 
P3(142) - CGTCGATGGCAACACACCGAAA 
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 RESULTS 3.4
 
3.4.1 Identification of polymorphisms in 3R genes in Beijing/W strains 
A collection of 58 clinical isolates with a Beijing/W spoligotype from different geographic origins 
(Table A1, materials and methods), was used to search for variations in 3R genes. Of the 56 
described genes encoding 3R components (Dos Vultos et al., 2008), 22 were previously 
demonstrated to be polymorphic among Beijing/W strains. However, these studies analyzed either 
a small number of isolates or a restricted number of genes (Dos Vultos et al., 2008; Ebrahimi-Rad et 
al., 2003).  Therefore, these 22 genes (Table 3) were sequenced for each of the 58 Beijing/W 
isolates as well as for a non-Beijing strain (Myc2), resulting in roughly 1,6 Mbp of sequence data. 
Comparative analysis with the M. tuberculosis H37Rv (Myc1) genome sequence identified 48 SNPs. 
Forty-one (85%) SNPs appeared to be specific for Beijing/W strains, as these were absent from the 
non-Beijing strain (Myc2), as well from the 86 non-Beijing strains included in our previous analysis 
of 3R polymorphisms using a global M. tuberculosis collection (Dos Vultos et al., 2008). Almost half 
of these SNPs (19/41) corresponded to new variations, not previously described in Beijing/W 
strains (Dos Vultos et al., 2008; Ebrahimi-Rad et al., 2003; Hershberg et al., 2008). Thirty of the 41 
Beijing/W specific SNPs enabled discrimination of 24 different sequence types for which a 
preliminary phylogenetic network was constructed using the Network software (Table 3) (Figure 
1A). Based on the inferred proteins, the number of non-synonymous SNPs (nsSNPs) was twice the 
number of synonymous SNPs (sSNPs) (Table 3). 
Analysis of large sequence polymorphisms (LSPs) revealed that these isolates included the four 
different sublineages previously defined in Beijing/W strains using these markers (Tsolaki et al., 
2005)(Figure 1B).  
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Table 3. List of SNPs identified by sequencing 3R genes in Beijing/W strains, which define 
different sequence types (Figure 1 and 2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* Most informative SNPs (identified in more than one isolate) observed in this study.  
 
 
 
 
 
 
 
 
 
SNP number Gene  Codon position SNP type 
1* ligD 580 (CTG > TTG) Synonymous 
2 ligD 162 (GAT > GCT) Non-synonymous 
3* recR 44 (GGT > TGT) Non-synonymous 
4 ligD 346 (GGC > GGT) Synonymous 
5 uvrC 388 (CGG > CGC) Synonymous 
6* mutT4 48 (CGG > GGG) Non-synonymous 
7* ogt 37 (CGC > CTC) Non-synonymous 
8 uvrC 166 (CAG > AAG) Non-synonymous 
9 recX 8 (CCG > CTG) Non-synonymous 
10* recX 59 (GTT > CTT) Non-synonymous 
11 recG 285 (CCT > TCT) Non-synonymous 
12* muT2 58 (GGA > CGA) Non-synonymous 
13* ogt 12 (GGG > GGA) Synonymous 
14 recR 89 (GAC > GAT) Synonymous 
15* recF 269 (GGG > GGT) Synonymous 
16* uvrD1 462 (GGC > AGC) Non-synonymous 
17 ligB 77 (GTC > GCC) Non-synonymous 
18 dnaQ 161 (TTC > TTT) Synonymous 
19 nth 122 (TTG > TGG) Non-synonymous 
20* dnaZX 92 (CTG > TTG) Synonymous 
21 nth 34 (GAG > GCG) Non-synonymous 
22 alkA 11 (GCG > ACG) Non-synonymous 
23* mutT4 99 (TCG > TCA) Synonymous 
24* tagA 129 (GCG > ACG) Non-synonymous 
25* recX 153 (GGC > GAC) Non-synonymous 
26* radA 276 (ATC > ACC) Non-synonymous 
27 recD 139 (GTA > TTA) Non-synonymous 
28 recD 277 (ACG > ACA) Non-synonymous 
29 radA 186 (GTC > GCC) Non-synonymous 
30 tagA 179 (GTC > GTT) Synonymous 
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Figure 1. Phylogenetic network based on SNPs discovered in the collection of 58 Beijing/W isolates. This 
phylogenetic network was constructed using the median-joining algorithm with the final set of 48 SNPs  
characterized by sequencing 22 3R genes in 58 Beijing/W isolates plus one non-Beijing isolate (Myc2). Isolates are 
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color coded according to their geographic origin (A), large sequence polymorphisms (LSPs) (B) and, SNPs in mutT2 
mutT4 and ogt genes (C). The reference strain M. tuberculosis H37Rv (Myc1) was also included. The numbers in 
each branch correspond to SNPs (Table 3) that enabled discrimination of sequence types. Node sizes are 
proportional to the number of isolates belonging to the same sequence type: Bmyc4 node (2); Bmyc12 node (3); 
Bmyc13 node (3); Bmyc19 (2); Bmyc16 node (7); Bmyc10 node (23). Table A1 describes the strains that belong to 
each node. Mv represents a median vector created by the software and can be interpreted as possibly extant 
unsampled sequences or extinct ancestral sequences. The evolutionary pathways proposed previously for 
Beijing/W strains using LSPs (Tsolaki et al., 2005) and SNPs in mutT2, mutT4 and ogt (Ebrahimi-Rad et al., 2003) 
have been included for comparison (B and C right bottom). 
 
The same SNP patterns were found in isolates from different geographic regions (Figure 1A), 
suggesting that the present collection of Beijing/W isolates is representative of this family.  
A color code was attributed to each node according to SNPs previously described in mutT2, 
mutT4 and ogt DNA repair genes (Ebrahimi-Rad et al., 2003), as well as according to LSPs (Tsolaki et 
al., 2005) (Figure 1B and C). Phylogenetic relationships established by 3R SNPs were in agreement 
with evolutionary pathways suggested previously using these genetic markers (Ebrahimi-Rad et al., 
2003; Tsolaki et al., 2005) (Figure 1B and 1C). However, sequencing of 3R genes was more 
discriminatory than LSPs; 24 sequence types versus four sublineages defined by the LSPs.  
 
3.4.2 Construction of a phylogeny for Beijing/W strains using 3R SNPs  
Next, we investigated the set of 30 polymorphic SNPs (Table 3), discovered by sequence analysis 
of the 3R genes, in a larger collection of Beijing/W strains including: 192 Beijing/W clinical isolates 
from China and 55 Beijing/W strains isolated in South Africa (Table A1). The M. tuberculosis 
Beijing/W strain, GC1237, responsible for a tuberculosis epidemic in Gran Canaria (Caminero et al., 
2001), was also included.  
A phylogenetic network was constructed including this larger set of isolates (Figure 2). Certain 
SNPs that were previously found in a single isolate were confirmed with this larger sample. Overall, 
fourteen SNPs were found in more than one isolate and were therefore informative (Table 1). Two 
new sequence types (Bmyc25 and Bmyc26) were identified (Figure 2). Strikingly, sixty-two percent 
of the isolates belonged to a single group, Bmyc10, which included strains from distinct parts of the 
world. The second most represented sequence-type was Bmyc25 that included the Gran Canaria TB 
outbreak strain GC1237 (Caminero et al., 2001). 
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Figure 2. Phylogenetic network based on SNPs characterized in the entire collection of 305 
Beijing/W isolates. This phylogenetic network was constructed using the median-joining algorithm with 
the set of SNPs identified in the 3R genes analyzed on the final collection of 305 Beijing/W isolates. 
Isolates are color coded according to their geographic origin. M. tuberculosis strains Myc1 (H37Rv) and 
Myc2 are included as non-Beijing strains. The numbers in each branch correspond to SNPs (Table 3) that 
enabled discrimination of sequence types. Node sizes are proportional to the number of isolates 
belonging to the same SNP type: Bmyc1 node (2); Bmyc2 node (14); Bmyc4 node (13); Bmyc6 node (7); 
Bmyc25 node (28); Bmyc26 node (13); Bmyc12 node (3); Bmyc13 node (13); Bmyc16 node (7); Bmyc19 
node (2); Bmyc10 node (188). Table A1 describes the strains that belong to each node. Mv represents a 
median vector created by the software and can be interpreted as possibly extant unsampled sequences 
or extinct ancestral sequences. The relative proportion of isolates in each node, of a given geographic 
origin, may not reflect the population structure of the Beijing/W family of that geographic region.  
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 DISCUSSION 3.5
M. tuberculosis complex strains have been considered as highly clonal, when compared to other 
pathogens (Achtman, 2008). Initial reports have even suggested that these strains share 99% 
similarity at the nucleotide level (Sreevatsan et al., 1997). However, in the recent years, large 
numbers of SNPs have been identified and used in order to get a more detailed insight into the 
diversity and evolutionary history of this bacteria (Baker et al., 2004; Dos Vultos et al., 2008; Filliol 
et al., 2006; Hershberg et al., 2008). SNPs analysis is a simple and relatively fast way to compare 
organisms and trace back the evolutionary history of strains, as some SNPs are highly informative. 
Therefore, SNPs analyses are becoming more and more attractive with the increasing number of 
genome sequencing projects. This will provide data particularly relevant to understand the genetic 
basis for strain differences in pathogenesis.  
Allelic variation in 3R genes seems to be an important mechanism in evolution and adaptation 
of microorganisms. Defective 3R systems could potentially increase genomic variability, due to an 
increase in mutation rates. Strains with high mutations rates (mutators), may have, in certain 
conditions, a selective advantage, as they produce more adaptive mutations (Denamur and Matic, 
2006; Taddei et al., 1997; Tonjum and Seeberg, 2001). The Beijing/W family is a group of strains 
that seems to have a selective advantage when compared to other M. tuberculosis families. 
Therefore, polymorphisms in 3R genes were analyzed in a collection of Beijing/W isolates from 
different geographic origins. SNPs in 3R genes associated with the Beijing/W family were identified 
that enabled the discrimination of 26 different sequence types for which a phylogeny was 
constructed. Phylogenetic relationships established by sequence types were in agreement with 
evolutionary pathways suggested by other genetic markers, such as Large Sequence 
Polymorphisms (LSPs). The remarkable clonality of M. tuberculosis implies that different genetic 
markers reveal similar phylogenies (Supply et al., 2003), if not, these are not robust markers 
appropriate to evolutionary analyses.  
Polymorphisms in 3R genes show that the Beijing/W family can be subdivided in different 
groups, as previously shown using other genetic markers (Hanekom et al., 2007; Tsolaki et al., 
2005). We did find however, a recently expanded group, Bmyc10, which seems to be predominant 
as it includes over 60% of strains. This sequence type was identified in isolates from China, where 
the Beijing/W family is highly prevalent, but also in other countries, where the Beijing/W family is 
less prevalent, such as Madagascar and The Netherlands. In a previous study, a group of Beijing/W 
strains characterized by the RD181 deletion and polymorphisms in mutT4 and mutT2 appears to be 
predominant in a collection of strains isolated in Italy (Rindi et al., 2009). Strains belonging to 
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Bmyc10 node also had the RD181 deletion and the same SNPs in mutT4 and mutT2 genes (SNP6 
and SNP12). This seems, though, to be a prevalent group in different parts of the world, suggesting 
that Beijing/W strains of this genotype might have some selective advantage. The Bmyc25 group 
that includes the Gran Canaria TB outbreak strain GC 1237 (Caminero et al., 2001), might represent 
another predominant group among Beijing/W strains. Taken together, these observations suggest 
that polymorphisms in 3R genes may confer advantageous phenotypes on certain Beijing/W 
genotypes. Indeed, different Beijing/W strains show different pathogenic characteristics in human 
macrophages (Theus et al., 2007), as well as in mice (Aguilar et al., 2010; Dormans et al., 2004), or 
guinea pigs (Kato-Maeda et al., 2011; Palanisamy et al., 2009). However, host cell transcriptome 
responses were found to be similar in Beijing/W strains from different genotypes defined by 3R 
SNPs (Wu et al., 2012). Similarly, different Beijing/W genotypes, including Bmyc10 and Bmyc25 
strains, do not seem to induce a differential cytokine modulation in macrophages (Wang et al., 
2010). Therefore, other pathogenic characteristics might explain the increased adaptability of 
strains with the Bmyc10 and Bmyc25 genotypes (Wang et al., 2010; Wu et al., 2012). For example, 
Beijing/W strains belonging to different sublineages defined by LSPs (Tsolaki et al., 2005) seem to 
present differences in transmissibility in a mouse model of infection (Aguilar et al., 2010). 
Beijing/W strains have also shown variability in the expression levels of the dormancy regulon 
(DosR) (Fallow et al., 2010). Therefore, it could be interesting to evaluate differences in Beijing/W 
strains ability to persist in a dormant state inside host cells. It should also be interesting to analyze 
if these strains have different capacity to resist macrophage antimicrobial mechanisms during 
hypoxia, a granuloma characteristic condition that determines DosR activation in M. tuberculosis 
(Nickel et al., 2012). Hypoxia doesn’t change cytokine release but triggers an antimicrobial pathway 
associated with growth inhibition of the bacilli (Nickel et al., 2012). 
Analysis of the effect on enzyme characteristics of the variation in the mutT2 gene, a 
characteristic of all Bmyc10 isolates (SNP12, Figure 2), has revealed significant changes in enzyme 
properties, caused by a single amino acid substitution, that leads to protein destabilization. It was 
suggested that this altered MutT2 enzyme may contribute to the success of strains due to an 
increase in nucleotide-dependent reactions (Moreland et al., 2009). Therefore, some of the SNPs 
identified in this study might have an effect on protein’s function. The analysis of the functional 
effects of the polymorphisms observed in 3R genes might be crucial to understand the real 
meaning of such variations. In our previous analysis we have shown that the observed variations in 
3R might be slightly deleterious, resulting in suboptimal 3R system activity (Dos Vultos et al., 2008). 
Therefore, some of these strains might have a mutator phenotype, increasing the probability of 
acquiring mutations in genes conferring some selective advantage. For example, mutator strains 
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may generate mutations that confer antibiotic-resistance at a higher rate than non-mutator strains 
(Denamur and Matic, 2006). When antibiotic-resistance is mainly determined by the acquisition of 
mutations in the chromosome, as is the case of M. tuberculosis (Heym et al., 1994), the advantage 
of being a mutator increases significantly (Tenaillon et al., 1999). A study tried to evaluate 
contribution of polymorphism on the DNA repair genes, mutT, to resistance to antibiotics. Even 
though no statistically significant association of missense mutations on these genes with and 
increased prevalence of antibiotic-resistance was detected, the authors couldn’t rule out the 
hypothesis that mutator phenotypes might increase the rate of drug resistance (Lari et al., 2006). 
Beijing/W strains have been often associated with drug resistance, even though, the underlying 
mechanisms for this association remain unknown (Tuberculosis, 2006). Beijing/W strains have 
shown similar rates of mutation-conferring resistance to rifampin compared to non-Beijing strains 
(Werngren and Hoffner, 2003). Therefore, another explanation would be that drug-resistance in 
Beijing/W strains has a lower or no cost on fitness, given that resistance-conferring mutations are 
often associated with a fitness cost (Andersson and Levin, 1999). The fitness of non-Beijing drug 
resistant strains was found to be slightly reduced when compared to drug-susceptible M. 
tuberculosis. However, drug resistant Beijing/W strains presented some variability: some strains 
showed loss of fitness while others did not (Toungoussova et al., 2004). Given that the fitness 
impact of resistance-conferring mutations in M. tuberculosis depends on the genetic background of 
the strain (Fenner et al., 2012; Gagneux et al., 2006b), the fitness cost of these mutations may vary 
among different Beijing/W sublineages. Indeed, different sublineages of the Beijing/W family may 
differ in their mechanisms of adaptation to drug selection pressures (Iwamoto et al., 2008; 
Mokrousov et al., 2006). It is also possible that the accumulation of compensatory mutations will 
mitigate the biological cost of drug-resistance mutations (Gagneux et al., 2006b). Thus, certain 
Beijing/W sublineages could have an advantage due to the occurrence of compensatory mutations. 
In mutator strains, the probability for this to occur is much higher. However, the concept of a 
mutator phenotype in Beijing/W strains was not supported when the frequency of spontaneous 
mutations was calculated using the Luria–Delbruck fluctuation test. The rate of spontaneous 
mutations was the same in Beijing/W, non-Beijing and laboratory strains (Werngren and Hoffner, 
2003). In mutator strains, reduction in mutation rates should occur, for example, by the acquisition 
of suppressor/compensatory mutations, before the load of deleterious mutations becomes too 
high (Denamur and Matic, 2006; Taddei et al., 1997). Thus, polymorphisms found in 3R genes may 
be related to transient mutator phenotypes in Beijing/W strains.  
In conclusion, analysis of polymorphisms in 3R genes has shown that different Beijing/W groups 
can be identified and characterized by specific 3R SNPs. These might have induced some selective 
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advantage that allowed the expansion of certain genotypes, therefore contributing to the evolution 
of the Beijing/W family. We hope that our study will contribute to better understand the molecular 
basis for the enhanced pathogenicity attributed to the Beijing/W family. 
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Mycobacterium tuberculosis is one of the most successful pathogens, being extremely adapted 
to its host. It is estimated that one-third of the world’s population is infected with this pathogen 
(WHO at www.who.int/topic/tuberculosis/en/) and, even though in 90-95% of these cases the 
infection is contained, M. tuberculosis is not eliminated and is able to persist in its host for years, 
until, disease develops due to not always well-understood reasons (Kaufmann and McMichael, 
2005). Understanding the mechanisms used by M. tuberculosis to successfully persist in its host, 
particularly inside macrophages, will lead to insights into possible targets for new effective anti-TB 
strategies. 
M. tuberculosis cell envelope constitution explains part of its resistance against host 
antimicrobial mechanisms. It forms a permeability barrier and is, thus, the first line of defense 
against toxic molecules (Brennan and Nikaido, 1995). However, the contribution of M. tuberculosis 
envelope components to this remains poorly documented. We have shown, by screening, for the 
first time, a transposon mutant library for mutants with increased susceptibility to reactive oxygen 
species (ROS), that M. tuberculosis cell envelope is the first line of defense against ROS, 
antimicrobial molecules produced by macrophages to destroy intracellular pathogens such as M. 
tuberculosis (Flannagan et al., 2009). Certain cell wall lipids, such as LAM, have been previously 
identified as ROS scavengers (Chan et al., 1991). Even though we did not identify any known genes 
involved in the biosynthesis of mycobacterial lipids, such as pks (polyketide synthases), we have 
identified transporters possibly involved in transport of lipids or other molecules to the cell 
envelop (MmpL9 and Rv0986). We have identified as well, proteins that seem to be involved in the 
synthesis of components of the cell envelope, although no known function has been assigned so 
far (Rv1507c, Rv1508a, Rv1509, Rv3594). Several PPE coding genes were also identified. However, 
how these proteins protect mycobacteria against ROS is not clear once not much is known about 
the molecular function of PE/PPEs (Akhter et al., 2012). Nonetheless, PE_PGRS11 was shown to be 
exposed to the cell surface and to be involved in mycobacterial resistance against H2O2-induced 
oxidative stress. This protein was found to be a phosphoglycerate mutase, a protein involved in 
glycolysis that has been previously demonstrated to decrease the accumulation of ROS in cells 
(Chaturvedi et al., 2010). In addition, a transcriptomic analysis has also shown that several PE/PPE 
genes are induced by H2O2, but not by NO, in M. tuberculosis (Voskuil et al., 2011). These results 
provide proof that PE/PPEs have indeed a role in protecting mycobacteria against oxidative stress.  
The highly impermeable cell wall of M. tuberculosis also contributes to its intrinsic resistance 
against chemotherapeutic agents (Jarlier and Nikaido, 1994; Nikaido, 2001). Therefore, cell wall 
components are good targets for developing new chemotherapeutic agents against TB. Indeed, 
these are currently the target of several antimycobacterial agents, including the two important first 
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line drugs, isoniazid and ethambutol (Sarkar and Suresh, 2011). Nonetheless, there is an ongoing 
search for new cell wall targets. Certain bacterial antibiotics are responsible for an increase in ROS 
production within cells via the fenton reaction (Kohanski et al., 2007). Tolerance to these 
antibiotics may, therefore, depend on the ability of the cell to defend itself against ROS. Thus, 
targeting molecules involved in resistance to ROS, such as those identified in our study, could 
enhance the efficacy of mycobacterial drugs known to generate ROS, such as isoniazid, kanamycin 
or ofloxacin (Kohanski et al., 2007; Mukherjee et al., 2009). Indeed, a mutant overexpressing 
Wag31, a protein involved in regulation of polar cell wall synthesis, had increased susceptibility to 
hydrogen peroxide as well as to isoniazid and ofloxacin (Mukherjee et al., 2009). This kind of 
approach could significantly contribute to TB treatment accomplishment. On the other hand, it 
could also avoid the appearance of drug-resistant bacteria. It was shown recently that bacterial 
death induced by ROS might eliminate persisters (Grant et al., 2012), small populations that resist 
to high doses of antibiotics and contribute to the rise in MDR- and XDR-TB (Keren et al., 2011). 
Furthermore, these drug-tolerant, persistent bacteria have, in M. tuberculosis, the physiological 
state of dormant bacilli, typically found in latent TB (Keren et al., 2011; Ulrichs and Kaufmann, 
2006). Therefore, targeting M. tuberculosis molecules involved in resistance to ROS may contribute 
to TB treatment improvement and could be suitable to treat patients latently infected with M. 
tuberculosis, which represent today a huge reservoir for the disease, without increasing the burden 
of drug-resistant TB. 
Usually, basal oxidative defences are sufficient to protect bacteria from endogenous ROS that 
result from aerobic respiration. However, these defences are inadequate if rates of ROS are 
accelerated, for example during the phagocytic oxidative burst. Most microbes induce additional 
responses when this happens (Imlay, 2008; Storz and Imlay, 1999). Thus, it is important to 
discriminate the effects of phagocytic and endogenous ROS (Craig and Slauch, 2009; Storz and 
Imlay, 1999). The fact that most of the genes identified in our study are components of the cell 
envelop suggests that these are relevant to counteract ROS generated exogenously, such as those 
originated during the phagocytic burst. However, extracellular ROS that penetrate bacterial 
membranes will increase intracellular ROS to superior levels to those induced by endogenous ROS 
(Imlay, 2008; Storz and Imlay, 1999). Therefore, mechanisms against high intracellular levels of ROS 
are also important for bacteria to counteract oxidative stress induced by phagocytes. This would 
explain the identification of genes in our screen that do not code for envelope components, such 
as moaD1. One might hypothesise that these genes are not essential for sustaining endogenous 
ROS as no significant growth defects were observed in vitro without H2O2 for these mutants (Table 
1). Additionally, many of the genes identified in our screening seem to have a role in the 
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intracellular lifestyle of M. tuberculosis, suggesting that these are important to resist against ROS 
produced by host cells. However, to confirm that these proteins are specific for resistance against 
phagocytic ROS, mutants’ growth in phox-deficient macrophages should be investigated. 
The proteins identified in our study might thus contribute to M. tuberculosis virulence. Putative 
virulence factors could be useful for designing attenuated vaccine candidates. Indeed, PPEs and 
MmpL proteins have been frequently associated with virulence (Akhter et al., 2012; Domenech et 
al., 2005). In a recent study, the comparative genomic analysis of free-living soil mycobacteria and 
obligate parasites of the M. tuberculosis complex has shown that, along with the known gene 
families related to pathogenesis such as PE/PPE genes, gene families related to biosynthesis of 
Molybdenum Cofactor (MoCo) were found to be expanded in pathogenic mycobacteria. These 
results suggest an important role for MoCo in the adaptation of environmental mycobacteria to 
obligate pathogenesis (McGuire et al., 2012). Proteins involved in MoCo biosynthesis, such as 
MoaD1, seem to represent potential virulence factors as well.  
In the study of McGuire et al. (2012) it was also shown that genes related to DNA repair are 
associated with adaptation of environmental mycobacteria to obligate pathogenesis. Surprisingly, 
we did not select any mutant in known DNA repair genes during our screen. In E. coli, at low 
concentrations (1mM) of H2O2, the main mechanism of ROS-dependent antibacterial activity is 
DNA damage (Imlay and Linn, 1986). In M. tuberculosis induction of DNA repair gene expression 
indicates that DNA damage occurs only at 5-10 mM H2O2 (Voskuil et al., 2011). However, bacteria 
are not killed at these concentrations, suggesting that the damage does not result in DNA-
dependent killing, like in E. coli. These results suggest that M. tuberculosis DNA repair mechanisms 
are highly effective in repairing the damages caused by H2O2. In addition, M. tuberculosis possesses 
many genes with redundant functions, particularly in the BER pathway, one of the major 
mechanisms involved in the repair of oxidative DNA damage (Dos Vultos et al., 2009; Friedberg et 
al., 2006). These observations could explain why we did not identify any H2O2 sensitive mutant in 
genes playing a role in DNA repair mechanisms. DNA repair mechanisms have also been suggested 
to be essential for the survival of the intracellular pathogen Salmonella typhimurium (Buchmeier et 
al., 1995). However, a recent study has shown that phagocytic superoxide primarily damages an 
extracytoplasmic target to inhibit or kill this pathogen, suggesting that the dogma that DNA is a 
primary bacterial target of the phagocytic oxidative burst needs to be re-evaluated (Craig and 
Slauch, 2009).  
In conclusion, our study has allowed us to identify genes involved in M. tuberculosis defence 
against oxidative stress. However, there are still many genes with apparently unknown functions 
that seem to have a role in such kind of mechanisms. This means that further studies are required 
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to expand our knowledge about the molecular mechanisms used by M. tuberculosis to counteract 
oxidative stress, particularly during macrophage infection.  
Genome variability is required for bacteria to successfully adapt to constantly changing and 
stressful environments, such as the ones found in human hosts or those induced by antibiotic 
treatment. DNA repair, recombination and replication (3R) are important mechanisms in 
generating this genomic variability (Denamur and Matic, 2006; Tonjum and Seeberg, 2001). 
Therefore, analysis of polymorphisms in 3R genes can provide clues into which strains are/were 
more prone to adapt and evolve. Our previous analysis of polymorphisms in 3R genes have shown 
that these genes may indeed play a role in M. tuberculosis evolution and could be a useful tool for 
strain discrimination (Dos Vultos et al., 2008). These results prompt us to investigate 
polymorphisms in a successful group of M. tuberculosis strains, the Beijing/W family. We have 
shown that different groups carrying specific polymorphisms in 3R genes exist within the Beijing/W 
family (Chapter 3). It has been previously, shown that the Beijing/W family can be divided into 
several groups/sublineages using other genetic markers (Hanekom et al., 2007; Tsolaki et al., 2005). 
3R mechanisms might have contributed to this genetic diversity observed in Beijing/W strains. 
However, an important question needs to be asked: what is the meaning of these polymorphisms? 
Polymorphisms in 3R genes might have induced the accumulation of mutations conferring a 
selective advantage (Denamur and Matic, 2006). Indeed, certain mutations could have conferred 
some advantage to M. tuberculosis Beijing/W strains. For example, it was shown that typical 
Beijing/W strains carry a high number of non-synonymous SNPs in genes coding for the regulatory 
network (Schurch et al., 2011) that could result in changes in cellular processes controlled by 
transcriptional regulation. These variations may play an important role in adaptation of these 
bacteria to different environments and explain why typical Beijing/W strains are an emerging 
phenotype (Schurch et al., 2011). A frameshift mutation in the gene encoding the DosT sensor 
kinase, which senses the environmental stimuli that trigger dosR expression, was found to 
correlate with the appearance of constitutive overexpression of the DosR regulon in the most 
recently evolved Beijing/W sublineages (Fallow et al., 2010). Even though mutation in dosT doesn’t 
seem to be directly responsible for DosR constitutive expression, its inactivation might have 
induced for selection of this phenotype, which is associated with M. tuberculosis adaptation and 
survival to conditions found in human lungs (Voskuil et al., 2003). Another frameshift mutation that 
might have induced a selective advantage to Beijing/W strains was the one identified by us in the 
mmpL9 gene given that all publicly available modern Beijing/W genomes were found to carry it. 
Despite this mutation, MmpL9 seems to be functional in Beijing/W strains and to have a role in 
bacterial response to oxidative stress as well as in survival inside host cells (Chapter 2). This 
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mutation might have induced a protein change that confers a better protection to bacteria in these 
conditions. 
 Studies in vitro (Firmani and Riley, 2002; O'Brien et al., 1994) and in animal models (Aguilar et 
al., 2010; Dormans et al., 2004; Lopez et al., 2003; Palanisamy et al., 2009; Tsenova et al., 2005), 
have demonstrated strain-dependent variation in key aspects of virulence such as stress survival, 
transmission, pathology and lethality. On the other hand, it is also important to consider the 
genetic diversity of any pathogen when identifying drug targets, vaccine antigens and developing 
tools for molecular diagnostics. The analysis of 3R genes in Beijing/W strains might indicate which 
strains are more prone to develop mutations conferring-drug resistance, or are more able to adapt 
and persist in host cells. This is important considering that Beijing/W strains have been frequently 
associated with drug resistance (Tuberculosis, 2006), and seem to have increased virulence when 
compared to strains from other M. tuberculosis families (Lopez et al., 2003; Tsenova et al., 2005).  
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Table A1. Description of M. tuberculosis Beijing/W strains belonging to each node found in Figure 1 and 
2, and respective country of isolation.  
Node Strain Origin of isolation Node Strain Origin of isolation 
Bmyc1 NL25 USA Bmyc10 BE5 Singapore 
 ZA40 South Africa  BE8 USA 
Bmyc2 NL20 The Netherlands  BE10 USA 
 CN1 China  BE12 USA 
 CN2 China  BE14 USA 
 CN3 China  BE17 USA 
 CN4 China  BE19 USA 
 CN5 China  BE20 USA 
 CN6 China  BE23 USA 
 CN7 China  BE27 USA 
 CN8 China  MG3 Madagascar 
 CN9 China  MG10 Madagascar 
 ZA13 South Africa  MG11 Madagascar 
 ZA42 South Africa  MG21 Madagascar 
 ZA43 South Africa  CN60 China 
 ZA51 South Africa  CN61 China 
Bmyc3 NL34 USA  CN62 China 
Bmyc4 NL17 USA  CN63 China 
 BE26 USA  CN64 China 
 CN10 China  CN65 China 
 CN11 China  CN66 China 
 CN12 China  CN67 China 
 CN13 China  CN68 China 
 CN14 China  CN69 China 
 CN15 China  CN70 China 
 CN16 China  CN71 China 
 CN17 China  CN72 China 
 CN18 China  CN73 China 
 ZA45 South Africa  CN74 China 
 ZA52 South Africa  CN75 China 
Bmyc5 NL33 USA  CN76 China 
Bmyc6 NL19 South Korea  CN77 China 
 CN20 China  CN78 China 
 CN21 China  CN79 China 
 CN22 China  CN80 China 
 CN23 China  CN81 China 
 CN24 China  CN82 China 
 CN25 China  CN83 China 
Bmyc7 BE3 South Korea  CN84 China 
Bmyc8 NL21 The Netherlands  CN85 China 
Bmyc9 MG9 Madagascar  CN86 China 
Bmyc10 NL1 Mongolia  CN87 China 
 NL2 South Africa  CN88 China 
 NL3 Malaysia  CN89 China 
 NL7 Thailand  CN90 China 
 NL18 The Netherlands  CN91 China 
 NL23 The Netherlands  CN92 China 
 NL24 The Netherlands  CN93 China 
 NL31 The Netherlands  CN94 China 
 BE1 USA  CN95 China 
  
135 Annex 
Node Strain Origin of isolation Node Strain Origin of isolation 
Bmyc10 CN96 China Bmyc10 CN150 China 
 CN97 China  CN151 China 
 CN98 China  CN153 China 
 CN99 China  CN154 China 
 CN100 China  CN155 China 
 CN101 China  CN156 China 
 CN102 China  CN157 China 
 CN103 China  CN158 China 
 CN104 China  CN159 China 
 CN105 China  CN160 China 
 CN106 China  CN161 China 
 CN107 China  CN162 China 
 CN108 China  CN163 China 
 CN109 China  CN164 China 
 CN110 China  CN165 China 
 CN111 China  CN166 China 
 CN112 China  CN167 China 
 CN113 China  CN168 China 
 CN114 China  CN169 China 
 CN115 China  CN170 China 
 CN116 China  CN171 China 
 CN117 China  CN172 China 
 CN118 China  CN173 China 
 CN119 China  CN174 China 
 CN120 China  CN175 China 
 CN121 China  CN176 China 
 CN122 China  CN177 China 
 CN123 China  CN178 China 
 CN124 China  CN179 China 
 CN125 China  CN180 China 
 CN126 China  CN181 China 
 CN127 China  CN182 China 
 CN128 China  ZA1 South Africa 
 CN129 China  ZA2 South Africa 
 CN130 China  ZA3 South Africa 
 CN131 China  ZA4 South Africa 
 CN132 China  ZA5 South Africa 
 CN133 China  ZA6 South Africa 
 CN134 China  ZA7 South Africa 
 CN135 China  ZA8 South Africa 
 CN136 China  ZA10 South Africa 
 CN137 China  ZA11 South Africa 
 CN138 China  ZA12 South Africa 
 CN139 China  ZA15 South Africa 
 CN140 China  ZA16 South Africa 
 CN141 China  ZA17 South Africa 
 CN142 China  ZA18 South Africa 
 CN143 China  ZA20 South Africa 
 CN144 China  ZA21 South Africa 
 CN145 China  ZA22 South Africa 
 CN146 China  ZA23 South Africa 
 CN147 China  ZA24 South Africa 
 CN148 China  ZA25 South Africa 
 CN149 China  ZA26 South Africa 
  
136 Annex 
Node Strain Origin of isolation Node Strain Origin of isolation 
Bmyc10 ZA28 South Africa Bmyc25 GC1237 Spain 
 ZA29 South Africa  ZA9 South Africa 
 ZA31 South Africa  ZA14 South Africa 
 ZA32 South Africa  ZA19 South Africa 
 ZA33 South Africa  ZA35 South Africa 
 ZA34 South Africa  CN26 China 
 ZA36 South Africa  CN27 China 
 ZA38 South Africa  CN28 China 
 ZA41 South Africa  CN29 China 
 ZA44 South Africa  CN30 China 
 ZA46 South Africa  CN31 China 
 ZA47 South Africa  CN32 China 
 ZA48 South Africa  CN33 China 
 ZA49 South Africa  CN34 China 
 ZA50 South Africa  CN35 China 
 ZA53 South Africa  CN36 China 
 ZA54 South Africa  CN37 China 
 ZA55 South Africa  CN38 China 
 ZA56 South Africa  CN39 China 
 ZA57 South Africa  CN40 China 
Bmyc11 NL4 China  CN41 China 
Bmyc12 NL28 South Africa  CN42 China 
 BE6 Russia  CN43 China 
 BE9 China  CN44 China 
Bmyc13 MG8 Madagascar  CN45 China 
 MG12 Madagascar  CN46 China 
 CN183 China  CN47 China 
 CN184 China  CN48 China 
 CN185 China Bmyc26 CN49 China 
 CN186 China  CN50 China 
 CN187 China  CN51 China 
 CN188 China  CN52 China 
 CN189 China  CN53 China 
 CN190 China  CN54 China 
 CN191 China  CN55 China 
 CN192 China  CN56 China 
Bmyc14 MG7 Madagascar  CN57 China 
Bmyc15 NL6 Malaysia  CN58 China 
Bmyc16 MG13 Madagascar  CN59 China 
 MG14 Madagascar  ZA30 South Africa 
 MG15 Madagascar   ZA58 South Africa 
 MG16 Madagascar    
 MG17 Madagascar    
 MG19 Madagascar    
 MG20 Madagascar    
Bmyc17 MG6 Madagascar    
Bmyc18 BE21 USA    
Bmyc19 MG4 Madagascar    
 MG5 Madagascar    
Bmyc20 BE13 USA    
Bmyc21 BE16 USA    
Bmyc22 NL5 Thailand    
Bmyc23 BE15 Philippines    
 
